{"meta":{"query_hash":"244635836ca0","filters":{"venue":"Clinical Breast Cancer"},"cohort_total":133,"direct_labels_cover":0,"predictions_cover":133,"exported":133,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/244635836ca0","api":"https://metacan.xera.ac/api/v1/cohort?venue=Clinical+Breast+Cancer"},"results":[{"id":"W1970601130","doi":"10.3816/cbc.2007.n.057","title":"National Cancer Institute of Canada Clinical Trials Group MAP.3 Trial: Evaluation of Exemestane to Prevent Breast Cancer in Postmenopausal Women","year":2007,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université Laval; Queen's University","funders":"Pfizer; Eli Lilly and Company; Amgen","keywords":"Medicine; Exemestane; Breast cancer; Postmenopausal women; Cancer; Clinical trial; Oncology; Internal medicine; Gynecology; Aromatase","score_opus":0.05930763312104776,"score_gpt":0.4460798653727648,"score_spread":0.38677223225171703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970601130","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99062407,0.0020769872,0.000025262385,0.0012553256,0.0034354131,0.0014020806,0.0010168442,0.000005892529,0.00015814153],"genre_scores_gemma":[0.9960002,0.0010195521,0.00006359272,0.0006052701,0.0016432328,0.00037562905,0.000072987765,0.000029605808,0.00018996086],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9946237,0.000983596,0.0024343284,0.00060295383,0.00088156795,0.00047384747],"domain_scores_gemma":[0.9973688,0.0003307727,0.0008040288,0.000302455,0.0008226945,0.00037124447],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015554902,0.00024570685,0.00088610785,0.00008807636,0.000038537462,0.0000073661163,0.00027050648,0.0004471259,0.0003243828],"category_scores_gemma":[0.0010924309,0.00020693339,0.00022571294,0.00029068228,0.00019198662,0.000013160664,0.00011253021,0.00032483484,0.0000015546648],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15850359,0.005695816,0.094075546,0.0002852022,0.003148212,0.000036931466,0.00017705119,0.007244057,0.08038755,0.000257868,0.023011267,0.6271769],"study_design_scores_gemma":[0.074701294,0.0030596794,0.8938372,0.0008379436,0.00073441607,0.000047617235,0.00014419758,0.00056922366,0.008365825,0.00023063176,0.016397381,0.0010745657],"about_ca_topic_score_codex":0.03681009,"about_ca_topic_score_gemma":0.12918922,"teacher_disagreement_score":0.79976165,"about_ca_system_score_codex":0.00055885635,"about_ca_system_score_gemma":0.00602334,"threshold_uncertainty_score":0.99961156},"labels":[],"label_agreement":null},{"id":"W1971954228","doi":"10.3816/cbc.2004.n.032","title":"Final Results of a Phase II Clinical Trial of Weekly Docetaxel in Combination with Capecitabine in Anthracycline-Pretreated Metastatic Breast Cancer","year":2004,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; University of Alberta","funders":"","keywords":"Medicine; Docetaxel; Capecitabine; Metastatic breast cancer; Internal medicine; Anthracycline; Discontinuation; Progressive disease; Breast cancer; Chemotherapy; Phases of clinical research; Gastroenterology; Cancer; Surgery; Oncology; Colorectal cancer","score_opus":0.09835630191254444,"score_gpt":0.4714088183810935,"score_spread":0.3730525164685491,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971954228","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9832596,0.0004571882,0.000013732259,0.012559308,0.00069079956,0.0015391998,0.0012615238,0.000024647003,0.00019396056],"genre_scores_gemma":[0.99644667,0.0017912171,0.00027521176,0.00037106432,0.0004637088,0.00022725933,0.00013313821,0.000035768044,0.00025595902],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99523467,0.00033660437,0.002882236,0.0006913972,0.00043220108,0.00042287476],"domain_scores_gemma":[0.9972918,0.0006782177,0.0009639261,0.00039892842,0.00040610542,0.00026102594],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012992582,0.00033365627,0.0017780161,0.00029738847,0.00003537842,0.000005457525,0.00017535618,0.00023916221,0.0005504732],"category_scores_gemma":[0.00024420925,0.00025381093,0.0003230107,0.0009588317,0.0006780025,0.00015100293,0.00006257349,0.0006820616,0.0000039073343],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6454203,0.052747227,0.19536646,0.00020097542,0.00073590036,0.00027084257,0.00027515745,0.00027943478,0.00055632,0.00004247126,0.00061828824,0.103486635],"study_design_scores_gemma":[0.554781,0.011569927,0.43084085,0.0008950584,0.00076262065,0.00007311091,0.000050721224,0.00029258736,0.0002735978,0.00008365595,0.0001797527,0.00019710224],"about_ca_topic_score_codex":0.0074387407,"about_ca_topic_score_gemma":0.0060306164,"teacher_disagreement_score":0.2354744,"about_ca_system_score_codex":0.0003567662,"about_ca_system_score_gemma":0.0016088637,"threshold_uncertainty_score":0.9999914},"labels":[],"label_agreement":null},{"id":"W1973960663","doi":"10.3816/cbc.2008.n.035","title":"A Randomized Clinical Trial of Adjuvant Chemotherapy for Radically Resected Locoregional Relapse of Breast Cancer: IBCSG 27-02, BIG 1-02, and NSABP B-37","year":2008,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Centre Hospitalier de l’Université de Montréal","funders":"National Cancer Institute","keywords":"Medicine; Breast cancer; Radiation therapy; Hormonal therapy; Oncology; Mastectomy; Chemotherapy; Randomized controlled trial; Trastuzumab; Internal medicine; Adjuvant; Cancer; Adjuvant therapy; Randomization; Surgery","score_opus":0.05316196569667762,"score_gpt":0.37524060280148075,"score_spread":0.3220786371048031,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973960663","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9814222,0.0058493507,0.00041692186,0.006338199,0.0017470293,0.0020371384,0.002070398,0.000030956584,0.00008779854],"genre_scores_gemma":[0.95377433,0.040057946,0.0006703089,0.0010034083,0.0032808112,0.0007174397,0.00011519735,0.00008199955,0.00029853376],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9950932,0.0006420868,0.0022776912,0.0010577878,0.00042144573,0.00050774816],"domain_scores_gemma":[0.99585104,0.0013161995,0.0010967848,0.0006622049,0.00073563145,0.00033813654],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0017029112,0.000473871,0.0021983946,0.000066695844,0.00013342645,0.000009533234,0.00037693398,0.0006105651,0.000106745414],"category_scores_gemma":[0.0007738689,0.00037023492,0.0011934103,0.00021184063,0.0031217907,0.000011207654,0.0001888518,0.0003283478,0.0000018883443],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.84118164,0.0017476247,0.04852879,0.00010491028,0.0022824632,0.000006896296,0.0000669152,0.000007929692,0.00096430996,0.00005856634,0.010948167,0.094101764],"study_design_scores_gemma":[0.7670337,0.0012632629,0.22315286,0.00025836687,0.00061705016,0.0001634244,0.000032392792,0.000090098125,0.0010264907,0.00017574885,0.005680822,0.0005057613],"about_ca_topic_score_codex":0.00056909584,"about_ca_topic_score_gemma":0.0002073613,"teacher_disagreement_score":0.17462407,"about_ca_system_score_codex":0.000056394463,"about_ca_system_score_gemma":0.0010982215,"threshold_uncertainty_score":0.99987495},"labels":[],"label_agreement":null},{"id":"W1981743837","doi":"10.3816/cbc.2007.n.028","title":"Feasibility and Cardiac Safety of Pegylated Liposomal Doxorubicin plus Trastuzumab in Heavily Pretreated Patients with Recurrent HER2-Overexpressing Metastatic Breast Cancer","year":2007,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Chemotherapy-induced cardiotoxicity and mitigation","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"NIH Clinical Center; National Cancer Institute; National Center for Research Resources; Genentech; European Society for Medical Oncology","keywords":"Medicine; Trastuzumab; Ejection fraction; Metastatic breast cancer; Heart failure; Internal medicine; Cardiotoxicity; Breast cancer; Regimen; Oncology; Cancer; Chemotherapy; Surgery; Cardiology","score_opus":0.03062241698754341,"score_gpt":0.34935280822758746,"score_spread":0.31873039124004404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981743837","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99584067,0.0010066692,0.00007022821,0.00041613294,0.00027771646,0.0012724702,0.0009502445,0.0000419726,0.0001239108],"genre_scores_gemma":[0.9987108,0.00052957877,0.0001768438,0.00019182148,0.00020061704,0.00003314389,0.00008406694,0.00004324341,0.00002989928],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99703693,0.00023372864,0.0010998672,0.00066777697,0.0005110008,0.00045068443],"domain_scores_gemma":[0.99820876,0.00030515782,0.00036207488,0.0003719728,0.00041124932,0.00034079092],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00087957067,0.00032314635,0.0011332157,0.00011079344,0.000065209075,0.00001684344,0.0000733971,0.00022301609,0.00013177402],"category_scores_gemma":[0.00007318167,0.00025434932,0.00021969462,0.0004907506,0.0003646398,0.00017160471,0.000040276485,0.0005675663,0.0000010882253],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015119363,0.0007968667,0.8479572,0.00024808958,0.0003630852,0.000012532546,0.00035419952,0.000035843736,0.0033481119,0.0000047663593,0.000033491437,0.13172647],"study_design_scores_gemma":[0.012416683,0.00039127548,0.9815847,0.0017637525,0.0003722326,0.000031379328,0.00012960652,0.00011108768,0.0028846238,0.000012386323,0.000043398846,0.0002588674],"about_ca_topic_score_codex":0.0016723546,"about_ca_topic_score_gemma":0.00060600165,"teacher_disagreement_score":0.13362753,"about_ca_system_score_codex":0.0008874222,"about_ca_system_score_gemma":0.0005399517,"threshold_uncertainty_score":0.9999909},"labels":[],"label_agreement":null},{"id":"W1989283938","doi":"10.1016/j.clbc.2012.01.002","title":"Experience of Young Women Diagnosed With Breast Cancer Who Undergo Fertility Preservation Consultation","year":2012,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Reproductive Biology and Fertility","field":"Medicine","cited_by":109,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto; CReATe Fertility Centre; Health Sciences Centre","funders":"","keywords":"Medicine; Referral; Fertility preservation; Fertility; Family medicine; Breast cancer; Psychosocial; Gynecology; Cancer; Disease; Oocyte cryopreservation; Infertility; Internal medicine; Population; Pregnancy; Psychiatry","score_opus":0.053947994569379945,"score_gpt":0.3819651529906141,"score_spread":0.3280171584212342,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989283938","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962219,0.000530244,0.0001319026,0.0017024295,0.00045271727,0.0004992445,0.00016964131,0.0000386058,0.00025332742],"genre_scores_gemma":[0.9979882,0.00022663275,0.000056514833,0.000466534,0.0004854199,0.0003932264,0.000017189946,0.000014226972,0.00035203077],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981443,0.00019672058,0.00058752345,0.00046723828,0.0002346808,0.00036948407],"domain_scores_gemma":[0.99804944,0.00031334892,0.0002712641,0.0004826455,0.0006203112,0.00026297316],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007647416,0.00016653915,0.00049128814,0.00002905089,0.000068192276,0.0000056888316,0.00010440282,0.00018789293,0.0008859234],"category_scores_gemma":[0.00052832166,0.00011578191,0.000076432116,0.0002462417,0.0007681355,0.00040025252,0.00004363295,0.00026563325,0.0000070045103],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015404153,0.00062366924,0.9664863,0.000086326705,0.00013102434,0.0000012328805,0.002241354,0.0000036074005,0.00074481097,0.000022516673,0.00014788067,0.014107131],"study_design_scores_gemma":[0.0019791748,0.000130542,0.99610895,0.00013588264,0.00007487293,0.000023146042,0.0006752152,0.00004377741,0.00038089015,0.000043225813,0.00027622553,0.00012810431],"about_ca_topic_score_codex":0.0010752297,"about_ca_topic_score_gemma":0.00014945342,"teacher_disagreement_score":0.02962265,"about_ca_system_score_codex":0.00021555276,"about_ca_system_score_gemma":0.0003009614,"threshold_uncertainty_score":0.97002405},"labels":[],"label_agreement":null},{"id":"W1992079963","doi":"10.3816/cbc.2009.n.020","title":"Prevalence and Severity of Urogenital Symptoms in Postmenopausal Women Receiving Endocrine Therapy for Breast Cancer","year":2009,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Menopause: Health Impacts and Treatments","field":"Medicine","cited_by":79,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Breast cancer; Endocrine system; Genitourinary system; Postmenopausal women; Oncology; Gynecology; Internal medicine; Cancer; Obstetrics; Hormone","score_opus":0.035752135160468934,"score_gpt":0.3954673185564606,"score_spread":0.3597151833959917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992079963","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98893875,0.0034952983,0.0000026345765,0.0049670115,0.00022645855,0.0011585918,0.0011190273,0.00002963473,0.00006262022],"genre_scores_gemma":[0.9898313,0.006689007,0.00011959832,0.0025639227,0.00035944697,0.00020533336,0.000008346262,0.000026127638,0.00019689195],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99784005,0.00008358782,0.00076572614,0.0004828959,0.00022762432,0.0006001109],"domain_scores_gemma":[0.9985525,0.00024989332,0.00023293585,0.00028527385,0.00017429734,0.0005050697],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043641173,0.00024327735,0.00068826566,0.000074833515,0.000056163666,0.000012766325,0.00009594755,0.000119535616,0.0004713339],"category_scores_gemma":[0.00007874165,0.00018470218,0.00003289179,0.00017624187,0.00013769763,0.00013534898,0.000028677738,0.00024130782,0.0000020513387],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005545973,0.0008645782,0.6648988,0.00025692597,0.00014416025,0.000018988856,0.00013954028,0.0000010104751,0.00078685884,0.000012539432,0.000080124315,0.32725048],"study_design_scores_gemma":[0.011427679,0.00404648,0.9830828,0.0004877862,0.000097381744,0.0002264301,0.000014373125,0.00004231943,0.00008207917,0.0001343995,0.00019957019,0.00015873104],"about_ca_topic_score_codex":0.00041504958,"about_ca_topic_score_gemma":0.000037880713,"teacher_disagreement_score":0.32709175,"about_ca_system_score_codex":0.00027688406,"about_ca_system_score_gemma":0.00046092118,"threshold_uncertainty_score":0.7531936},"labels":[],"label_agreement":null},{"id":"W1997732467","doi":"10.3816/cbc.2008.n.061","title":"A BRCA1 Mutation Is Not Associated with Increased Indicators of Oxidative Stress","year":2008,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; London Health Sciences Centre; Women's College Hospital; University of Toronto","funders":"","keywords":"Medicine; Oxidative stress; Mutation; Breast cancer; Genetics; Internal medicine; Oncology; Cancer research; Cancer; Gene; Biology","score_opus":0.02346509766736525,"score_gpt":0.32887464314167764,"score_spread":0.30540954547431237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997732467","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975445,0.00016231214,0.00029053917,0.00039649766,0.00012914198,0.00018465774,0.001003955,0.000013915482,0.00027446172],"genre_scores_gemma":[0.9976862,0.00018713734,0.00037184692,0.0010683264,0.00021867859,0.00006928126,0.00021028043,0.000028259392,0.00015995938],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985831,0.00013696583,0.000436691,0.0004137399,0.00023979078,0.00018971466],"domain_scores_gemma":[0.99878424,0.00009451898,0.00038686462,0.0003138388,0.00030824935,0.000112309004],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020974426,0.00015302768,0.00025942465,0.000058126505,0.000074196294,0.0000057283996,0.00018879474,0.00022884068,0.00017302662],"category_scores_gemma":[0.00021472151,0.00013358117,0.000113191294,0.00029399802,0.0004926679,0.0000067920782,0.00005754693,0.00015345786,0.0000057761326],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013046043,0.00075019384,0.9549453,0.000030205085,0.0011550463,0.000020714297,0.00042972094,0.00035533682,0.014851619,0.00002334616,0.008213833,0.01792007],"study_design_scores_gemma":[0.0021033937,0.00030205137,0.875977,0.000071878625,0.00008797509,0.00002309418,0.000076928925,0.000051210354,0.120294,0.000014197447,0.000773589,0.0002246739],"about_ca_topic_score_codex":0.00016008115,"about_ca_topic_score_gemma":0.00017681274,"teacher_disagreement_score":0.10544238,"about_ca_system_score_codex":0.00007858955,"about_ca_system_score_gemma":0.00078822905,"threshold_uncertainty_score":0.54472816},"labels":[],"label_agreement":null},{"id":"W1997955685","doi":"10.3816/cbc.2006.n.038","title":"Molecular Predictive Factors in Patients Receiving Trastuzumab-Based Chemotherapy for Metastatic Disease","year":2006,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Michael Smith Health Research BC","keywords":"Medicine; Trastuzumab; Oncology; Metastatic breast cancer; Internal medicine; Breast cancer; Chemotherapy; Disease; Cancer","score_opus":0.04488971125718346,"score_gpt":0.41535157853292376,"score_spread":0.3704618672757403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997955685","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99243116,0.000217745,0.0013997986,0.0029009867,0.00031065897,0.0018587625,0.00065659656,0.00005884444,0.00016544694],"genre_scores_gemma":[0.99719465,0.000031881944,0.00036562825,0.0013002037,0.00026327418,0.00050071743,0.00015838082,0.00007626454,0.00010897968],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997394,0.00016455294,0.00073465524,0.00060207734,0.0005708877,0.00053380546],"domain_scores_gemma":[0.99818826,0.0005800346,0.00013846946,0.000382864,0.00029795835,0.00041243705],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005182984,0.00023939776,0.0005693367,0.0001312919,0.00004602567,0.000022178865,0.00016515343,0.00008928574,0.0003387987],"category_scores_gemma":[0.00046797947,0.00020063971,0.0003176345,0.00032875605,0.00021439558,0.00006739608,0.000024008486,0.00038166047,0.000007159077],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003539648,0.0014105485,0.97030884,0.00020142873,0.00008021693,0.000020553021,0.000022586813,0.000418064,0.000050474555,0.000011807355,0.0018160942,0.022119738],"study_design_scores_gemma":[0.009864765,0.00050706696,0.9842064,0.00039042468,0.00011597445,4.8570877e-7,0.000016085683,0.0029712708,0.00029913356,0.00019137579,0.0012479464,0.00018909849],"about_ca_topic_score_codex":0.00039741676,"about_ca_topic_score_gemma":0.000087711196,"teacher_disagreement_score":0.021930639,"about_ca_system_score_codex":0.0005963996,"about_ca_system_score_gemma":0.00097118143,"threshold_uncertainty_score":0.81818503},"labels":[],"label_agreement":null},{"id":"W1998371653","doi":"10.3816/cbc.2003.n.042","title":"A Clinical Trial of Breast Radiation Therapy Versus Breast and Regional Radiation Therapy in Early-Stage Breast Cancer: The MA20 Trial","year":2003,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":53,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario; Queen's University; University of British Columbia; McMaster University; BC Cancer Agency","funders":"","keywords":"Medicine; Breast cancer; Radiation therapy; Oncology; Stage (stratigraphy); Clinical trial; Internal medicine; Randomized controlled trial; Cancer","score_opus":0.06298448628436581,"score_gpt":0.3882923112205548,"score_spread":0.325307824936189,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998371653","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98391944,0.0047515975,0.0000118016815,0.005520101,0.0026734911,0.0015897083,0.001379241,0.00002506432,0.00012957198],"genre_scores_gemma":[0.9463421,0.048314754,0.00002776163,0.0007603142,0.0037229836,0.00056657963,0.00009636829,0.000066027584,0.00010308867],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.995204,0.0011371068,0.0015334367,0.0010845301,0.00047439948,0.0005665315],"domain_scores_gemma":[0.9973417,0.00058200146,0.0008150746,0.00074070116,0.0002779412,0.00024259677],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016102181,0.00051254814,0.00089457113,0.000087861605,0.0001907377,0.00005615399,0.00037893653,0.0005580203,0.00019737985],"category_scores_gemma":[0.00012768104,0.00037838158,0.00055176317,0.00036104186,0.00083792704,0.000039282702,0.00009207307,0.0004826461,0.000005600728],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4192176,0.0012386042,0.26471427,0.000010070963,0.0007360989,0.000003081498,0.00010440978,0.000019786772,0.00009720091,0.00010760132,0.0010502806,0.31270102],"study_design_scores_gemma":[0.27307448,0.0012010679,0.71567994,0.000041997097,0.00008726143,0.00006230528,0.000064156906,0.000015366575,0.000056053024,0.000038280617,0.009338492,0.0003405968],"about_ca_topic_score_codex":0.0019407158,"about_ca_topic_score_gemma":0.00064027956,"teacher_disagreement_score":0.45096567,"about_ca_system_score_codex":0.00014042966,"about_ca_system_score_gemma":0.0008271601,"threshold_uncertainty_score":0.9998668},"labels":[],"label_agreement":null},{"id":"W1999666422","doi":"10.3816/cbc.2000.n.005","title":"Prevalence of BRCA1 and BRCA2 Mutations in Male Breast Cancer Patients in Canada","year":2000,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto; Health Sciences Centre; Queen's University","funders":"","keywords":"Medicine; Breast cancer; Oncology; Internal medicine; BRCA2 Protein; Cancer; Gynecology; Mutation; Demography; Genetics; Gene; Germline mutation; Biology","score_opus":0.011861123139301166,"score_gpt":0.30441687057051,"score_spread":0.2925557474312088,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999666422","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99573207,0.0011825042,0.0000020249056,0.00075499824,0.00023380325,0.00021782363,0.0015861663,0.0000026305206,0.00028796206],"genre_scores_gemma":[0.9951564,0.0034996017,0.00006118686,0.00051404815,0.00014320946,0.000120887744,0.00003140284,0.000019041492,0.0004541911],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99843234,0.00009349962,0.000589368,0.0004649478,0.00016423388,0.00025559744],"domain_scores_gemma":[0.9993394,0.0000486072,0.00012035107,0.00025798436,0.00013012646,0.00010351566],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00015429585,0.00014512452,0.00022532654,0.000039342114,0.000026865677,0.00000703672,0.00018817482,0.00012263992,0.0015078407],"category_scores_gemma":[0.00003396531,0.00014904965,0.000047036265,0.00019976377,0.00018042358,0.0000101987935,0.00005592654,0.00016056799,0.0000026261378],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015125146,0.0001180673,0.9228786,0.00006069936,0.000021390291,0.0000022512106,0.00003533297,0.0010410156,0.00024969486,0.000001993525,0.0008547946,0.0745849],"study_design_scores_gemma":[0.0012938478,0.000032682172,0.9968398,0.00011313377,0.000020283242,0.000014418976,0.00003090089,0.00017385342,0.00029180237,0.000014757092,0.0010058538,0.00016867339],"about_ca_topic_score_codex":0.43713617,"about_ca_topic_score_gemma":0.77619475,"teacher_disagreement_score":0.33905855,"about_ca_system_score_codex":0.0003290941,"about_ca_system_score_gemma":0.0021014137,"threshold_uncertainty_score":0.9994049},"labels":[],"label_agreement":null},{"id":"W2007037292","doi":"10.3816/cbc.2009.n.044","title":"TRIO-012: A Multicenter, Multinational, Randomized, Double-Blind Phase III Study of IMC-1121B Plus Docetaxel Versus Placebo Plus Docetaxel in Previously Untreated Patients With HER2-Negative, Unresectable, Locally Recurrent or Metastatic Breast Cancer","year":2009,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of Alberta","funders":"","keywords":"Docetaxel; Medicine; Metastatic breast cancer; Ramucirumab; Placebo; Internal medicine; Oncology; Chemotherapy; Randomized controlled trial; Breast cancer; Phases of clinical research; Cancer; Pathology","score_opus":0.07878283885101223,"score_gpt":0.4425120655689957,"score_spread":0.36372922671798347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007037292","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98170525,0.0011337462,0.00003055452,0.0016196935,0.00094354147,0.013107935,0.0012308056,0.00007752859,0.00015093132],"genre_scores_gemma":[0.9941907,0.0015614626,0.0001932922,0.00048678424,0.00034360518,0.002143948,0.0003065005,0.000074500575,0.00069918594],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9934639,0.0009042693,0.0024623703,0.001245103,0.0010272056,0.0008971879],"domain_scores_gemma":[0.994126,0.0021697641,0.0012628235,0.00054168125,0.0012751078,0.00062461576],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00095359056,0.0008257023,0.0031818508,0.00042025454,0.00013514597,0.00004676144,0.00036473072,0.00022830778,0.002270751],"category_scores_gemma":[0.0002682881,0.0005492329,0.00042679522,0.0012201504,0.00054390705,0.00033226758,0.00010345642,0.0008789704,0.000011960652],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8934966,0.03750375,0.026802061,0.00018557625,0.0032105162,0.00016139494,0.001450427,0.0010563465,0.000006030092,0.000004814436,0.0006825153,0.035440028],"study_design_scores_gemma":[0.89484096,0.007388646,0.087027036,0.0010296738,0.00452749,0.000028799346,0.0004805139,0.004021514,0.00002333801,0.0000046226364,0.000112193644,0.00051521376],"about_ca_topic_score_codex":0.010103681,"about_ca_topic_score_gemma":0.017482614,"teacher_disagreement_score":0.060224976,"about_ca_system_score_codex":0.0015400869,"about_ca_system_score_gemma":0.0022187184,"threshold_uncertainty_score":0.9996959},"labels":[],"label_agreement":null},{"id":"W2009590627","doi":"10.3816/cbc.2005.n.016","title":"Phase II Study of Pemetrexed in Patients Pretreated with an Anthracycline, a Taxane, and Capecitabine for Advanced Breast Cancer","year":2005,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Shaughnessy Hospital","funders":"Eli Lilly and Company","keywords":"Medicine; Pemetrexed; Neutropenia; Internal medicine; Breast cancer; Capecitabine; Taxane; Metastatic breast cancer; Oncology; Leukopenia; Phases of clinical research; Nausea; Cancer; Gastroenterology; Chemotherapy; Surgery; Cisplatin; Colorectal cancer","score_opus":0.03156877664350103,"score_gpt":0.4302681399291997,"score_spread":0.39869936328569866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009590627","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937856,0.00053893524,0.000004311114,0.0017737104,0.00020680176,0.0023666483,0.0012498274,0.00003772712,0.000036413236],"genre_scores_gemma":[0.99714804,0.00045696247,0.00026772093,0.00054439367,0.00048853585,0.0007021428,0.00010519227,0.00004895297,0.00023806642],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977826,0.000089407644,0.0008378374,0.0006670714,0.00023918526,0.0003839063],"domain_scores_gemma":[0.9984443,0.00017279033,0.00034625575,0.0003067426,0.0004064106,0.00032347118],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019841894,0.0003087159,0.0009484524,0.00015323173,0.000075767915,0.000006464934,0.000101247584,0.00012851528,0.0006503769],"category_scores_gemma":[0.00003108856,0.00022874083,0.000088588386,0.00039141372,0.00020222156,0.00021203342,0.00004801471,0.00024560135,8.923374e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.038831424,0.030064246,0.6021574,0.000055461413,0.0002898387,0.000007568039,0.00028224388,0.000036701415,0.00015000842,8.6917225e-7,0.0002773264,0.32784688],"study_design_scores_gemma":[0.14022058,0.023703111,0.83365583,0.00017604949,0.0007234574,0.00001668616,0.00017928552,0.00058890117,0.00010352695,0.0000030082783,0.00039873843,0.00023083478],"about_ca_topic_score_codex":0.001207361,"about_ca_topic_score_gemma":0.008326407,"teacher_disagreement_score":0.32761604,"about_ca_system_score_codex":0.00018785428,"about_ca_system_score_gemma":0.00021743943,"threshold_uncertainty_score":0.932778},"labels":[],"label_agreement":null},{"id":"W2018810533","doi":"10.3816/cbc.2008.n.049","title":"Extended Adjuvant Endocrine Therapy in Breast Cancer: Current Status and Future Directions","year":2008,"lang":"en","type":"review","venue":"Clinical Breast Cancer","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; University of Toronto; McMaster University","funders":"","keywords":"Letrozole; Medicine; Tamoxifen; Breast cancer; Aromatase inhibitor; Oncology; Interim analysis; Anastrozole; Adjuvant therapy; Internal medicine; Exemestane; Adjuvant; Clinical trial; Randomized controlled trial; Cancer; Gynecology","score_opus":0.0269639738199417,"score_gpt":0.39009444971629276,"score_spread":0.36313047589635106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018810533","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0028779935,0.99268246,5.35968e-7,0.00031787946,0.0022032799,0.00066826167,0.0011679907,0.000026425596,0.000055153505],"genre_scores_gemma":[0.00023256963,0.9946047,0.000010370468,0.0001083267,0.0040871757,0.00045418664,0.00030360767,0.000083423976,0.00011562702],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.997084,0.00036596687,0.00085268414,0.0009526181,0.00016405473,0.00058063056],"domain_scores_gemma":[0.99867153,0.00006553698,0.0003377553,0.00046491678,0.00009968438,0.0003605461],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00013238053,0.0005730398,0.0013954302,0.000098937315,0.00010280542,0.000023349925,0.00022353002,0.00067720684,0.00010036656],"category_scores_gemma":[0.000013428227,0.00041371994,0.0006263437,0.00028351822,0.00026107245,0.000006200011,0.0001480966,0.0010895112,0.000010376344],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013152363,0.0002979557,0.0024976097,0.00048788494,0.0003346112,0.000020968408,0.000007633443,4.1946055e-7,0.0000076054175,0.0000043363248,0.0018947341,0.99431473],"study_design_scores_gemma":[0.0011978698,0.0001152819,0.020130822,0.0017868566,0.00018935179,0.0006322624,0.0000038650896,0.0000019259696,0.0000035206024,0.0000032920939,0.97546166,0.00047326146],"about_ca_topic_score_codex":0.00024502294,"about_ca_topic_score_gemma":0.00006251363,"teacher_disagreement_score":0.99384147,"about_ca_system_score_codex":0.000099674275,"about_ca_system_score_gemma":0.0009776347,"threshold_uncertainty_score":0.99983144},"labels":[],"label_agreement":null},{"id":"W2023764867","doi":"10.1016/j.clbc.2012.01.001","title":"Phase II Interventional Study (N0337) of Capecitabine in Combination With Vinorelbine and Trastuzumab for First- or Second-Line Treatment of HER2-Positive Metastatic Breast Cancer: A North Central Cancer Treatment Group Trial","year":2012,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saskatchewan Cancer Agency","funders":"National Cancer Institute; U.S. Public Health Service; Genentech; National Institutes of Health; Mayo Clinic","keywords":"Vinorelbine; Capecitabine; Medicine; Trastuzumab; Metastatic breast cancer; Internal medicine; Oncology; Breast cancer; Cancer; Phases of clinical research; Chemotherapy; Colorectal cancer","score_opus":0.10161322086899631,"score_gpt":0.4580827344753126,"score_spread":0.3564695136063163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2023764867","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98142207,0.0018237936,0.00006984749,0.0017256708,0.00048636412,0.00623501,0.008208971,0.000018594792,0.000009709939],"genre_scores_gemma":[0.99276006,0.0014194757,0.00017597165,0.000049968603,0.0007800653,0.0041146073,0.00025928646,0.00006544553,0.00037513077],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961931,0.00027088445,0.0015671486,0.0006632444,0.0005856442,0.00071994384],"domain_scores_gemma":[0.99747473,0.0006261388,0.00056582515,0.00035020278,0.00047932487,0.000503765],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005156058,0.0004610636,0.0016593429,0.00022125346,0.00010123108,0.000013300971,0.00013060009,0.00011291187,0.0020311847],"category_scores_gemma":[0.000053925865,0.00030221403,0.00034460018,0.0004811492,0.00039229693,0.00019435376,0.000055599812,0.00021370356,7.619102e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.21851927,0.10922541,0.4784179,0.0004808726,0.0022668922,0.000030062145,0.0019997738,0.000037032685,0.0000445165,0.000018587352,0.00012285137,0.18883681],"study_design_scores_gemma":[0.28470117,0.102959454,0.60824776,0.00070371083,0.001400618,0.00006328277,0.0004579861,0.0005470576,0.00018114423,0.0000061498877,0.0004783273,0.0002533657],"about_ca_topic_score_codex":0.010188073,"about_ca_topic_score_gemma":0.07804325,"teacher_disagreement_score":0.18858345,"about_ca_system_score_codex":0.0020376407,"about_ca_system_score_gemma":0.0011193004,"threshold_uncertainty_score":0.999943},"labels":[],"label_agreement":null},{"id":"W2028929628","doi":"10.3816/cbc.2003.s.005","title":"Use of the Anti-idiotype Breast Cancer Vaccine 11D10 in Conjunction with Autologous Stem Cell Transplantation in Patients with Metastatic Breast Cancer","year":2003,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Breast cancer; Oncology; Metastatic breast cancer; Internal medicine; Cancer; Autologous stem-cell transplantation; Transplantation; Immune system; Immunology","score_opus":0.018533008153167323,"score_gpt":0.2724970796983422,"score_spread":0.25396407154517486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028929628","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99427414,0.0022531233,0.000024010764,0.0006504888,0.0008875439,0.0006957277,0.0011744065,0.000024098144,0.000016449827],"genre_scores_gemma":[0.9966994,0.0022688066,0.000017301221,0.00040848527,0.000018995224,0.00012856841,0.00003538666,0.000043700653,0.00037933892],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969396,0.00108519,0.00088585145,0.00049404986,0.000115491355,0.0004798211],"domain_scores_gemma":[0.99842745,0.0003669665,0.00050309265,0.00040715042,0.0002620689,0.00003328949],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038871364,0.00034663948,0.00076641666,0.00014483395,0.000109488836,0.000016889662,0.00022722542,0.00025890244,0.0008985572],"category_scores_gemma":[0.000010550314,0.00021105132,0.00012429053,0.0005944492,0.0003405057,0.0002854216,0.000021012913,0.0006292931,0.000011390953],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019102016,0.00093504897,0.94542825,0.00009261514,0.00035600524,0.000005830751,0.0002529538,0.00069584965,0.0032021387,0.000019840169,0.000108455315,0.02980101],"study_design_scores_gemma":[0.01043175,0.00027095288,0.9845354,0.0005732373,0.00023419152,0.00014285931,0.00008418232,0.000007118998,0.0027906639,0.0000027503993,0.00063340476,0.00029350846],"about_ca_topic_score_codex":0.0052686757,"about_ca_topic_score_gemma":0.0034392779,"teacher_disagreement_score":0.039107144,"about_ca_system_score_codex":0.00018258531,"about_ca_system_score_gemma":0.0006060173,"threshold_uncertainty_score":0.98385715},"labels":[],"label_agreement":null},{"id":"W2030801788","doi":"10.3816/cbc.2002.n.030","title":"Phase III Trial Comparing Granulocyte Colony-Stimulating Factor to Leridistim in the Prevention of Neutropenic Complications in Breast Cancer Patients Treated with Docetaxel/Doxorubicin/Cyclophosphamide: Results of the BCIRG 004 Trial","year":2002,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation; Hôpital Saint-Luc; Lakeridge Health; Hôtel-Dieu de Montréal","funders":"","keywords":"Medicine; Docetaxel; Cyclophosphamide; Breast cancer; Oncology; Granulocyte colony-stimulating factor; Internal medicine; Cancer; Clinical trial; Neutropenia; Chemotherapy; Surgery","score_opus":0.08372146754036529,"score_gpt":0.3929917698684891,"score_spread":0.3092703023281238,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030801788","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914464,0.00006755788,0.000011359581,0.0023981745,0.00045585062,0.004381243,0.0007130377,0.00002167485,0.00050475245],"genre_scores_gemma":[0.9983361,0.00010323558,0.0000163541,0.0003355401,0.00028360053,0.0007203708,0.00003804008,0.000028759481,0.00013803794],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964667,0.00039984772,0.0017813153,0.0005269518,0.0004754868,0.00034972717],"domain_scores_gemma":[0.9977585,0.00037096773,0.0007794913,0.0006350181,0.0003112222,0.00014477687],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045656174,0.0002679672,0.0009632101,0.00011902308,0.00013642087,0.000021396278,0.00034426796,0.00012774016,0.0002149249],"category_scores_gemma":[0.00011062308,0.00016379403,0.00028797632,0.0012161615,0.0002729795,0.000121404955,0.000077978795,0.0005430507,0.0000047227422],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.36663613,0.0074195964,0.61013705,0.00005838142,0.00015052433,0.0000032152354,0.0004063721,0.0014261504,0.00041410667,0.000020754527,0.00065381126,0.012673875],"study_design_scores_gemma":[0.3270172,0.0016428173,0.6695861,0.0005937347,0.00021386507,0.000007089598,0.000028708788,0.0004296252,0.00010524932,0.0000032779783,0.00024098286,0.00013136005],"about_ca_topic_score_codex":0.0059899436,"about_ca_topic_score_gemma":0.0040790155,"teacher_disagreement_score":0.05944904,"about_ca_system_score_codex":0.0003167913,"about_ca_system_score_gemma":0.00026213497,"threshold_uncertainty_score":0.9055043},"labels":[],"label_agreement":null},{"id":"W2034693832","doi":"10.1016/j.clbc.2011.04.001","title":"Concurrent Bevacizumab with a Sequential Regimen of Doxorubicin and Cyclophosphamide Followed by Docetaxel and Capecitabine as Neoadjuvant Therapy for HER2− Locally Advanced Breast Cancer: A Phase II Trial of the NSABP Foundation Research Group","year":2011,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"National Cancer Institute","keywords":"Medicine; Docetaxel; Bevacizumab; Capecitabine; Breast cancer; Mucositis; Internal medicine; Oncology; Cyclophosphamide; Chemotherapy; Metastatic breast cancer; Regimen; Cancer; Surgery; Colorectal cancer","score_opus":0.07746102873287435,"score_gpt":0.44725440114429066,"score_spread":0.3697933724114163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034693832","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.987146,0.003932501,0.000050630668,0.003860267,0.00072113634,0.0034708735,0.00067649904,0.000018026247,0.00012403441],"genre_scores_gemma":[0.9904295,0.0073934756,0.00009921895,0.0003225962,0.0004191598,0.0008819782,0.00004206807,0.000039628405,0.00037236663],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99752825,0.00022883817,0.0008151613,0.0005900492,0.00042917693,0.00040854805],"domain_scores_gemma":[0.9980739,0.00035263758,0.00047061805,0.00032893606,0.0005205286,0.000253389],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007453062,0.00027486443,0.000864072,0.000067952045,0.00017385717,0.000011010793,0.00016340548,0.00016277481,0.00047673614],"category_scores_gemma":[0.00004222274,0.0001722509,0.0001877816,0.00028111044,0.0010924784,0.000121286634,0.000097259595,0.00035263936,5.9598676e-7],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.41335753,0.0050069764,0.011957479,0.00016393834,0.0009156137,0.000008825024,0.00066735776,0.0000012540452,0.017802333,0.00014683598,0.0019096679,0.5480622],"study_design_scores_gemma":[0.8406132,0.047739632,0.07356015,0.0013047282,0.0016366794,0.00021692987,0.0003480546,0.00023667394,0.015092913,0.00032282056,0.018366337,0.00056187104],"about_ca_topic_score_codex":0.0034094402,"about_ca_topic_score_gemma":0.00067646336,"teacher_disagreement_score":0.5475003,"about_ca_system_score_codex":0.0001734757,"about_ca_system_score_gemma":0.0008214139,"threshold_uncertainty_score":0.7024188},"labels":[],"label_agreement":null},{"id":"W2035191914","doi":"10.1016/j.clbc.2014.07.006","title":"Cysteine Rhenium Colloid: A Novel Radiocolloid for Identifying Sentinel Lymph Nodes in Breast Cancer Surgery","year":2014,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; University of Toronto; London Health Sciences Centre; Lawson Health Research Institute; Sunnybrook Health Science Centre; Western University","funders":"Canadian Institutes of Health Research; London Health Sciences Centre","keywords":"Medicine; Breast cancer; Sentinel node; Sentinel lymph node; Odds ratio; Lymph node; Lymph; Cancer; Axillary Lymph Node Dissection; Internal medicine; Oncology; Surgery; Radiology; Pathology","score_opus":0.04488594632235332,"score_gpt":0.3584862492876611,"score_spread":0.3136003029653078,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035191914","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9816367,0.0025407434,0.0017614014,0.008271288,0.002435608,0.00080624915,0.0022929115,0.000071315284,0.00018375649],"genre_scores_gemma":[0.99074167,0.001366365,0.00032914357,0.0020930932,0.0031034518,0.0015585487,0.00016007543,0.0001029979,0.00054466753],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99663246,0.00013715042,0.0010467076,0.0011266479,0.00027000334,0.0007870371],"domain_scores_gemma":[0.9980323,0.00040390526,0.00039261972,0.0005806978,0.00034415943,0.00024635682],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008789189,0.0004810319,0.0009300112,0.00011816896,0.00018135665,0.000060522372,0.0003294537,0.00035528754,0.000072673036],"category_scores_gemma":[0.00019036577,0.00044593558,0.000570319,0.00032355695,0.0003000545,0.000020935873,0.00023895949,0.00017440596,0.000011518118],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017868703,0.00059774803,0.95315737,0.00019979442,0.0005119165,0.0000027749716,0.000030134694,0.00012758432,0.021736396,0.00004113529,0.005840417,0.015967855],"study_design_scores_gemma":[0.006215185,0.000019329193,0.9836345,0.0003709258,0.00018897258,0.00010174445,0.00005564234,0.00031441177,0.0011956769,0.000033131244,0.007271997,0.00059849786],"about_ca_topic_score_codex":0.0013850646,"about_ca_topic_score_gemma":0.00047667592,"teacher_disagreement_score":0.030477114,"about_ca_system_score_codex":0.00021180259,"about_ca_system_score_gemma":0.00048340537,"threshold_uncertainty_score":0.99979925},"labels":[],"label_agreement":null},{"id":"W2036145991","doi":"10.3816/cbc.2000.s.012","title":"Epirubicin in Breast Cancer: Present and Future","year":2000,"lang":"en","type":"review","venue":"Clinical Breast Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Epirubicin; Medicine; Anthracycline; Breast cancer; Oncology; Trastuzumab; Taxane; Internal medicine; Cyclophosphamide; Chemotherapy; Metastatic breast cancer; Doxorubicin; Cancer; Pharmacology","score_opus":0.08241764795168283,"score_gpt":0.4870500193305227,"score_spread":0.4046323713788399,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036145991","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00024834828,0.9772361,6.1466366e-8,0.016119681,0.0018165491,0.0014432966,0.0018971966,0.000055590648,0.0011831751],"genre_scores_gemma":[0.000047896927,0.97726595,0.000010720272,0.0015601201,0.017482413,0.000879282,0.00014120835,0.00009785172,0.0025145425],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963825,0.00032251253,0.0013821253,0.0010482713,0.00026260197,0.0006020336],"domain_scores_gemma":[0.9981917,0.00035744172,0.00036254092,0.00047105487,0.000075077754,0.00054219237],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00030646328,0.0006687359,0.0035028858,0.00015726162,0.000054617136,0.000022834036,0.00020544225,0.0008774517,0.010908657],"category_scores_gemma":[0.000003929725,0.00048015965,0.0007235812,0.0004704547,0.00030471684,0.00006704821,0.00010174928,0.0013972509,0.00009331168],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006652409,0.00055019255,0.009709244,0.004857874,0.0006100632,0.00019130211,0.000022316983,3.4876035e-7,6.461394e-8,0.000005469627,0.03231211,0.9510758],"study_design_scores_gemma":[0.0032281291,0.00011537632,0.036102675,0.009173558,0.003343843,0.00091928616,0.0000064194187,0.0000046707933,5.9819236e-8,0.000008443669,0.9467006,0.0003969712],"about_ca_topic_score_codex":0.0017637481,"about_ca_topic_score_gemma":0.000309169,"teacher_disagreement_score":0.9506788,"about_ca_system_score_codex":0.0005601144,"about_ca_system_score_gemma":0.0015823244,"threshold_uncertainty_score":0.999765},"labels":[],"label_agreement":null},{"id":"W2037157828","doi":"10.1016/j.clbc.2013.08.011","title":"Safety and Efficacy of Everolimus With Exemestane vs. Exemestane Alone in Elderly Patients With HER2-Negative, Hormone Receptor–Positive Breast Cancer in BOLERO-2","year":2013,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":112,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Sunnybrook Health Science Centre; University of Toronto","funders":"Novartis Pharmaceuticals Corporation; Pfizer","keywords":"Exemestane; Medicine; Everolimus; Breast cancer; Oncology; Internal medicine; Hormone receptor; Aromatase; Cancer; Gynecology","score_opus":0.009278835326357648,"score_gpt":0.29030447419732325,"score_spread":0.2810256388709656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037157828","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910856,0.001120382,0.00007765364,0.0044627916,0.00013912808,0.0021523968,0.0007610025,0.0000572924,0.00014378663],"genre_scores_gemma":[0.9951111,0.0019133729,0.0012568219,0.0007944156,0.00020308446,0.00034792852,0.00005430928,0.00012411407,0.00019485231],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9958433,0.00022625139,0.0013524643,0.0010643717,0.0007022753,0.00081136276],"domain_scores_gemma":[0.9968758,0.000566213,0.00061326986,0.00058341346,0.0008674758,0.0004938205],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00032448434,0.0006147909,0.0016720043,0.00022027137,0.00006607875,0.00002466077,0.00022155228,0.0002878138,0.0008007568],"category_scores_gemma":[0.00007202429,0.000448456,0.00011045789,0.00092842156,0.0011545754,0.00052574574,0.00010255322,0.00088589726,0.0000127642625],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.051632203,0.0014542472,0.6972159,0.000103746315,0.00031579201,0.00003263195,0.00049324706,0.0001156204,0.0002500658,0.000011137947,0.00006593342,0.24830945],"study_design_scores_gemma":[0.03665011,0.002062334,0.95734006,0.0025517894,0.00015443093,0.00008428402,0.00023313607,0.000061892526,0.00009766408,0.000032967633,0.0002018912,0.0005294398],"about_ca_topic_score_codex":0.008351845,"about_ca_topic_score_gemma":0.0027818724,"teacher_disagreement_score":0.26012412,"about_ca_system_score_codex":0.00060380547,"about_ca_system_score_gemma":0.0005425698,"threshold_uncertainty_score":0.99979675},"labels":[],"label_agreement":null},{"id":"W2040839197","doi":"10.3816/cbc.2008.n.028","title":"Basal Breast Cancer Molecular Subtype Predicts for Lower Incidence of Axillary Lymph Node Metastases in Primary Breast Cancer","year":2008,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":146,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Breast cancer; Medicine; Lymphovascular invasion; Oncology; Lumpectomy; Internal medicine; Axilla; Progesterone receptor; Pathology; Lymph node; Cancer; Stage (stratigraphy); Immunohistochemistry; Biopsy; Estrogen receptor; Mastectomy; Metastasis; Biology","score_opus":0.021425438747411815,"score_gpt":0.32080971284967447,"score_spread":0.29938427410226265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040839197","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9671563,0.011124496,0.00021685752,0.00412481,0.0012770873,0.000789988,0.015128332,0.000046422163,0.00013570933],"genre_scores_gemma":[0.98207265,0.011425024,0.00044465982,0.003240591,0.0012274013,0.0010771748,0.00024321995,0.00012702741,0.000142257],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9957633,0.00021183824,0.001243423,0.0013518722,0.0005344379,0.00089515204],"domain_scores_gemma":[0.99732447,0.0001829172,0.000564314,0.000846084,0.0007392359,0.0003429646],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000432791,0.0006640334,0.0011541621,0.00012449316,0.00016448573,0.000018330573,0.0005921938,0.00045745197,0.0003122454],"category_scores_gemma":[0.00009766544,0.0005996402,0.0005842846,0.00044103808,0.0009345103,0.000044683777,0.00042530632,0.00027978997,0.000007396415],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0060667973,0.0011273971,0.95511836,0.00026864113,0.0010998814,0.00009245914,0.00007122435,0.0008265763,0.010449193,0.000017584374,0.0047946144,0.020067267],"study_design_scores_gemma":[0.0051432084,0.00012295716,0.9885981,0.00046225596,0.00036307905,0.0003683352,0.000038758026,0.00007443056,0.0030920762,0.000034646528,0.0010378881,0.00066424743],"about_ca_topic_score_codex":0.0030730392,"about_ca_topic_score_gemma":0.0007594022,"teacher_disagreement_score":0.033479754,"about_ca_system_score_codex":0.00038231118,"about_ca_system_score_gemma":0.001893583,"threshold_uncertainty_score":0.9996455},"labels":[],"label_agreement":null},{"id":"W2044133019","doi":"10.3816/cbc.2010.n.011","title":"A Phase II Neoadjuvant Trial of Sequential Nanoparticle Albumin-Bound Paclitaxel Followed by 5-Fluorouracil/Epirubicin/Cyclophosphamide in Locally Advanced Breast Cancer","year":2010,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":65,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Epirubicin; Trastuzumab; Breast cancer; Paclitaxel; Internal medicine; Chemotherapy; Oncology; Cyclophosphamide; Clinical endpoint; Metastatic breast cancer; Febrile neutropenia; Anthracycline; Gastroenterology; Neutropenia; Cancer; Clinical trial","score_opus":0.01581447337146425,"score_gpt":0.3545481122868749,"score_spread":0.33873363891541064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044133019","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98852336,0.0019091006,0.00003272482,0.0036312516,0.0023357747,0.0008688547,0.002557242,0.000035369063,0.00010634062],"genre_scores_gemma":[0.9955036,0.0013144524,0.00015492874,0.00074459094,0.0011371459,0.0006132282,0.0001225203,0.000078886354,0.00033066724],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99600327,0.00018196064,0.0014288379,0.001138553,0.00042168054,0.000825709],"domain_scores_gemma":[0.997843,0.0001240344,0.00055350485,0.0007691287,0.0003376467,0.0003726513],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00056906056,0.00054300315,0.0009807401,0.00006065749,0.00018639967,0.000029711091,0.00046347664,0.00045459415,0.0003830524],"category_scores_gemma":[0.00017491981,0.00048704754,0.00046265355,0.00032188557,0.0007460627,0.00003622687,0.00035627652,0.00051447295,0.000011404915],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09031645,0.0067192423,0.04479714,0.000048434853,0.00058642146,0.000028969536,0.0001389469,0.00005342754,0.65678644,0.000028009525,0.005475526,0.19502099],"study_design_scores_gemma":[0.5151799,0.007364368,0.14920716,0.00058723846,0.0009467616,0.00019784352,0.00033081236,0.00019650502,0.2949016,0.0002272647,0.028300123,0.0025604493],"about_ca_topic_score_codex":0.0024620052,"about_ca_topic_score_gemma":0.004544225,"teacher_disagreement_score":0.42486343,"about_ca_system_score_codex":0.00012660341,"about_ca_system_score_gemma":0.0007430692,"threshold_uncertainty_score":0.9997581},"labels":[],"label_agreement":null},{"id":"W2048550637","doi":"10.1016/j.clbc.2011.07.006","title":"Routine Cardiac Evaluation in Patients With Early-Stage Breast Cancer Before Adjuvant Chemotherapy","year":2011,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Medicine; Breast cancer; Stage (stratigraphy); Oncology; Adjuvant chemotherapy; Chemotherapy; Internal medicine; Adjuvant; Cancer","score_opus":0.023924683254184564,"score_gpt":0.31827265526639004,"score_spread":0.29434797201220547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048550637","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958056,0.0006705203,0.000010850146,0.00061585096,0.0005293186,0.0006613303,0.0013780989,0.000022775528,0.00030562427],"genre_scores_gemma":[0.9973232,0.00047316443,0.00009595871,0.0005893547,0.00065752503,0.00046794914,0.00016463558,0.00006445579,0.00016374477],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99770856,0.00016093446,0.00050578214,0.00077942613,0.00038531286,0.00045998424],"domain_scores_gemma":[0.9986068,0.000015984637,0.00024085715,0.0005203662,0.0004526101,0.00016339499],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00038416692,0.00035258345,0.00049864646,0.000047066023,0.00007382297,0.000014535602,0.00021885592,0.00022620252,0.00060127943],"category_scores_gemma":[0.00001888658,0.00026940464,0.00018202075,0.0001936689,0.00024811173,0.000018209861,0.00010658159,0.00019814172,0.0000138769265],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023391226,0.00047540755,0.9046274,0.000012165705,0.0003801802,0.0000012714501,0.00020042046,0.000012813425,0.000020449303,0.000005388538,0.00031767413,0.0916077],"study_design_scores_gemma":[0.006204032,0.00026945965,0.9920216,0.00009684327,0.00016001714,0.0000018099801,0.00004373781,0.000013974344,0.00016716594,0.000014617463,0.0006879007,0.0003188265],"about_ca_topic_score_codex":0.0030070834,"about_ca_topic_score_gemma":0.0017349466,"teacher_disagreement_score":0.09128887,"about_ca_system_score_codex":0.0001905911,"about_ca_system_score_gemma":0.00030259992,"threshold_uncertainty_score":0.9999758},"labels":[],"label_agreement":null},{"id":"W2051872169","doi":"10.3816/cbc.2008.n.060","title":"Insulin-Lowering Effects of Metformin in Women with Early Breast Cancer","year":2008,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":228,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Mount Sinai Hospital; Lunenfeld-Tanenbaum Research Institute; Statistics Canada; University of Toronto","funders":"","keywords":"Medicine; Metformin; Breast cancer; Oncology; Internal medicine; Insulin; Cancer; Diabetes mellitus; Gynecology; Endocrinology","score_opus":0.011421107830951092,"score_gpt":0.28709030809243263,"score_spread":0.27566920026148156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051872169","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9441804,0.054759655,0.000028665227,0.0000569049,0.00048467432,0.00022802594,0.00014692699,0.00001189318,0.00010281402],"genre_scores_gemma":[0.92270315,0.075327665,0.00006089187,0.00069171435,0.0007615621,0.00028347466,0.0000060191887,0.000040937768,0.00012460754],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9981345,0.000080982834,0.0005437799,0.0005221971,0.00022243765,0.0004961207],"domain_scores_gemma":[0.9989437,0.00005490012,0.0002112058,0.00040415558,0.00015911057,0.00022696001],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002775267,0.00024495888,0.0005561193,0.00005569549,0.00004523552,0.000008417425,0.00026573858,0.00023332024,0.00016175819],"category_scores_gemma":[0.00004401302,0.00019786842,0.00011824199,0.00024281951,0.00031639275,0.000014269588,0.00009936041,0.00024055441,0.0000057737084],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029946787,0.00042875472,0.29668716,0.00020443115,0.00032358017,0.000032702836,0.00027783154,0.000098246,0.009789475,0.0000079517495,0.0006932357,0.68846196],"study_design_scores_gemma":[0.003814604,0.00032119485,0.9626326,0.0002456559,0.000047159505,0.00004452752,0.000028895,0.00000842263,0.015399111,0.000018689005,0.017064428,0.00037471313],"about_ca_topic_score_codex":0.0005987408,"about_ca_topic_score_gemma":0.00022975726,"teacher_disagreement_score":0.6880872,"about_ca_system_score_codex":0.00006492362,"about_ca_system_score_gemma":0.00043135116,"threshold_uncertainty_score":0.806884},"labels":[],"label_agreement":null},{"id":"W2051878959","doi":"10.3816/cbc.2010.n.023","title":"Phase III Trials of Eribulin Mesylate (E7389) in Extensively Pretreated Patients With Locally Recurrent or Metastatic Breast Cancer","year":2010,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":107,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Eisai Canada","keywords":"Eribulin; Medicine; Metastatic breast cancer; Capecitabine; Internal medicine; Oncology; Anthracycline; Breast cancer; Taxane; Clinical endpoint; Cancer; Randomized controlled trial; Colorectal cancer","score_opus":0.08561982642156016,"score_gpt":0.46778926604650717,"score_spread":0.382169439624947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051878959","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895259,0.0005237635,0.000012997226,0.0030142374,0.0014949319,0.0019879928,0.003312182,0.000045755573,0.00008224429],"genre_scores_gemma":[0.9960813,0.0010696182,0.00022534002,0.0009861498,0.00045028096,0.00046826593,0.00018172011,0.000058726477,0.00047858042],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9959332,0.00037977812,0.0020259542,0.00071040564,0.0004288311,0.0005218551],"domain_scores_gemma":[0.9964524,0.0008479437,0.00093911757,0.00040898353,0.00088216114,0.00046942386],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010408574,0.00042829165,0.0021793568,0.00017882673,0.0000467729,0.000013858361,0.00017696929,0.00021769521,0.0093478365],"category_scores_gemma":[0.00030925547,0.00026046607,0.00032770023,0.00057719345,0.00046104897,0.00012439796,0.000058932794,0.0007635176,0.000017748209],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.17898147,0.012770887,0.38519505,0.00022007126,0.0018413212,0.00017015483,0.0002010465,0.000018276518,0.0012510685,0.000012887092,0.003921921,0.41541585],"study_design_scores_gemma":[0.13736372,0.004472576,0.8500146,0.00092367,0.0028627247,0.000092792514,0.000032743275,0.00028858118,0.0005649915,0.000025951505,0.0029309625,0.0004266448],"about_ca_topic_score_codex":0.0016956409,"about_ca_topic_score_gemma":0.0035298401,"teacher_disagreement_score":0.4648196,"about_ca_system_score_codex":0.00019236586,"about_ca_system_score_gemma":0.0014451094,"threshold_uncertainty_score":0.99998474},"labels":[],"label_agreement":null},{"id":"W2051989799","doi":"10.3816/cbc.2009.n.005","title":"Survival Outcomes for Patients with Metastatic Triple-Negative Breast Cancer: Implications for Clinical Practice and Trial Design","year":2009,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":472,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Credit Valley Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Breast cancer; Chemotherapy; Internal medicine; Metastatic breast cancer; Clinical trial; Surgery; Cancer","score_opus":0.08327100169660151,"score_gpt":0.4464181951761753,"score_spread":0.3631471934795738,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051989799","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.67022395,0.0044926973,0.06840879,0.16721582,0.0074826884,0.03443499,0.047185376,0.0002586949,0.00029697584],"genre_scores_gemma":[0.95576066,0.0031837455,0.025841545,0.0055280607,0.0023961717,0.0065942844,0.00036799858,0.00010313963,0.00022438218],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99715877,0.00031259874,0.00093468995,0.00095538853,0.00018296012,0.0004555779],"domain_scores_gemma":[0.995421,0.0023386355,0.0005763019,0.00043906597,0.00096890517,0.00025610055],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008500701,0.00038460604,0.00083959714,0.000033545588,0.00025593277,0.00004637576,0.00022021648,0.00019214328,0.0000128244765],"category_scores_gemma":[0.0013076178,0.0002821434,0.0003419436,0.00012548495,0.00033769547,0.00003169086,0.00006346835,0.00016163774,0.000001307466],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19508865,0.0035804738,0.47196424,0.000036084653,0.0029332803,7.931764e-7,0.000040604904,0.000020970978,0.000013843282,0.00024240652,0.010471702,0.31560692],"study_design_scores_gemma":[0.07449152,0.0027509928,0.9158084,0.000033295153,0.001139157,0.000009086311,0.00004961176,0.000013358659,0.000012002106,0.00039495708,0.004922674,0.00037495582],"about_ca_topic_score_codex":0.00010018553,"about_ca_topic_score_gemma":0.00012209392,"teacher_disagreement_score":0.44384414,"about_ca_system_score_codex":0.00007147051,"about_ca_system_score_gemma":0.00048570102,"threshold_uncertainty_score":0.99996305},"labels":[],"label_agreement":null},{"id":"W2061136852","doi":"10.1016/s1526-8209(11)70099-4","title":"Commentary on “Prevalence of BRCA1 and BRCA2 Mutations in Male Breast Cancer Patients in Canada”","year":2000,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Breast cancer; Oncology; BRCA2 Protein; Male breast cancer; Gynecology; Internal medicine; Cancer; Mutation; Demography; Genetics; Germline mutation; Gene; Biology","score_opus":0.012467432172761314,"score_gpt":0.30934350909109176,"score_spread":0.29687607691833046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061136852","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99241716,0.00062114367,0.000001112937,0.004072273,0.0002456086,0.00022239225,0.002179866,0.0000025256104,0.0002379032],"genre_scores_gemma":[0.99224997,0.0027610387,0.000038340237,0.004404595,0.00017627951,0.0001064376,0.00006123767,0.000019014333,0.00018310685],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99848026,0.00011187629,0.00054775464,0.00044737902,0.00017002891,0.00024267258],"domain_scores_gemma":[0.99937016,0.0000652394,0.000110632274,0.00026596457,0.00008709697,0.000100920755],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00014944538,0.00015188452,0.00022619321,0.000043871045,0.000031739295,0.0000061553924,0.0001839922,0.000107606254,0.0012909719],"category_scores_gemma":[0.000020208863,0.00015495271,0.00004771914,0.00016810927,0.00017536404,0.000008406629,0.000053369244,0.0001837364,0.0000027430206],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027480247,0.00020772492,0.9175094,0.000046689875,0.000026236243,0.0000028840418,0.000035572153,0.001348697,0.00016245407,0.0000017058495,0.006246957,0.074136876],"study_design_scores_gemma":[0.0016036475,0.000062729996,0.99519956,0.00014996137,0.000019680532,0.0000081471,0.00003432641,0.00014643739,0.00033439472,0.00001238768,0.002258774,0.00016992356],"about_ca_topic_score_codex":0.39949727,"about_ca_topic_score_gemma":0.7094813,"teacher_disagreement_score":0.30998403,"about_ca_system_score_codex":0.00041160043,"about_ca_system_score_gemma":0.0009998935,"threshold_uncertainty_score":0.999622},"labels":[],"label_agreement":null},{"id":"W2063413445","doi":"10.3816/cbc.2002.n.025","title":"Bisphosphonates: Biological Response Modifiers in Breast Cancer","year":2002,"lang":"en","type":"review","venue":"Clinical Breast Cancer","topic":"Bone health and treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Bisphosphonate; Bone pain; Bone resorption; Osteonecrosis of the jaw; Breast cancer; Osteoclast; Internal medicine; Bone remodeling; Osteoporosis; Cancer; Oncology; Pharmacology; Endocrinology","score_opus":0.19873458699543295,"score_gpt":0.48398274573362987,"score_spread":0.2852481587381969,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063413445","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013334028,0.98808706,5.072596e-7,0.004498815,0.0014445565,0.0016935526,0.0026174686,0.00011404819,0.00021057832],"genre_scores_gemma":[0.0009511612,0.9916447,0.000043152228,0.0025474501,0.00053679413,0.0013589186,0.000117533775,0.0001196859,0.0026806293],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99395275,0.000865366,0.0023125384,0.0014011916,0.00040161805,0.0010665425],"domain_scores_gemma":[0.99598444,0.001268862,0.0006292163,0.0008240686,0.00016153695,0.0011318563],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010502154,0.0008455408,0.004342934,0.00027593737,0.00008851282,0.000023126506,0.00031923281,0.00170432,0.0043645096],"category_scores_gemma":[0.0002339649,0.0005539846,0.0012526298,0.00091130467,0.0004551715,0.000064610336,0.00013034615,0.0019867152,0.0006860966],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032579591,0.00095243537,0.028094959,0.0027790836,0.00038975882,0.0004626421,0.000012623822,4.4186447e-7,4.4467196e-8,0.0000054120674,0.0053033866,0.95874125],"study_design_scores_gemma":[0.0033610326,0.00020853436,0.12973838,0.02096071,0.00094629754,0.0007948992,0.000006407882,0.00001534234,3.8582506e-8,0.000010299467,0.84345984,0.0004981996],"about_ca_topic_score_codex":0.0024975582,"about_ca_topic_score_gemma":0.00015124449,"teacher_disagreement_score":0.9582431,"about_ca_system_score_codex":0.0013385941,"about_ca_system_score_gemma":0.002518332,"threshold_uncertainty_score":0.9996912},"labels":[],"label_agreement":null},{"id":"W2065575837","doi":"10.3816/cbc.2004.n.003","title":"Adjuvant Radiation Therapy After Breast-Conserving Surgery in Elderly Women with Early-Stage Breast Cancer: Controversy or Consensus?","year":2004,"lang":"en","type":"review","venue":"Clinical Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Breast cancer; Mastectomy; Radiation therapy; Breast-conserving surgery; Population; Randomized controlled trial; Clinical trial; Disease; Stage (stratigraphy); Cancer; Oncology; Internal medicine","score_opus":0.03575336091794758,"score_gpt":0.3542707294309918,"score_spread":0.31851736851304424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065575837","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.053180482,0.9340748,0.000004927416,0.0012023768,0.0009215875,0.0014757117,0.009050775,0.00006197487,0.000027340113],"genre_scores_gemma":[0.049114306,0.9445816,0.000025933688,0.00070956,0.0014882286,0.003266882,0.00022966917,0.00022991716,0.0003538564],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99409175,0.0005970237,0.0017944566,0.0018230663,0.0004421259,0.0012515658],"domain_scores_gemma":[0.9963895,0.0006311246,0.001167037,0.0010390083,0.000318448,0.00045486947],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0006638517,0.0012819902,0.0034725685,0.00021531282,0.00013816706,0.00010229767,0.0004642554,0.0009681281,0.0007611822],"category_scores_gemma":[0.000064859036,0.0008959022,0.00079969876,0.00054482254,0.0006174295,0.000024349545,0.00020576321,0.00074903015,0.000030366098],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008986492,0.00044602674,0.07736848,0.002420773,0.0022123624,0.00021794657,0.00008138262,0.000011840399,0.0000017843469,0.000001726027,0.00061646994,0.90763474],"study_design_scores_gemma":[0.009647944,0.00056316337,0.5618962,0.021276798,0.0010376062,0.0014736976,0.00012193424,0.0000017918836,0.000003876057,0.000009059546,0.40166318,0.0023047496],"about_ca_topic_score_codex":0.0044010067,"about_ca_topic_score_gemma":0.0027796596,"teacher_disagreement_score":0.90532994,"about_ca_system_score_codex":0.0011246189,"about_ca_system_score_gemma":0.0049765115,"threshold_uncertainty_score":0.9999932},"labels":[],"label_agreement":null},{"id":"W2066920175","doi":"10.1016/j.clbc.2013.09.001","title":"Contemporary Systemic Therapy for Male Breast Cancer","year":2013,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Male Breast Health Studies","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Michael Smith Health Research BC","keywords":"Medicine; Tamoxifen; Breast cancer; Internal medicine; Oncology; Trastuzumab; Male breast cancer; Aromatase; Population; Tolerability; Gynecology; Cohort; Adjuvant therapy; Cancer; Adverse effect","score_opus":0.09822054884637849,"score_gpt":0.4268114209734858,"score_spread":0.3285908721271073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2066920175","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8283434,0.027546128,0.00012416927,0.12567711,0.0038351926,0.0074497373,0.0022290086,0.00036400044,0.0044312384],"genre_scores_gemma":[0.96778136,0.0044962117,0.00015896895,0.013222597,0.004237044,0.00398826,0.000027009704,0.00009000926,0.0059985174],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99681836,0.0001301071,0.0012565828,0.0007531136,0.0003566891,0.00068515434],"domain_scores_gemma":[0.9968919,0.00054763106,0.0003988713,0.0005877001,0.0009524597,0.0006214275],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006096297,0.00037493464,0.0011710577,0.00007750446,0.00016868993,0.000032308417,0.00022592714,0.00030088087,0.004900127],"category_scores_gemma":[0.00007962096,0.00027544858,0.00042178232,0.00020928385,0.0003357191,0.00017451892,0.00007990322,0.00043439903,0.00029896194],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017831067,0.00033242666,0.6618598,0.00065482536,0.00029570263,0.00000924952,0.000057300906,0.0000014447517,0.00016156663,0.000029834506,0.20274533,0.1320694],"study_design_scores_gemma":[0.006849771,0.00022727238,0.96473014,0.0010458621,0.000093312534,0.0009175386,0.00015449231,0.00021474512,0.000010689895,0.000040648585,0.025403535,0.00031196597],"about_ca_topic_score_codex":0.0033604952,"about_ca_topic_score_gemma":0.000045219283,"teacher_disagreement_score":0.30287036,"about_ca_system_score_codex":0.0002323516,"about_ca_system_score_gemma":0.0012018483,"threshold_uncertainty_score":0.9999698},"labels":[],"label_agreement":null},{"id":"W2068559390","doi":"10.3816/cbc.2004.n.025","title":"Quality of Life in Women with Advanced Breast Cancer Treated with Docetaxel","year":2004,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Docetaxel; Medicine; Quality of life (healthcare); Nausea; Breast cancer; Internal medicine; Adverse effect; Oncology; Vomiting; Clinical trial; Cancer; Nursing","score_opus":0.0456254794329484,"score_gpt":0.42091801635756826,"score_spread":0.37529253692461984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068559390","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98984706,0.00081105315,0.00000867338,0.007454408,0.00013961781,0.0006165395,0.00048264104,0.00005759157,0.00058241974],"genre_scores_gemma":[0.9947458,0.0012593196,0.00014334336,0.0026142043,0.0003535139,0.0005071888,0.00001581819,0.000044490604,0.0003163201],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99762756,0.000106253465,0.0008573773,0.00057175325,0.00032144095,0.0005156174],"domain_scores_gemma":[0.99836946,0.00015720961,0.00037169905,0.00035089315,0.00027062293,0.00048012153],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003045384,0.0003064228,0.0011908108,0.00009563323,0.000036247508,0.0000069047633,0.00012444831,0.00016449057,0.0016659878],"category_scores_gemma":[0.000021019183,0.00020064402,0.00010833826,0.00057053287,0.00045881292,0.0001227318,0.00003124002,0.00040010776,0.000010518172],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.058171485,0.0019777063,0.8903866,0.0001614186,0.00061954325,0.00005664615,0.00020658222,0.00050880166,0.00057196105,0.000026769114,0.00015638156,0.0471561],"study_design_scores_gemma":[0.036162432,0.0012219972,0.9608149,0.000506886,0.0001886234,0.00006836725,0.00013222257,0.000005377015,0.0001425434,0.000030000907,0.00047756106,0.00024912655],"about_ca_topic_score_codex":0.007007781,"about_ca_topic_score_gemma":0.004039771,"teacher_disagreement_score":0.07042826,"about_ca_system_score_codex":0.0007223124,"about_ca_system_score_gemma":0.0015752857,"threshold_uncertainty_score":0.99960464},"labels":[],"label_agreement":null},{"id":"W2071269150","doi":"10.1016/j.clbc.2014.12.006","title":"Three-Arm Randomized Phase III Trial: Quality Aloe and Placebo Cream Versus Powder as Skin Treatment During Breast Cancer Radiation Therapy","year":2014,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Phytochemistry and biological activity of medicinal plants","field":"Agricultural and Biological Sciences","cited_by":72,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services; Ontario Institute for Cancer Research; BC Cancer Agency","funders":"Canadian Cancer Society","keywords":"Medicine; Regimen; Randomized controlled trial; Placebo; Dry skin; Acute toxicity; Breast cancer; Clinical endpoint; Toxicity; Sunburn; Internal medicine; Dermatology; Cancer; Pathology","score_opus":0.06983728022871558,"score_gpt":0.3803238545652436,"score_spread":0.31048657433652804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071269150","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98986375,0.00050315756,0.0000021962003,0.0071904524,0.00058506214,0.0009382914,0.00049855455,0.00007586712,0.00034268314],"genre_scores_gemma":[0.9918119,0.004008537,0.0000042211664,0.0006099241,0.003100975,0.00027934348,0.000082503284,0.0000024608526,0.00010015805],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99737245,0.00051932345,0.0007108304,0.0006945104,0.00029629777,0.00040659],"domain_scores_gemma":[0.99596477,0.0030666606,0.00040171487,0.00011411825,0.0000769233,0.00037580793],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013696946,0.00033366447,0.0010510879,0.0000089384675,0.0002635715,0.00006025255,0.00020724132,0.00030904764,0.002436008],"category_scores_gemma":[0.00026272386,0.00012008872,0.00036559656,0.00012642419,0.00041205637,0.0001304792,0.0000508509,0.00025794117,0.000026872274],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5174222,0.0011755793,0.0019901977,0.0000055457895,0.00014692557,0.0000019254746,0.000013935057,7.453891e-7,0.005176763,0.0000098835335,0.00009750569,0.4739588],"study_design_scores_gemma":[0.7855138,0.002277737,0.20558183,0.00007967598,0.00014385892,0.000028434419,0.000052816267,0.000118168355,0.0017530378,0.00054342736,0.0034127065,0.00049450074],"about_ca_topic_score_codex":0.004873943,"about_ca_topic_score_gemma":0.0008660114,"teacher_disagreement_score":0.47346428,"about_ca_system_score_codex":0.00008976072,"about_ca_system_score_gemma":0.00004062095,"threshold_uncertainty_score":0.9984759},"labels":[],"label_agreement":null},{"id":"W2072712535","doi":"10.3816/cbc.2008.s.014","title":"Basal and Triple-Negative Breast Cancers: Impact on Clinical Decision-Making and Novel Therapeutic Options","year":2008,"lang":"en","type":"review","venue":"Clinical Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Breast cancer; Subtyping; Triple negative; Oncology; Clinical decision making; Triple-negative breast cancer; Internal medicine; Bioinformatics; Cancer; Intensive care medicine; Biology","score_opus":0.08261093959511503,"score_gpt":0.4686493979078485,"score_spread":0.3860384583127334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072712535","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012631346,0.99138314,0.00017726717,0.00023722489,0.0011424758,0.00091763184,0.004739917,0.00003359999,0.00010560924],"genre_scores_gemma":[0.011396812,0.9841714,0.0004009056,0.00075549923,0.002641252,0.00032984721,0.00010860009,0.0001342427,0.0000614349],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99528867,0.00042772834,0.0016026788,0.001751617,0.00031272558,0.00061655324],"domain_scores_gemma":[0.9958561,0.0019070663,0.0008013762,0.00078649144,0.0002233103,0.0004256579],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000491278,0.0010087406,0.0025882572,0.00012036467,0.00031179027,0.000069726084,0.0003641881,0.0009946628,0.000090175716],"category_scores_gemma":[0.00031250514,0.00070196827,0.0012692277,0.00026873473,0.0011984118,0.000015364156,0.00042260854,0.0008818466,0.000016811326],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009351338,0.00033720885,0.0050175413,0.00023047302,0.0024521167,0.000012581385,0.000014911914,0.000005036599,3.574446e-7,0.00002003677,0.0029009706,0.98807365],"study_design_scores_gemma":[0.00976182,0.00206224,0.42649055,0.022363028,0.0045408546,0.0038964362,0.000083687366,0.000050393668,7.2450825e-7,0.0003342585,0.52744764,0.0029683765],"about_ca_topic_score_codex":0.0002451191,"about_ca_topic_score_gemma":0.0001970265,"teacher_disagreement_score":0.9851053,"about_ca_system_score_codex":0.0003113242,"about_ca_system_score_gemma":0.0015016621,"threshold_uncertainty_score":0.99954313},"labels":[],"label_agreement":null},{"id":"W2076902557","doi":"10.3816/cbc.2000.n.013","title":"Internet Usage Among Women with Breast Cancer: An Exploratory Study","year":2000,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Complementary and Alternative Medicine Studies","field":"Medicine","cited_by":122,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Grey Nuns Community Hospital","funders":"Hope Foundation","keywords":"The Internet; Medicine; Breast cancer; Family medicine; Cancer; Medical information; Internet access; Internal medicine; World Wide Web","score_opus":0.0735965495379866,"score_gpt":0.39662678512393285,"score_spread":0.32303023558594623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076902557","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99622077,0.00018526574,0.000011787742,0.0013493742,0.00040184936,0.00066314184,0.00022996611,0.00009546416,0.0008423776],"genre_scores_gemma":[0.99267983,0.00037338442,0.000019626317,0.001484401,0.0024458712,0.0004975477,0.000012784155,0.000041344276,0.002445194],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975595,0.00020995589,0.0006306103,0.000685822,0.00043398904,0.00048011696],"domain_scores_gemma":[0.9986032,0.00012321056,0.00013458359,0.00044355314,0.00017397373,0.0005214797],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005275157,0.0003104638,0.0007593245,0.00006123345,0.000103623555,0.000021407002,0.00022020753,0.000027579772,0.02483663],"category_scores_gemma":[0.000010383328,0.00020653348,0.00007917446,0.00022910174,0.0005281482,0.00025218658,0.00009022028,0.0004688264,0.000052024363],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028164003,0.0012827917,0.77241236,0.000022619599,0.0005741847,0.00014218004,0.00271381,0.000011979278,0.0000027909664,0.0000016681416,0.0011373862,0.21888185],"study_design_scores_gemma":[0.006242774,0.0029876148,0.97646433,0.0003401046,0.00025031113,0.00006543737,0.0070282687,0.0000888557,0.0000032538196,0.0000075022103,0.0062696533,0.00025188268],"about_ca_topic_score_codex":0.0018489261,"about_ca_topic_score_gemma":0.0030982494,"teacher_disagreement_score":0.21862996,"about_ca_system_score_codex":0.00021772273,"about_ca_system_score_gemma":0.00017040114,"threshold_uncertainty_score":0.9760548},"labels":[],"label_agreement":null},{"id":"W2077037832","doi":"10.1016/j.clbc.2013.10.016","title":"Randomized Phase II Trial of the Cyclin-Dependent Kinase Inhibitor Dinaciclib (MK-7965) Versus Capecitabine in Patients With Advanced Breast Cancer","year":2013,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":153,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Merck","keywords":"Medicine; Capecitabine; Oncology; Breast cancer; Randomized controlled trial; Internal medicine; Cancer; Colorectal cancer","score_opus":0.020141642534631344,"score_gpt":0.34714416053795083,"score_spread":0.3270025180033195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077037832","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98297477,0.0006048027,0.000022731218,0.006465147,0.0033848945,0.0055604433,0.00071920716,0.00007835169,0.00018963379],"genre_scores_gemma":[0.9945513,0.00033025912,0.00021991113,0.00082812837,0.0014447834,0.002057454,0.00003394544,0.0001203025,0.00041393057],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9945728,0.00045939718,0.0020746216,0.0009873607,0.0010948529,0.0008109654],"domain_scores_gemma":[0.9956139,0.00082028715,0.0010821486,0.0011191678,0.0008877214,0.00047678538],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00071021845,0.0006379546,0.0022662873,0.0001544913,0.00015692062,0.000025836296,0.000470214,0.00030427618,0.0022231296],"category_scores_gemma":[0.00042312435,0.00038411943,0.0006500065,0.0006852327,0.0012292736,0.00046618175,0.00027146772,0.0009508395,0.000022185362],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.766441,0.004497262,0.02904811,0.00006999733,0.0004461997,0.0000061336295,0.0001158161,0.000086061715,0.00024197875,0.000022084947,0.00012342993,0.19890197],"study_design_scores_gemma":[0.8377685,0.0018618488,0.15759577,0.0008721678,0.0004719827,0.000009660178,0.000104565945,0.00007627709,0.0002527585,0.00006646404,0.0004982018,0.00042180854],"about_ca_topic_score_codex":0.0011631994,"about_ca_topic_score_gemma":0.00036159248,"teacher_disagreement_score":0.19848016,"about_ca_system_score_codex":0.00059282983,"about_ca_system_score_gemma":0.00074766466,"threshold_uncertainty_score":0.99986106},"labels":[],"label_agreement":null},{"id":"W2081331508","doi":"10.3816/cbc.2005.s.003","title":"Evaluating Bone Mass and Bone Quality in Patients with Breast Cancer","year":2005,"lang":"en","type":"review","venue":"Clinical Breast Cancer","topic":"Bone health and osteoporosis research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation","funders":"","keywords":"Medicine; Bone remodeling; Bone mineral; Osteoporosis; Cancellous bone; Bone density; Internal medicine; Endocrinology; Cortical bone; Breast cancer; Cancer; Pathology","score_opus":0.21201654103952186,"score_gpt":0.5646748522907314,"score_spread":0.3526583112512096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081331508","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012080155,0.9807724,8.074832e-7,0.0025251592,0.0003123112,0.0026008342,0.0015380388,0.000044206703,0.0001261166],"genre_scores_gemma":[0.0011586399,0.99423856,0.00029973898,0.0011865856,0.0014837191,0.00076299394,0.0001823372,0.00012369746,0.0005637151],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99283516,0.00092472776,0.0027245556,0.0012651149,0.0012394075,0.001011008],"domain_scores_gemma":[0.9958147,0.0008189817,0.0009141473,0.0007484934,0.00061459775,0.0010890876],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0033322992,0.0006200899,0.004100564,0.00023278946,0.000110964036,0.00004214673,0.00017732069,0.0007923063,0.0012634732],"category_scores_gemma":[0.0003649786,0.00041904734,0.0003899402,0.00065720925,0.00041580715,0.00012721696,0.00015944258,0.0023253972,0.000053404852],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001226433,0.00043218792,0.17645256,0.011438784,0.000110489884,0.0000150486285,0.000010802939,4.1478586e-7,5.6332247e-8,0.000002389924,0.00036925758,0.8099416],"study_design_scores_gemma":[0.00666053,0.00035208758,0.7425266,0.030052159,0.00070695457,0.000082962484,0.000009062748,0.000016931837,1.356861e-8,0.000003196717,0.21912263,0.00046686735],"about_ca_topic_score_codex":0.0020593614,"about_ca_topic_score_gemma":0.0011244109,"teacher_disagreement_score":0.8094747,"about_ca_system_score_codex":0.0008695751,"about_ca_system_score_gemma":0.0038746838,"threshold_uncertainty_score":0.9999763},"labels":[],"label_agreement":null},{"id":"W2081584264","doi":"10.3816/cbc.2004.n.030","title":"Survival Benefit with Capecitabine/Docetaxel Versus Docetaxel Alone: Analysis of Therapy in a Randomized Phase III Trial","year":2004,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame","funders":"","keywords":"Docetaxel; Capecitabine; Medicine; Chemotherapy; Internal medicine; Oncology; Vinorelbine; Hazard ratio; Randomized controlled trial; Breast cancer; Surgery; Cancer; Confidence interval; Colorectal cancer; Cisplatin","score_opus":0.06626576878013078,"score_gpt":0.4365959759552752,"score_spread":0.3703302071751444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081584264","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920236,0.001490146,0.000043791897,0.0028380863,0.0010723232,0.0016363417,0.00019118562,0.00003342013,0.0006711192],"genre_scores_gemma":[0.99442536,0.0034057295,0.00010888521,0.00048278732,0.00078578107,0.00039682258,0.000108885855,0.000028841168,0.0002568885],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99722683,0.00019436934,0.0012752552,0.00054416456,0.00038600853,0.00037339146],"domain_scores_gemma":[0.9976015,0.0011018197,0.00043969473,0.00037683593,0.00022255273,0.00025758444],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00093841506,0.00030437385,0.003026443,0.00033126381,0.000036487665,0.000010169938,0.00014165974,0.00019296138,0.002256634],"category_scores_gemma":[0.00008973058,0.00020474472,0.0009938391,0.0012412221,0.0004823478,0.00007563584,0.000025831163,0.00035569194,0.000006630051],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9538747,0.0050676786,0.0111478735,0.0000136840235,0.010006495,0.00006954716,0.0001643209,0.0004336032,0.0000966679,0.00010250059,0.00005921106,0.018963719],"study_design_scores_gemma":[0.9590756,0.0028521607,0.029309362,0.00006427799,0.0078061703,0.0000065853183,0.0000377251,0.00019469603,0.00009758174,0.000043629152,0.00030851783,0.00020366142],"about_ca_topic_score_codex":0.0044587166,"about_ca_topic_score_gemma":0.0041564326,"teacher_disagreement_score":0.018760057,"about_ca_system_score_codex":0.00022913939,"about_ca_system_score_gemma":0.0006553866,"threshold_uncertainty_score":0.99865544},"labels":[],"label_agreement":null},{"id":"W2091553548","doi":"10.1016/j.clbc.2014.03.003","title":"Juvenile Papillomatosis: A Case Report and Literature Review","year":2014,"lang":"en","type":"review","venue":"Clinical Breast Cancer","topic":"Breast Lesions and Carcinomas","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queensway-Carleton Hospital; Ottawa Hospital","funders":"","keywords":"Papillomatosis; Medicine; Apocrine; Atypia; Papilloma; Metaplasia; Pathology; Dermatology; Duct (anatomy)","score_opus":0.059216333683049426,"score_gpt":0.4315251327352076,"score_spread":0.3723087990521582,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091553548","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00001480422,0.9953256,0.0000028815577,0.0017984108,0.00062656996,0.0011962886,0.00029723012,0.000082326624,0.0006558571],"genre_scores_gemma":[0.000022693648,0.99137855,0.000101508595,0.0032682528,0.002157414,0.00046888055,0.00022070344,0.00010454729,0.0022774702],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99558455,0.00037941278,0.0022798574,0.0010793277,0.0002896687,0.00038717035],"domain_scores_gemma":[0.9964344,0.00032527224,0.00091467483,0.0013017067,0.00029140894,0.00073252746],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013950046,0.00061576604,0.0049809176,0.00009796515,0.0000945835,0.000047653775,0.00014807092,0.000845396,0.0006671474],"category_scores_gemma":[0.00034177635,0.00039308547,0.001495896,0.0004777934,0.00022136094,0.000056574154,0.00017721816,0.0013989017,0.00010285093],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012797864,0.00008379196,0.0001066645,0.11744365,0.00021285123,0.087860785,0.0000034407453,8.2722573e-10,7.5972775e-9,0.000016206382,0.026886642,0.76737314],"study_design_scores_gemma":[0.00021436445,0.000031717263,0.00023681327,0.19903523,0.0028698898,0.362516,0.0000011822862,4.2936674e-7,2.4132483e-9,0.0000023675852,0.4349155,0.00017650827],"about_ca_topic_score_codex":0.00003243286,"about_ca_topic_score_gemma":0.0000065252098,"teacher_disagreement_score":0.76719666,"about_ca_system_score_codex":0.00008678221,"about_ca_system_score_gemma":0.00081553345,"threshold_uncertainty_score":0.9998521},"labels":[],"label_agreement":null},{"id":"W2096797962","doi":"10.1016/j.clbc.2014.09.002","title":"Comparison of Toxicity Experienced by Older Versus Younger Patients Enrolled in Breast Cancer Clinical Trials","year":2014,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Breast cancer; Discontinuation; Clinical trial; Internal medicine; Adverse effect; Hormonal therapy; Chemotherapy; Cancer; Toxicity; Geriatric oncology; Hormone therapy; Clinical endpoint; Oncology; Radiation therapy","score_opus":0.08454920997608419,"score_gpt":0.47579596784393613,"score_spread":0.39124675786785196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096797962","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99286383,0.0011337992,0.00006772377,0.0015425856,0.0025606067,0.00052329677,0.0010713167,0.000020381483,0.00021643717],"genre_scores_gemma":[0.9962442,0.0010646007,0.00006305476,0.00086109014,0.0011658216,0.00035752667,0.00012217795,0.000044759337,0.00007675573],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99429953,0.0012943032,0.002475252,0.001017351,0.000387688,0.00052588544],"domain_scores_gemma":[0.9969582,0.0008208497,0.0009595527,0.0006188714,0.00036359506,0.00027890972],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0019974718,0.00041803622,0.0017740243,0.000050873154,0.00008427757,0.000019789975,0.00041491218,0.0005204545,0.00041700364],"category_scores_gemma":[0.00096189306,0.00034165426,0.00059400214,0.0002116725,0.0005904153,0.00001928517,0.00025635175,0.00033955096,0.000011623537],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00752447,0.0019764279,0.90440565,0.000020940719,0.0004196935,4.0444033e-7,0.00010657118,0.000019748284,0.0012194519,0.0000064164874,0.013149657,0.071150556],"study_design_scores_gemma":[0.018464118,0.00039585063,0.97406393,0.00011055413,0.00018051776,0.0000012669105,0.00013543956,0.00007817018,0.0020778088,0.0000067836836,0.004079449,0.00040611887],"about_ca_topic_score_codex":0.00066315255,"about_ca_topic_score_gemma":0.00042686483,"teacher_disagreement_score":0.07074444,"about_ca_system_score_codex":0.00010820104,"about_ca_system_score_gemma":0.0002291901,"threshold_uncertainty_score":0.99990356},"labels":[],"label_agreement":null},{"id":"W2103707992","doi":"10.3816/cbc.2009.n.019","title":"Phase I Study of Nonpegylated Liposomal Doxorubicin plus Trastuzumab in Patients with HER2-Positive Breast Cancer","year":2009,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Trastuzumab; Medicine; Breast cancer; Doxorubicin; Oncology; Internal medicine; Cancer; Chemotherapy","score_opus":0.037202716011297425,"score_gpt":0.43187942971137866,"score_spread":0.3946767137000812,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2103707992","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928052,0.00020846986,0.0000072819407,0.002919678,0.00029417482,0.0024636283,0.0008549072,0.00005999202,0.00038666427],"genre_scores_gemma":[0.99791974,0.000121496465,0.00003657749,0.00091803016,0.00052594277,0.00018221608,0.000046759564,0.00006972524,0.00017950548],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9951991,0.00035900006,0.001388889,0.0009796391,0.0012509725,0.00082244375],"domain_scores_gemma":[0.9972054,0.00023720734,0.00034963898,0.0006992043,0.0009173665,0.0005912191],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00059552904,0.00043702996,0.0013712692,0.00025151076,0.00007443216,0.000025841124,0.00029781304,0.00028193562,0.0011951054],"category_scores_gemma":[0.00007298303,0.00033376866,0.00017758546,0.0011205553,0.00035897826,0.00017224287,0.000083219216,0.0011746987,0.000022338218],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028701684,0.022818033,0.7501715,0.00007306363,0.0003559002,0.00019434057,0.0008127352,0.00010939706,0.00011105143,0.0000033681072,0.00064303743,0.19600588],"study_design_scores_gemma":[0.055110585,0.013010752,0.9292996,0.0011860235,0.00026125927,0.00004017546,0.00030696343,0.00025594427,0.000109170345,0.0000056368767,0.00007997273,0.00033393243],"about_ca_topic_score_codex":0.0055611217,"about_ca_topic_score_gemma":0.0015936114,"teacher_disagreement_score":0.19567195,"about_ca_system_score_codex":0.0011154391,"about_ca_system_score_gemma":0.00159405,"threshold_uncertainty_score":0.9999114},"labels":[],"label_agreement":null},{"id":"W2106968573","doi":"10.1016/j.clbc.2012.07.006","title":"Treatment and Outcomes of Primary Breast Lymphoma","year":2012,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"BC Cancer Agency","keywords":"Medicine; Breast cancer; Lymphoma; Stage (stratigraphy); Internal medicine; Univariate analysis; Chemotherapy; Surgery; Radiation therapy; Population; Aggressive lymphoma; Oncology; Cancer; Multivariate analysis; Rituximab","score_opus":0.04203916915508224,"score_gpt":0.36359237589206034,"score_spread":0.32155320673697807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106968573","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913415,0.0021840374,0.000001254636,0.003922497,0.00035621194,0.00028249048,0.00024349395,0.00003068293,0.0016378417],"genre_scores_gemma":[0.9966001,0.0012837832,0.00017429556,0.0009609574,0.00042123123,0.00008965054,0.000019647325,0.000019293277,0.00043105247],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987964,0.000044535824,0.0004723663,0.0002446957,0.00015431498,0.00028767227],"domain_scores_gemma":[0.99881524,0.00027861798,0.00013408599,0.00030378584,0.00006595034,0.00040233147],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001325331,0.00019547515,0.0007363049,0.000036541795,0.000034044977,0.000006345801,0.00004060809,0.00011454757,0.00027965705],"category_scores_gemma":[0.00001852395,0.000119766984,0.0002519148,0.00007093108,0.0001847883,0.00008171733,0.00004651106,0.000034335837,0.000036451933],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002409588,0.002395798,0.6583265,0.000025415502,0.0003680176,0.000007149116,0.00003401462,4.4240718e-8,0.000016116492,0.00014337669,0.00022329696,0.33821929],"study_design_scores_gemma":[0.0076857833,0.0002759199,0.98568976,0.000066632674,0.00057175354,0.00051120104,0.000020481893,0.0000028673337,0.00008829879,0.000009651669,0.004969286,0.00010836604],"about_ca_topic_score_codex":0.0004171056,"about_ca_topic_score_gemma":0.000009417059,"teacher_disagreement_score":0.33811092,"about_ca_system_score_codex":0.00030878145,"about_ca_system_score_gemma":0.00019472763,"threshold_uncertainty_score":0.4883956},"labels":[],"label_agreement":null},{"id":"W2108152062","doi":"10.1016/j.clbc.2015.09.006","title":"A Uridine Glucuronosyltransferase 2B7 Polymorphism Predicts Epirubicin Clearance and Outcomes in Early-Stage Breast Cancer","year":2015,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Chemotherapy-induced cardiotoxicity and mitigation","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa; University of Alberta","funders":"Indiana Clinical and Translational Sciences Institute; National Institutes of Health; Alberta Cancer Foundation; Pfizer","keywords":"Epirubicin; Medicine; Internal medicine; Gastroenterology; Breast cancer; Toxicity; Single-nucleotide polymorphism; Oncology; Genotype; Endocrinology; Cancer; Biology; Genetics","score_opus":0.046572645488112414,"score_gpt":0.3573558239700384,"score_spread":0.310783178481926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2108152062","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97631234,0.0011169753,0.00005126238,0.020251092,0.00060022157,0.0006459751,0.00064775196,0.0000967978,0.00027757182],"genre_scores_gemma":[0.9916636,0.0015514198,0.000058959075,0.0047274516,0.00098374,0.000116738775,0.000016093409,0.000059250306,0.0008227511],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99751633,0.00014528749,0.00076333364,0.00066533184,0.00042694373,0.00048274803],"domain_scores_gemma":[0.99840915,0.0001622051,0.00013530006,0.00041119277,0.0001776385,0.0007044989],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00065410364,0.0003260554,0.0009263861,0.00011475886,0.000052547228,0.000031944954,0.00013143627,0.00032624733,0.00025111306],"category_scores_gemma":[0.00010202784,0.00028024663,0.00022787265,0.0003028156,0.00033194237,0.00023736896,0.0000442161,0.0006636599,0.000023148803],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026467955,0.00040601837,0.94534886,0.000088672976,0.0001896984,0.000081486294,0.00043298383,0.00003097617,0.0036172457,0.000056652734,0.0005438199,0.04655677],"study_design_scores_gemma":[0.010172522,0.00020296527,0.9841823,0.00046690844,0.00013266243,0.00015137793,0.00007483121,0.00021650243,0.0024244778,0.00005765514,0.0016185789,0.0002992211],"about_ca_topic_score_codex":0.0037200605,"about_ca_topic_score_gemma":0.00088791846,"teacher_disagreement_score":0.04625755,"about_ca_system_score_codex":0.000260332,"about_ca_system_score_gemma":0.0005403449,"threshold_uncertainty_score":0.99996495},"labels":[],"label_agreement":null},{"id":"W2118299978","doi":"10.3816/cbc.2005.n.043","title":"The Global Breast Cancer Burden: Variations in Epidemiology and Survival","year":2005,"lang":"en","type":"review","venue":"Clinical Breast Cancer","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":587,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"Sanofi","keywords":"Medicine; Breast cancer; Epidemiology; Oncology; Internal medicine; Cancer","score_opus":0.27353927788110155,"score_gpt":0.5376905810052716,"score_spread":0.26415130312417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118299978","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000039339408,0.97570515,0.000025432635,0.019098649,0.0017314205,0.00076334446,0.0015168032,0.000047770078,0.001072089],"genre_scores_gemma":[0.00040070337,0.9902311,0.00011350235,0.0018684798,0.006512303,0.00040849796,0.000047871734,0.00004361079,0.00037393888],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99442935,0.0009964099,0.00229833,0.0010042327,0.00035236715,0.000919305],"domain_scores_gemma":[0.9950789,0.002671799,0.0007603934,0.0006825542,0.00024385095,0.00056250946],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0031774205,0.0005607322,0.0032790913,0.00006456867,0.00020330556,0.00004079767,0.00044240212,0.00087486126,0.00053715764],"category_scores_gemma":[0.000884046,0.00035195396,0.0007384567,0.0006467664,0.00064036733,0.000103216335,0.00025012353,0.0014256694,0.00006393514],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016743202,0.00004252538,0.06526375,0.000598096,0.0002918915,0.00002547637,0.000006657268,0.0000062232066,3.5057173e-9,0.0009798913,0.002407267,0.93021077],"study_design_scores_gemma":[0.00078859326,0.000042585933,0.17774808,0.008308696,0.0011197017,0.0007823583,0.000021250522,0.00007261649,6.572889e-10,0.00019845375,0.8106126,0.00030501932],"about_ca_topic_score_codex":0.006322949,"about_ca_topic_score_gemma":0.006405963,"teacher_disagreement_score":0.9299058,"about_ca_system_score_codex":0.0011338302,"about_ca_system_score_gemma":0.0023887996,"threshold_uncertainty_score":0.99989325},"labels":[],"label_agreement":null},{"id":"W2123478677","doi":"10.3816/cbc.2007.n.030","title":"Method of Detection of New Contralateral Primary Breast Cancer in Younger Versus Older Women","year":2007,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Sudbury Regional Hospital","funders":"","keywords":"Medicine; Mammography; Breast cancer; Cancer; Estrogen receptor; Cohort; Primary tumor; Internal medicine; Oncology; Gynecology; Metastasis","score_opus":0.020521899953217522,"score_gpt":0.36803155380513236,"score_spread":0.34750965385191485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123478677","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99533284,0.0013459977,0.0009189733,0.00052881223,0.0009508817,0.0002484316,0.00044283387,0.000011892468,0.00021932433],"genre_scores_gemma":[0.9974729,0.00071140495,0.00043366288,0.00030957194,0.000800713,0.00005863998,0.000016270858,0.00003112816,0.00016571442],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9980158,0.00009334725,0.00077005517,0.00048509217,0.00019398883,0.00044167583],"domain_scores_gemma":[0.9989012,0.000117417156,0.0003164542,0.00030631296,0.00018895695,0.00016965628],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005673135,0.00023493909,0.0005636308,0.00006771822,0.000026975831,0.000004969181,0.00016933325,0.00026527586,0.00020151983],"category_scores_gemma":[0.000027086751,0.00020908493,0.0001992334,0.00021042346,0.00019963084,0.0000139406875,0.00011016921,0.00017222122,0.0000018662703],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015776709,0.0004595688,0.3768517,0.000088448076,0.00082845456,0.00000572546,0.0002743786,0.000072519266,0.07020839,0.000015070759,0.00021903471,0.5352],"study_design_scores_gemma":[0.006613189,0.00015881784,0.977571,0.00008812891,0.00009045944,0.000022850769,0.000108234424,0.000005526872,0.014430569,0.00002534677,0.0006809384,0.00020493603],"about_ca_topic_score_codex":0.0020437364,"about_ca_topic_score_gemma":0.0012119102,"teacher_disagreement_score":0.60071933,"about_ca_system_score_codex":0.00023016936,"about_ca_system_score_gemma":0.00032167442,"threshold_uncertainty_score":0.8526236},"labels":[],"label_agreement":null},{"id":"W2126279489","doi":"10.3816/cbc.2009.n.027","title":"A Phase II Trial of a Neoadjuvant Platinum Regimen for Locally Advanced Breast Cancer: Pathologic Response, Long-Term Follow-up, and Correlation With Biomarkers","year":2009,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Bristol-Myers Squibb","keywords":"Medicine; Breast cancer; Oncology; Regimen; Internal medicine; Neoadjuvant therapy; Correlation; Cancer","score_opus":0.020551854772295167,"score_gpt":0.35169779561455955,"score_spread":0.3311459408422644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126279489","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99029016,0.001685104,0.001002093,0.003800571,0.0005023961,0.0012716107,0.0013866877,0.000030504865,0.000030856892],"genre_scores_gemma":[0.99665093,0.0010939838,0.0005280905,0.0004863594,0.00044514984,0.0004214031,0.00013387953,0.00003535201,0.00020485451],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9977439,0.00015754253,0.0006867027,0.00080930843,0.00020191314,0.00040062997],"domain_scores_gemma":[0.9983649,0.00017096379,0.0005160964,0.00042498246,0.0003445752,0.0001784665],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00043976968,0.0003621379,0.0006423257,0.00005656774,0.00018004053,0.000016239452,0.0001739461,0.00027875972,0.000022566246],"category_scores_gemma":[0.00012712614,0.00028041963,0.00022603726,0.00016584719,0.0004008114,0.000019150388,0.00009229125,0.00013445385,6.185115e-7],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.563655,0.0013452601,0.027455226,0.000029956636,0.0005107192,0.000015460393,0.00008142921,0.000042892916,0.0075837197,0.000008259012,0.00062696205,0.39864507],"study_design_scores_gemma":[0.30978146,0.021578718,0.66404045,0.0005621193,0.00067980244,0.00026039287,0.0001008943,0.00012854986,0.001470068,0.0000755237,0.000605167,0.00071685674],"about_ca_topic_score_codex":0.000049727318,"about_ca_topic_score_gemma":0.00016041064,"teacher_disagreement_score":0.63658524,"about_ca_system_score_codex":0.00007826223,"about_ca_system_score_gemma":0.000418393,"threshold_uncertainty_score":0.9999648},"labels":[],"label_agreement":null},{"id":"W2140679483","doi":"10.3816/cbc.2007.n.055","title":"Delayed Resolution of Jaundice in the Arm of a Patient with Impaired Lymphatic Drainage: A Case Report","year":2007,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Jaundice; Lymphatic system; Lymphedema; Dissection (medical); Lymph node; Surgery; Axillary Lymph Node Dissection; Radiology; Breast cancer; Internal medicine; Pathology; Cancer; Sentinel lymph node","score_opus":0.04481662897447928,"score_gpt":0.4205379081652171,"score_spread":0.3757212791907378,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140679483","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99467653,0.00022602719,0.00026809963,0.0013694905,0.0000517569,0.000610283,0.000016463442,0.000007645043,0.002773707],"genre_scores_gemma":[0.998768,0.00003642188,0.000586015,0.00037446694,0.00009075415,0.00004617741,0.00000679386,0.00000951369,0.000081881975],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99789107,0.00020886776,0.0010204496,0.00022176931,0.000391156,0.00026670974],"domain_scores_gemma":[0.99766856,0.0011383352,0.0003813589,0.00041342445,0.00027096135,0.00012735093],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00309903,0.00009637998,0.00054478896,0.00008785185,0.000033749217,0.0000022279746,0.0000825749,0.00012692303,0.000098230135],"category_scores_gemma":[0.0006259505,0.0000554398,0.00009994931,0.0003963712,0.0005148427,0.000030097088,0.000031583084,0.00022165751,0.0000019219058],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009893916,0.0022787824,0.90449417,0.00020020342,0.000268771,0.053649597,0.0016628387,0.000009003982,0.000061428655,0.00018098163,0.0003613571,0.02693894],"study_design_scores_gemma":[0.0045137387,0.00257509,0.9269044,0.00038607707,0.0003825555,0.06202006,0.002141256,0.00067943777,0.00003205328,0.00014748378,0.00013424555,0.00008360759],"about_ca_topic_score_codex":0.0034563802,"about_ca_topic_score_gemma":0.0013684573,"teacher_disagreement_score":0.02685533,"about_ca_system_score_codex":0.00013255484,"about_ca_system_score_gemma":0.00075161905,"threshold_uncertainty_score":0.5225036},"labels":[],"label_agreement":null},{"id":"W2141987768","doi":"10.1016/j.clbc.2015.09.005","title":"Breast Cancer Subtype Variation by Race and Ethnicity in a Diverse Population in British Columbia","year":2015,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Breast cancer; Medicine; Demography; Ethnic group; Cancer; Population; Cancer registry; Estrogen receptor; Confidence interval; Health equity; Gynecology; Oncology; Internal medicine; Public health; Pathology; Environmental health","score_opus":0.026106701322343513,"score_gpt":0.3310841974471355,"score_spread":0.304977496124792,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141987768","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99518555,0.0020083915,0.000012717801,0.0012940033,0.00036182773,0.00022975112,0.00086226745,0.00001305859,0.000032399985],"genre_scores_gemma":[0.9965647,0.0021701262,0.00004219066,0.0004352145,0.00034120228,0.00011750811,0.00012647791,0.000021308993,0.0001812616],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99844927,0.00016431262,0.00040607847,0.000558178,0.00015356006,0.00026860196],"domain_scores_gemma":[0.99938774,0.00003464157,0.00011337404,0.00018121979,0.00013306191,0.00014995773],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036873127,0.00013481382,0.0003209176,0.000021661179,0.000049763057,0.000054091917,0.000099013974,0.00023994461,0.00007657728],"category_scores_gemma":[0.00007672149,0.00018706589,0.00005374422,0.00018051047,0.00012249938,0.000020205489,0.00014062108,0.00017271591,0.000002979076],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029616774,0.00020334576,0.9500924,0.000011145199,0.000046154233,0.000005989889,0.00006614926,0.00003816304,0.0001820891,7.0211803e-7,0.005887548,0.043170147],"study_design_scores_gemma":[0.0030857462,0.000041428593,0.99571764,0.00008371726,0.00003537601,0.000043341293,0.00008002356,0.00006358854,0.000009319195,0.000050636707,0.0005823204,0.00020688339],"about_ca_topic_score_codex":0.3121954,"about_ca_topic_score_gemma":0.54356575,"teacher_disagreement_score":0.23137037,"about_ca_system_score_codex":0.00020682554,"about_ca_system_score_gemma":0.00016323844,"threshold_uncertainty_score":0.7628325},"labels":[],"label_agreement":null},{"id":"W2153242757","doi":"10.3816/cbc.2004.n.010","title":"Use of Trastuzumab Beyond Disease Progression: Observations from a Retrospective Review of Case Histories","year":2004,"lang":"en","type":"review","venue":"Clinical Breast Cancer","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":126,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Roche (Canada); St. Boniface Hospital; Lions Gate Hospital; Ottawa Regional Cancer Foundation; BC Cancer Agency","funders":"","keywords":"Trastuzumab; Medicine; Regimen; Oncology; Internal medicine; Vinorelbine; Taxane; Metastatic breast cancer; Breast cancer; Chemotherapy; Cardiotoxicity; Cancer; Surgery; Cisplatin","score_opus":0.3380781820358026,"score_gpt":0.5386034532522701,"score_spread":0.20052527121646752,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153242757","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000056570556,0.9835534,0.0000065385943,0.0013873691,0.00081458775,0.0030637123,0.010993686,0.00004350005,0.00008060883],"genre_scores_gemma":[0.000098081844,0.99564844,0.00095697906,0.00028503872,0.0009736993,0.0009797247,0.0005378609,0.00011991697,0.0004002551],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9938587,0.00053966435,0.0030335218,0.0010102417,0.0011418083,0.00041605294],"domain_scores_gemma":[0.99335086,0.0011855833,0.0016080425,0.0015981009,0.001443834,0.0008135845],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007958433,0.00055266457,0.0048779887,0.0001411332,0.0000741275,0.000015725589,0.0003576842,0.00047604437,0.0018732923],"category_scores_gemma":[0.003194371,0.00040818666,0.001729186,0.0010229258,0.0010538214,0.00014381408,0.00021274512,0.0014120529,0.000015470136],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000226962,0.0009099335,0.0040685292,0.23528627,0.00071581616,0.0011822617,0.000035841487,1.2909793e-7,1.09682674e-7,0.00007823575,0.008642148,0.74885374],"study_design_scores_gemma":[0.00052734563,0.00023700799,0.0040381704,0.40873224,0.0044605867,0.00025812944,0.000005645005,8.166246e-7,2.2037665e-7,0.000056822802,0.58144087,0.0002421893],"about_ca_topic_score_codex":0.001145304,"about_ca_topic_score_gemma":0.000094504234,"teacher_disagreement_score":0.74861157,"about_ca_system_score_codex":0.0021906947,"about_ca_system_score_gemma":0.01169082,"threshold_uncertainty_score":0.999837},"labels":[],"label_agreement":null},{"id":"W2169656388","doi":"10.3816/cbc.2011.n.005","title":"Comparison of Clinical-Pathologic Characteristics and Outcomes of True Interval and Screen-Detected Invasive Breast Cancer Among Participants of a Canadian Breast Screening Program: A Nested Case-Control Study","year":2011,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Public Health Ontario; Dalhousie University; University of Toronto; Queen Elizabeth II Health Sciences Centre; Nova Scotia Health Authority","funders":"Coordenação de Aperfeiçoamento de Pessoal de Nível Superior","keywords":"Medicine; Breast cancer; Confidence interval; Odds ratio; Internal medicine; Population; Oncology; Cancer; Surgery; Gynecology","score_opus":0.298111550154427,"score_gpt":0.4710066680358696,"score_spread":0.17289511788144263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169656388","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99413604,0.00032593496,0.000026254838,0.00033079358,0.00023951844,0.0016908109,0.0031614776,0.0000445286,0.00004467048],"genre_scores_gemma":[0.9986015,0.00014902395,0.00058565964,0.000262329,0.00017939271,0.00015716994,0.000011530009,0.000041842453,0.000011547911],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99436617,0.0005732453,0.0031624364,0.0007681858,0.00043897508,0.00069098745],"domain_scores_gemma":[0.9949403,0.00073683396,0.0016661986,0.0005681542,0.0010419656,0.0010465728],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0018291759,0.0004316777,0.0028929,0.00033138867,0.00010003208,0.000021080958,0.0002552852,0.00039193107,0.000248132],"category_scores_gemma":[0.0008939231,0.0003425662,0.0003383359,0.00062493293,0.0013915366,0.00019713792,0.00016709429,0.0007131475,8.654341e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029283713,0.0010293968,0.8493453,0.00015351264,0.0008784218,0.00053176,0.0009765851,0.0000016475497,0.000031410644,0.0000032382798,0.000023019955,0.14409733],"study_design_scores_gemma":[0.0063528554,0.0020858308,0.983947,0.0011442016,0.001864597,0.0009929701,0.0025659679,0.0007230432,0.000020460751,0.0000044010544,0.0000037945183,0.00029490158],"about_ca_topic_score_codex":0.34603843,"about_ca_topic_score_gemma":0.30404603,"teacher_disagreement_score":0.14380243,"about_ca_system_score_codex":0.000061003575,"about_ca_system_score_gemma":0.0007454676,"threshold_uncertainty_score":0.9999026},"labels":[],"label_agreement":null},{"id":"W2175411741","doi":"10.1016/j.clbc.2015.11.002","title":"Risk of Recurrence or Contralateral Breast Cancer More than 5 Years After Diagnosis of Hormone Receptor-Positive Early-Stage Breast Cancer","year":2015,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Breast cancer; Internal medicine; Cancer; Stage (stratigraphy); Proportional hazards model; Univariate analysis; Confidence interval; Gynecology; Estrogen receptor; Oncology; Multivariate analysis","score_opus":0.023392160818099545,"score_gpt":0.33617740940609486,"score_spread":0.31278524858799533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2175411741","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.945209,0.0066530746,0.00001403696,0.0021233342,0.00092602026,0.0004910407,0.044520132,0.000025240457,0.00003808995],"genre_scores_gemma":[0.9772719,0.019537881,0.00012132032,0.00038115607,0.0012152353,0.0009686053,0.0001068839,0.0000813781,0.00031563314],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99648654,0.0002999875,0.001038222,0.0010116951,0.00048868125,0.0006748507],"domain_scores_gemma":[0.99694425,0.00014487046,0.0008080545,0.0006926143,0.0009392172,0.00047100888],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00038722195,0.0005489641,0.0010276111,0.00007361106,0.00007029657,0.000025815352,0.00045495274,0.00042170248,0.00051152444],"category_scores_gemma":[0.00008457685,0.00043976135,0.00046517325,0.00034025067,0.001051085,0.000041724372,0.00035244648,0.0003744499,0.000013022293],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012053181,0.0005513943,0.9490937,0.000043379005,0.0014169179,0.000015424528,0.0004542261,0.00006290668,0.00042803236,0.000003864407,0.005850938,0.030026015],"study_design_scores_gemma":[0.004055319,0.00033943387,0.99127233,0.00039154035,0.00050713023,0.000037912232,0.00017703898,0.000012774668,0.0015411754,0.000010575646,0.0011328281,0.00052194],"about_ca_topic_score_codex":0.018985786,"about_ca_topic_score_gemma":0.0027447124,"teacher_disagreement_score":0.044413246,"about_ca_system_score_codex":0.00021956189,"about_ca_system_score_gemma":0.0007487417,"threshold_uncertainty_score":0.9998054},"labels":[],"label_agreement":null},{"id":"W2207044386","doi":"10.1016/j.clbc.2015.06.011","title":"Early Occurrence of Angiosarcoma in a Woman With a BRCA2 Gene Variation of Unknown Significance Treated With Breast-Conserving Therapy for Bilateral Ductal Carcinoma: A Case Report","year":2015,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Vascular Tumors and Angiosarcomas","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Hospital; McMaster University","funders":"","keywords":"Angiosarcoma; Medicine; Breast cancer; Breast carcinoma; Radiation therapy; Malignancy; Lymphedema; Oncology; Internal medicine; Radiology; Cancer","score_opus":0.04476189011112873,"score_gpt":0.32511362420605894,"score_spread":0.2803517340949302,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2207044386","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99726325,0.00043592244,0.00023767876,0.00068600796,0.00006786083,0.00096824544,0.00029383425,0.000026798645,0.000020425212],"genre_scores_gemma":[0.9982009,0.000013755074,0.0012106127,0.00011444709,0.00017517267,0.00015071397,0.00005175848,0.00003242291,0.000050247145],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978236,0.00011423076,0.00088004547,0.0005403852,0.00031466925,0.0003270747],"domain_scores_gemma":[0.997882,0.00012806244,0.00051491574,0.00049661996,0.00071547646,0.0002629438],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065187743,0.00024696277,0.00081133866,0.00012868624,0.000030660547,0.000012192081,0.00011446276,0.00011779851,0.00001864422],"category_scores_gemma":[0.00006048542,0.00016616889,0.00021456424,0.0005100265,0.00025565812,0.00012742322,0.000027645996,0.00018969897,5.094743e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007392818,0.00083399256,0.97713184,0.00010461487,0.00022859887,0.009073451,0.00040874237,0.00002387829,0.001206875,0.000011541942,0.000044280452,0.0035393469],"study_design_scores_gemma":[0.011071499,0.0017400349,0.9407737,0.00039138776,0.0001961569,0.044433895,0.00007640728,0.0005432867,0.0005190063,0.00001506256,0.000026735677,0.00021281032],"about_ca_topic_score_codex":0.006659455,"about_ca_topic_score_gemma":0.00044334529,"teacher_disagreement_score":0.03635814,"about_ca_system_score_codex":0.00008759064,"about_ca_system_score_gemma":0.00091312255,"threshold_uncertainty_score":0.9999553},"labels":[],"label_agreement":null},{"id":"W2442066587","doi":"10.1016/j.clbc.2016.06.004","title":"Dual Blockade of HER-2 Provides a Greater Magnitude of Benefit in Patients With Hormone-Negative Versus Hormone-Positive Breast Cancer","year":2016,"lang":"en","type":"review","venue":"Clinical Breast Cancer","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute","funders":"","keywords":"Medicine; Breast cancer; Hormone; Blockade; Internal medicine; Oncology; Cancer; Hormone receptor; Gynecology; Endocrinology; Receptor","score_opus":0.07345930812789521,"score_gpt":0.42714991484241327,"score_spread":0.3536906067145181,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2442066587","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.045064986,0.9279253,0.0000016684486,0.00096248556,0.00061865884,0.005572472,0.019217247,0.000052225147,0.00058498955],"genre_scores_gemma":[0.02717349,0.9693309,0.00010984058,0.00008063205,0.0011027417,0.0013685258,0.00011832271,0.00024412351,0.00047143176],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9927317,0.0004864744,0.002682434,0.0014579911,0.001589708,0.0010517074],"domain_scores_gemma":[0.99360764,0.0013831373,0.0015304537,0.0010760045,0.0017751909,0.0006275735],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000773916,0.000988792,0.0048751775,0.00046659715,0.00005362994,0.00002426765,0.0005790567,0.0009211845,0.00085027417],"category_scores_gemma":[0.00028724808,0.0006146308,0.0008855711,0.0010045453,0.0014911685,0.00019049033,0.00039296976,0.0016237327,0.000047607253],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020443752,0.0011565497,0.057008788,0.006799184,0.002290116,0.000077628036,0.00013595725,0.0000010998177,0.0000026610685,0.000008009398,0.0008285701,0.9112477],"study_design_scores_gemma":[0.02641931,0.0048813913,0.83617854,0.096856385,0.0035015664,0.000077935874,0.00005027534,0.000003173424,0.000016899796,0.000016885375,0.03081547,0.001182183],"about_ca_topic_score_codex":0.0032076498,"about_ca_topic_score_gemma":0.0005916424,"teacher_disagreement_score":0.9100655,"about_ca_system_score_codex":0.001527901,"about_ca_system_score_gemma":0.0039731767,"threshold_uncertainty_score":0.9996305},"labels":[],"label_agreement":null},{"id":"W2471052102","doi":"10.1016/j.clbc.2016.07.001","title":"Differentiating the Causes of Spontaneous Rib Fracture After Breast Cancer","year":2016,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Cancer Diagnosis and Treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of British Columbia Hospital","funders":"","keywords":"Medicine; Breast cancer; Osteoporosis; Cancer; Disease; Aromatase; Population; Oncology; Surgery; Internal medicine","score_opus":0.023615177021308494,"score_gpt":0.35394680532502676,"score_spread":0.33033162830371826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2471052102","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94556445,0.0027781134,0.000018872584,0.049017437,0.0007530318,0.0004053238,0.0013170245,0.000039773637,0.000105977706],"genre_scores_gemma":[0.9896421,0.0037389356,0.000016545066,0.0040423,0.0015020495,0.00036616062,0.000005085289,0.000040316558,0.0006465487],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99812686,0.000083145416,0.0006445851,0.00044534195,0.00034825527,0.00035178196],"domain_scores_gemma":[0.99805194,0.0006776731,0.00027549453,0.0005392154,0.00022879316,0.00022689739],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00016777236,0.00025316558,0.00061769166,0.00003280715,0.00006506663,0.000015643305,0.00014121237,0.00016262283,0.008020592],"category_scores_gemma":[0.000055306653,0.00011201705,0.00039099032,0.0001191387,0.0003052897,0.00005947857,0.00007878283,0.00023954546,0.000037512298],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014104772,0.0004835842,0.8337197,0.000055609584,0.0004874515,0.00015670808,0.000071011564,0.00000229351,0.00014951789,0.000014176941,0.0035999054,0.1598496],"study_design_scores_gemma":[0.0025100822,0.000110368215,0.98820925,0.0011739513,0.00062643876,0.00053665636,0.00002365542,0.0000055596,0.00022172362,0.000038249495,0.0063897492,0.00015432417],"about_ca_topic_score_codex":0.0016704148,"about_ca_topic_score_gemma":0.0016051685,"teacher_disagreement_score":0.15969527,"about_ca_system_score_codex":0.00024262366,"about_ca_system_score_gemma":0.0002881043,"threshold_uncertainty_score":0.9928862},"labels":[],"label_agreement":null},{"id":"W2494806904","doi":"10.1016/j.clbc.2016.07.014","title":"Optimal Management of Leptomeningeal Carcinomatosis in Breast Cancer Patients—A Systematic Review","year":2016,"lang":"en","type":"review","venue":"Clinical Breast Cancer","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Breast cancer; Randomized controlled trial; Internal medicine; Quality of life (healthcare); Radiation therapy; Oncology; MEDLINE; Observational study; Chemotherapy; Systematic review; Prospective cohort study; Cancer; Surgery","score_opus":0.05572311220088244,"score_gpt":0.41747822756101355,"score_spread":0.3617551153601311,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2494806904","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000112393594,0.9896387,0.0000032289722,0.00075258047,0.0005208386,0.005487505,0.0032995646,0.000031615993,0.00015358678],"genre_scores_gemma":[0.00028642893,0.9948461,0.00014279329,0.00043238953,0.00026643838,0.0033502835,0.00014884393,0.00011230135,0.0004144285],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9934142,0.0006159295,0.0037443105,0.00096301583,0.00068370975,0.00057884003],"domain_scores_gemma":[0.9961808,0.00040942908,0.0017101531,0.0010452227,0.00026903872,0.00038537997],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001102667,0.00076349603,0.007651066,0.00019687522,0.000034644265,0.00001279551,0.00038094906,0.00034027765,0.0015436165],"category_scores_gemma":[0.000039182905,0.00044039375,0.0018374476,0.0005589366,0.00018525448,0.00006678222,0.00024056142,0.00047831624,0.00012609824],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000058202106,0.000655587,0.0037081663,0.64600164,0.0021756012,0.0000685901,0.000004153372,1.2450595e-7,2.5016489e-9,0.000016856338,0.0010213336,0.34628975],"study_design_scores_gemma":[0.0023394304,0.00012211314,0.008802932,0.9353029,0.020133493,0.00013977956,0.000007003359,0.0000011739304,3.2389796e-8,0.0000011045493,0.03275919,0.0003908275],"about_ca_topic_score_codex":0.00016394386,"about_ca_topic_score_gemma":0.000007682755,"teacher_disagreement_score":0.34589893,"about_ca_system_score_codex":0.00084444514,"about_ca_system_score_gemma":0.0005176123,"threshold_uncertainty_score":0.9998048},"labels":[],"label_agreement":null},{"id":"W2495043549","doi":"10.1016/j.clbc.2016.07.008","title":"Epirubicin With Cyclophosphamide Followed by Docetaxel With Trastuzumab and Bevacizumab as Neoadjuvant Therapy for HER2-Positive Locally Advanced Breast Cancer or as Adjuvant Therapy for HER2-Positive Pathologic Stage III Breast Cancer: A Phase II Trial of the NSABP Foundation Research Group, FB-5","year":2016,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Trastuzumab; Docetaxel; Epirubicin; Breast cancer; Internal medicine; Oncology; Cyclophosphamide; Neoadjuvant therapy; Regimen; Ejection fraction; Chemotherapy; Cancer; Heart failure","score_opus":0.028574340506992785,"score_gpt":0.38939238070556553,"score_spread":0.3608180401985728,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2495043549","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9598321,0.0038296108,0.0011475579,0.011184367,0.00048663467,0.006948575,0.016485272,0.000043499535,0.000042385465],"genre_scores_gemma":[0.9715536,0.016946556,0.00022433222,0.0012931873,0.0007947111,0.007931045,0.00021305257,0.00016952826,0.0008739549],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9945683,0.0006896631,0.0010995786,0.0017617423,0.0007427976,0.0011379297],"domain_scores_gemma":[0.9954912,0.00086617953,0.0009025335,0.00084632594,0.0015482147,0.00034551005],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001111328,0.00088694756,0.0013527314,0.0000816189,0.00097297126,0.00006820552,0.0006041555,0.0004400126,0.00015793773],"category_scores_gemma":[0.00010724635,0.0004534006,0.00044842833,0.00042896002,0.0019107129,0.000082312545,0.00022899118,0.00044645733,0.0000015779294],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.50809705,0.0033854656,0.0041745966,0.00005270925,0.0016089438,0.000013977384,0.0004037849,0.000020100739,0.022597276,0.000042032807,0.00073674956,0.4588673],"study_design_scores_gemma":[0.65472215,0.08674297,0.18166696,0.0030286114,0.0010122311,0.0006336707,0.0021005613,0.000041910047,0.056861527,0.00037597472,0.010406836,0.0024065764],"about_ca_topic_score_codex":0.004371937,"about_ca_topic_score_gemma":0.0037065533,"teacher_disagreement_score":0.45646074,"about_ca_system_score_codex":0.0005236024,"about_ca_system_score_gemma":0.0018697524,"threshold_uncertainty_score":0.9997918},"labels":[],"label_agreement":null},{"id":"W2533756834","doi":"10.1016/j.clbc.2016.10.005","title":"Hypofractionation Is an Acceptable Alternative to Conventional Fractionation in the Treatment of Postlumpectomy Ductal Carcinoma In Situ With Radiotherapy","year":2016,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Hazard ratio; Ductal carcinoma; Radiation therapy; Internal medicine; Breast cancer; Multivariate analysis; Oncology; Confidence interval; Carcinoma; Cancer; Urology","score_opus":0.03366775043726564,"score_gpt":0.36463582402644734,"score_spread":0.3309680735891817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2533756834","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934018,0.0002667143,0.00017923421,0.0053269425,0.00016614037,0.0003290746,0.00019213512,0.0000034694322,0.00013445991],"genre_scores_gemma":[0.99780697,0.0006918736,0.00016041112,0.000519593,0.0004931915,0.00019033373,0.00004983949,0.000012494359,0.000075314674],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989251,0.00011704812,0.00027998342,0.00035788643,0.00017825581,0.00014170742],"domain_scores_gemma":[0.9993723,0.00009365465,0.00012641221,0.0001931854,0.00017131957,0.00004315],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013503215,0.00013253845,0.00018084356,0.000064023574,0.00003393504,0.000008094212,0.000102642,0.00007319701,0.00020581335],"category_scores_gemma":[0.00001773713,0.000075697346,0.00006964426,0.00013789938,0.00009517202,0.000025095354,0.000010584326,0.000041304906,0.0000034422496],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024642784,0.0015004248,0.90198004,0.000003336679,0.0001770319,0.0000048621214,0.00049601187,0.00009196962,0.009128797,0.000056087152,0.00027770756,0.08381947],"study_design_scores_gemma":[0.004077128,0.0007278041,0.9856742,0.000017951157,0.000018712975,0.000018638611,0.00018879247,0.000013840087,0.00528074,0.000051312883,0.0038265781,0.000104325925],"about_ca_topic_score_codex":0.00095903646,"about_ca_topic_score_gemma":0.0025545973,"teacher_disagreement_score":0.08371515,"about_ca_system_score_codex":0.00022818589,"about_ca_system_score_gemma":0.00012790973,"threshold_uncertainty_score":0.30868483},"labels":[],"label_agreement":null},{"id":"W2576774687","doi":"10.1016/j.clbc.2017.01.002","title":"Competing Risks of Mortality by PAM50 Intrinsic Subtype of British Columbia Tamoxifen-Treated Cohort of Postmenopausal Patients With Breast Cancer","year":2017,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre for Advancing Health Outcomes; Robarts Clinical Trials; University of British Columbia; Queen's University","funders":"National Cancer Institute; University of British Columbia","keywords":"Medicine; Breast cancer; Lymphovascular invasion; Tamoxifen; Oncology; Internal medicine; Cancer; Cohort; Estrogen receptor; Progesterone receptor; Metastasis","score_opus":0.0250787222093636,"score_gpt":0.33822091961903855,"score_spread":0.31314219740967497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2576774687","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.982754,0.00060871185,0.0000031341738,0.00011036661,0.00025021314,0.00042711513,0.015654666,0.000011273988,0.00018055564],"genre_scores_gemma":[0.99821067,0.00097430375,0.000048912192,0.000078821446,0.00019437337,0.00008027383,0.00028678525,0.000045736062,0.00008014932],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975978,0.00012328158,0.0009029269,0.0006598277,0.0003657554,0.00035040674],"domain_scores_gemma":[0.9964693,0.00005940447,0.0014142805,0.0008411164,0.0010612307,0.00015463933],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00027698217,0.00024764007,0.00089364185,0.00001677594,0.00014762685,0.000032669897,0.00042847483,0.00023565852,0.00017669627],"category_scores_gemma":[0.00008611811,0.00027834423,0.00017228108,0.00009378596,0.0012628554,0.000018725157,0.00030008325,0.00016851757,9.955144e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010121095,0.00091573864,0.97022426,0.00009812905,0.0014449303,0.0000031835093,0.00001214719,0.000004648283,0.0010401389,7.0564204e-7,0.001752497,0.023491539],"study_design_scores_gemma":[0.003658459,0.0003549981,0.99372345,0.00033504737,0.0005150432,0.0000108687655,0.00002004179,0.0000029278274,0.0009801158,0.0000059039694,0.00012227097,0.000270872],"about_ca_topic_score_codex":0.17055008,"about_ca_topic_score_gemma":0.04680326,"teacher_disagreement_score":0.12374682,"about_ca_system_score_codex":0.000058009642,"about_ca_system_score_gemma":0.00026602426,"threshold_uncertainty_score":0.99996686},"labels":[],"label_agreement":null},{"id":"W25997855","doi":"10.1016/j.clbc.2015.04.004","title":"Representation de la peur dans le roman de premiere lecture au Quebec de 1995 a 2005 : nouvelles identites masculines ou statu quo?","year":2007,"lang":"en","type":"dissertation","venue":"Clinical Breast Cancer","topic":"Themes in Literature Analysis","field":"Arts and Humanities","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Status quo; Inscribed figure; Psychology; Narrative; Masculinity; Identity (music); Field (mathematics); Restructuring; Psychoanalysis; Humanities; Social psychology; Sociology; Art; Aesthetics; Literature; Political science","score_opus":0.017069072522762123,"score_gpt":0.36539843309412157,"score_spread":0.34832936057135944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W25997855","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9080199,0.009103453,0.0012068192,0.0018465075,0.0034674562,0.0007213663,0.0015526994,0.0003709588,0.073710866],"genre_scores_gemma":[0.6463076,0.0012644473,0.0007466688,0.0010035713,0.011859339,0.00017619345,0.002946755,0.00018994694,0.33550552],"study_design_codex":"qualitative","study_design_gemma":"not_applicable","domain_scores_codex":[0.996867,0.0005031716,0.00094294996,0.0006755256,0.00036606754,0.00064531295],"domain_scores_gemma":[0.9976188,0.00075621495,0.0005665606,0.00051370263,0.0002986245,0.0002460814],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010583197,0.00043714358,0.00067929924,0.00020053552,0.00040827223,0.00053572154,0.00047924469,0.0006696687,0.0020106614],"category_scores_gemma":[0.00033962468,0.00039426563,0.0007092096,0.00013745432,0.00043302358,0.00029075367,0.00004489621,0.0009922443,0.000025326743],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003441951,0.0020611556,0.16924296,0.0020036378,0.0062461523,0.0003124812,0.37646884,0.0015547521,0.0010718105,0.09384451,0.22838536,0.11536637],"study_design_scores_gemma":[0.0017360583,0.00007923441,0.2862016,0.0014754304,0.0027778188,0.00006207253,0.04180707,0.00047206445,0.0004981581,0.006432185,0.65694416,0.0015141596],"about_ca_topic_score_codex":0.09083843,"about_ca_topic_score_gemma":0.6933936,"teacher_disagreement_score":0.60255516,"about_ca_system_score_codex":0.00070841686,"about_ca_system_score_gemma":0.0022281327,"threshold_uncertainty_score":0.9998509},"labels":[],"label_agreement":null},{"id":"W2683062180","doi":"10.1016/j.clbc.2017.06.007","title":"A Pilot Randomized Controlled Trial on the Effects of a Progressive Exercise Program on the Range of Motion and Upper Extremity Grip Strength in Young Adults With Breast Cancer","year":2017,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Lymphatic System and Diseases","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Physiotherapy Association; McGill University; Jewish General Hospital","funders":"McGill University","keywords":"Medicine; Range of motion; Physical therapy; Randomized controlled trial; Breast cancer; Grip strength; Axilla; Physical medicine and rehabilitation; Surgery; Cancer","score_opus":0.02015011080360156,"score_gpt":0.3397694685597378,"score_spread":0.3196193577561362,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2683062180","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98023796,0.0010811959,9.953767e-7,0.0023940979,0.0004948506,0.015358473,0.00009478692,0.00002008169,0.00031756063],"genre_scores_gemma":[0.990884,0.00045806417,0.0000057091625,0.00013639555,0.00047252694,0.007957775,0.0000028490513,0.000021152187,0.00006150633],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9972445,0.0007530309,0.0008819482,0.00038207715,0.0005003984,0.00023806977],"domain_scores_gemma":[0.99374175,0.004059248,0.0010937976,0.0006404609,0.00030926924,0.00015549299],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014154662,0.00026096587,0.0018622148,0.00004864392,0.000113357026,0.000040021332,0.00019506205,0.00009476663,0.00011514237],"category_scores_gemma":[0.002880672,0.00010090854,0.00038358435,0.00008268135,0.0009744322,0.00007071598,0.00004234407,0.000118280586,0.0000011610703],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.777508,0.0027053268,0.17327073,0.00039081645,0.00032554276,0.000011054261,0.00017607713,4.120542e-7,0.000004338507,0.000059218542,0.0000695532,0.04547893],"study_design_scores_gemma":[0.5548367,0.0008354602,0.4364178,0.0067735757,0.000723385,0.000008850428,0.00006792207,0.00022884687,0.00001715565,0.00001659733,4.5554776e-7,0.00007324053],"about_ca_topic_score_codex":0.0015238468,"about_ca_topic_score_gemma":0.0002572167,"teacher_disagreement_score":0.26314706,"about_ca_system_score_codex":0.000058949583,"about_ca_system_score_gemma":0.00030286337,"threshold_uncertainty_score":0.41149306},"labels":[],"label_agreement":null},{"id":"W2766893338","doi":"10.1016/j.clbc.2017.10.009","title":"Vitamin D Levels, Vitamin D Receptor Polymorphisms, and Inflammatory Cytokines in Aromatase Inhibitor-Induced Arthralgias: An Analysis of CCTG MA.27","year":2017,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; BC Cancer Agency; Ontario Institute for Cancer Research; Queen's University","funders":"National Cancer Institute; Canadian Cancer Society Research Institute; Cancer Research Institute","keywords":"Calcitriol receptor; Medicine; Vitamin D and neurology; Internal medicine; Aromatase inhibitor; vitamin D deficiency; Subclinical infection; Endocrinology; Cytokine; Single-nucleotide polymorphism; Aromatase; Immunology; Genotype; Breast cancer; Cancer; Biology","score_opus":0.020924641065252034,"score_gpt":0.32332005447400325,"score_spread":0.3023954134087512,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766893338","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99799144,0.0006527397,0.0000070246897,0.00030705272,0.00037048143,0.0001782694,0.00043775336,0.000010901818,0.000044349432],"genre_scores_gemma":[0.99833703,0.0007526947,0.00010649876,0.00009992635,0.00038404026,0.000023775063,0.00016399966,0.00002756951,0.000104436505],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99811685,0.00019333723,0.0006432398,0.00060164306,0.0001519977,0.0002929224],"domain_scores_gemma":[0.99837685,0.00005181794,0.00040364667,0.0008402953,0.00008342121,0.00024399611],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005434959,0.00024232891,0.00054844486,0.00013474176,0.000104374696,0.000043121483,0.00031791197,0.0005147115,0.000056446912],"category_scores_gemma":[0.00017340726,0.00021336744,0.00022325735,0.0001324252,0.00035412714,0.0000257795,0.00020693772,0.00026035006,0.000006946372],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005588933,0.00026254135,0.46019325,0.00003115179,0.0006454047,0.000023573382,0.00003691512,0.000021409018,0.51068366,0.000025617905,0.00043062682,0.027086958],"study_design_scores_gemma":[0.0018499212,0.00028120648,0.94387895,0.00009587306,0.00030976694,0.000010905087,0.000035420064,0.00021879669,0.052641187,0.000008302457,0.0003686699,0.00030102275],"about_ca_topic_score_codex":0.00026676818,"about_ca_topic_score_gemma":0.00041006427,"teacher_disagreement_score":0.48368567,"about_ca_system_score_codex":0.000023078606,"about_ca_system_score_gemma":0.00013841865,"threshold_uncertainty_score":0.8700872},"labels":[],"label_agreement":null},{"id":"W2770903255","doi":"10.1016/j.clbc.2017.11.012","title":"Association of Tobacco Use, Alcohol Consumption and HER2 Polymorphisms With Response to Trastuzumab in HER2-Positive Breast Cancer Patients","year":2017,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital du Saint-Sacrement; Université Laval; Hôtel-Dieu de Québec; Centre hospitalier de l'Université Laval","funders":"Fonds de Recherche du Québec - Santé; Canadian Cancer Society","keywords":"Medicine; Trastuzumab; Breast cancer; Internal medicine; Oncology; Hazard ratio; Proportional hazards model; Genotype; Cancer; Gynecology; Confidence interval","score_opus":0.06898295181947652,"score_gpt":0.4281602336921043,"score_spread":0.3591772818726278,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2770903255","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9820267,0.00011209245,0.000005767865,0.014713901,0.00031763082,0.0011038632,0.0016091998,0.000021494825,0.000089376845],"genre_scores_gemma":[0.9967352,0.00057374005,0.00009611366,0.0010132481,0.00027617704,0.00023594296,0.000017119306,0.000050596936,0.0010018465],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968816,0.0004087634,0.0007375016,0.0006540686,0.000800552,0.0005175012],"domain_scores_gemma":[0.9970518,0.00064444635,0.00050775486,0.0005833632,0.00075479544,0.00045785963],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013657291,0.00024839496,0.0007217783,0.0001564328,0.00014084905,0.00008861047,0.00022616285,0.00029477105,0.0004786013],"category_scores_gemma":[0.0008626202,0.00020834178,0.00010080493,0.0001917197,0.0003804437,0.00030422336,0.00015050313,0.00057194487,0.000025443824],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019413352,0.00052219897,0.9102797,0.00005075226,0.00018415567,0.000023970528,0.00019789883,0.000006060123,0.0003932884,0.0000032934647,0.0013205721,0.067604795],"study_design_scores_gemma":[0.0070298193,0.0007034667,0.9893896,0.00155782,0.0001262342,0.000023873823,0.000029986099,0.000022772605,0.00021586932,0.0000044702765,0.0006721763,0.0002239357],"about_ca_topic_score_codex":0.010194618,"about_ca_topic_score_gemma":0.006038086,"teacher_disagreement_score":0.079109915,"about_ca_system_score_codex":0.0013809467,"about_ca_system_score_gemma":0.00082978,"threshold_uncertainty_score":0.9963966},"labels":[],"label_agreement":null},{"id":"W2781545660","doi":"10.1016/j.clbc.2017.12.013","title":"Review of Factors Influencing Women's Choice of Mastectomy Versus Breast Conserving Therapy in Early Stage Breast Cancer: A Systematic Review","year":2018,"lang":"en","type":"review","venue":"Clinical Breast Cancer","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":195,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Medicine; Mastectomy; Breast cancer; Socioeconomic status; Stage (stratigraphy); Family medicine; Ductal carcinoma; Radiation therapy; Cancer; Gynecology; Oncology; Internal medicine; Population","score_opus":0.20667500051181822,"score_gpt":0.47552711425279326,"score_spread":0.26885211374097506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2781545660","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004347413,0.9870409,9.2918526e-7,0.0003032164,0.00072681444,0.0051124236,0.0023071175,0.00005467801,0.00010652551],"genre_scores_gemma":[0.0008480759,0.9946218,0.000021791291,0.0024481823,0.0005653692,0.0012292541,0.000049366474,0.00013486702,0.000081287144],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.98904765,0.0012409855,0.0063178088,0.0012175583,0.0011979138,0.0009780854],"domain_scores_gemma":[0.98935705,0.0018184705,0.005023469,0.001759232,0.0014276495,0.00061409693],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0034702546,0.0011227038,0.012482086,0.0003065033,0.00006480528,0.000028067316,0.0011175434,0.0006445524,0.0017832705],"category_scores_gemma":[0.0012789754,0.000786727,0.0019737675,0.001993848,0.00054129586,0.00029324077,0.00028866093,0.0014112524,0.000030340772],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003854946,0.00013051751,0.011962351,0.9092128,0.001185601,0.00002239866,0.000069750204,1.5976957e-7,3.2801844e-7,0.00000292001,0.00042915685,0.07659852],"study_design_scores_gemma":[0.002077642,0.00038118789,0.011182757,0.9521031,0.0041998043,0.00021234783,0.00008916868,0.0000012581352,2.81859e-7,9.055657e-7,0.029143238,0.0006083429],"about_ca_topic_score_codex":0.006694,"about_ca_topic_score_gemma":0.0003323487,"teacher_disagreement_score":0.07599018,"about_ca_system_score_codex":0.0015099529,"about_ca_system_score_gemma":0.0037393128,"threshold_uncertainty_score":0.9999205},"labels":[],"label_agreement":null},{"id":"W2790548769","doi":"10.1016/j.clbc.2018.03.008","title":"Prospective Study of Breast Radiation Dermatitis","year":2018,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Effects of Radiation Exposure","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Common Terminology Criteria for Adverse Events; Breast cancer; Adverse effect; Dermatology; Radiation therapy; Prospective cohort study; Toxicity; Regimen; Internal medicine; Surgery; Cancer","score_opus":0.01885744899582218,"score_gpt":0.3806932599921902,"score_spread":0.361835810996368,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2790548769","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99418277,0.000106418964,0.00003833459,0.0027679682,0.00063560443,0.0009391691,0.000085249245,0.00006512018,0.0011793548],"genre_scores_gemma":[0.9968669,0.00003532528,0.000092807466,0.00088585634,0.0018272424,0.00007132328,0.0000074761133,0.000022946566,0.00019016664],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984809,0.00013869855,0.00058397837,0.00031180246,0.000313871,0.0001707375],"domain_scores_gemma":[0.99845403,0.0002099062,0.00026517772,0.00035413983,0.000543773,0.00017294979],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031058563,0.00012652708,0.00042055928,0.0000708643,0.00005476712,0.000009341054,0.0000930102,0.00011684802,0.0007962246],"category_scores_gemma":[0.00021512082,0.00010615204,0.000105326915,0.00027194087,0.00021344794,0.00012310156,0.00003251532,0.00020994572,0.00010555319],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032107945,0.0010901481,0.9117635,0.000032752032,0.00018525303,0.0000063366515,0.00041442527,0.0000025797158,0.00009037743,0.00003443144,0.0049640774,0.08109504],"study_design_scores_gemma":[0.004785445,0.001468525,0.99217725,0.00008047643,0.00017868016,0.000114901144,0.00015719015,0.00019195446,0.00011785885,0.000038099857,0.00058953284,0.000100102785],"about_ca_topic_score_codex":0.0002455339,"about_ca_topic_score_gemma":0.00013954351,"teacher_disagreement_score":0.08099494,"about_ca_system_score_codex":0.00010340976,"about_ca_system_score_gemma":0.00019098292,"threshold_uncertainty_score":0.8718101},"labels":[],"label_agreement":null},{"id":"W2791226420","doi":"10.1016/j.clbc.2018.02.008","title":"Estimating the Reliability and Validity of the Upper Extremity Functional Index in Women After Breast Cancer Surgery","year":2018,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Lymphatic System and Diseases","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Avon Foundation for Women","keywords":"Medicine; Confidence interval; Breast cancer; Reliability (semiconductor); Range of motion; Physical therapy; Upper limb; Physical medicine and rehabilitation; Cancer; Internal medicine","score_opus":0.047050581797090034,"score_gpt":0.34363248896369897,"score_spread":0.2965819071666089,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2791226420","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925957,0.00025495124,0.000024374958,0.005251166,0.0012479728,0.0002938734,0.0002095063,0.000015846872,0.00010665459],"genre_scores_gemma":[0.9958902,0.000029642619,0.000016198584,0.0021267326,0.0015938098,0.00020987968,0.0000013191499,0.000013335153,0.00011889456],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979679,0.00032574867,0.0007115725,0.00036702558,0.00035877174,0.00026896226],"domain_scores_gemma":[0.99761105,0.0012150225,0.00022038574,0.0004956661,0.00027369778,0.0001841555],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016194017,0.00014837204,0.0004581832,0.00002824231,0.000086518194,0.000014491267,0.000099169294,0.000120530494,0.0019587716],"category_scores_gemma":[0.0007236083,0.00007543891,0.00018601464,0.00023267203,0.0008993096,0.000083090694,0.00012555675,0.00009791778,0.0000061805135],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013977595,0.00020774908,0.9784278,0.00014218855,0.000036595167,0.0000016210386,0.00013039682,0.000011159931,0.0000050292388,0.0000018587467,0.0017236097,0.01791418],"study_design_scores_gemma":[0.00093734363,0.000012086112,0.9968406,0.0006006499,0.000073158524,0.000052825202,0.00008143191,0.0009784898,0.0000042789497,0.0001786387,0.00015216775,0.00008833444],"about_ca_topic_score_codex":0.0010955738,"about_ca_topic_score_gemma":0.00017594022,"teacher_disagreement_score":0.018412743,"about_ca_system_score_codex":0.00022239146,"about_ca_system_score_gemma":0.0008370946,"threshold_uncertainty_score":0.9989536},"labels":[],"label_agreement":null},{"id":"W2799541018","doi":"10.1016/j.clbc.2018.05.001","title":"Early Local Recurrence in a Patient With Encapsulated Papillary Carcinoma of the Breast","year":2018,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Breast Lesions and Carcinomas","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre","funders":"Joseph and Silvana Melara Cancer Research Fund","keywords":"Medicine; Myoepithelial cell; Papillary carcinoma; Breast cancer; Capsule; Carcinoma; Breast carcinoma; Ductal carcinoma; Pathology; Oncology; Cancer; Internal medicine; Immunohistochemistry","score_opus":0.020328493702090476,"score_gpt":0.2993965439465933,"score_spread":0.2790680502445028,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2799541018","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958197,0.0002815642,0.00002659934,0.0022628962,0.0003506715,0.00037495233,0.00009691361,0.000018070115,0.0007686342],"genre_scores_gemma":[0.9986912,0.000027581209,0.00005358822,0.00077425234,0.00031110653,0.000030110992,0.0000037198672,0.00002375031,0.00008470405],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99804103,0.00015208901,0.0006662122,0.00042707898,0.00037604183,0.00033755513],"domain_scores_gemma":[0.99844164,0.000085301974,0.00021168901,0.0006275678,0.0004084277,0.00022539245],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002589378,0.00019252922,0.0004635017,0.00005766856,0.000059453232,0.000007562076,0.00019945846,0.00017688508,0.0004588546],"category_scores_gemma":[0.000032187014,0.000108982844,0.00016666649,0.0006181911,0.001081477,0.000058386133,0.00012447342,0.0004599875,0.000025957648],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014452423,0.0003635445,0.8473851,0.000032752392,0.000035569778,0.00005773377,0.00018330518,0.00000209507,0.0001358003,0.000040172814,0.00037272775,0.14994594],"study_design_scores_gemma":[0.0019860268,0.00071339234,0.9941505,0.0008186798,0.00008124714,0.001225929,0.00011661787,0.0002374755,0.00016813913,0.00002535481,0.0003342672,0.00014232298],"about_ca_topic_score_codex":0.001455679,"about_ca_topic_score_gemma":0.00022261226,"teacher_disagreement_score":0.14980361,"about_ca_system_score_codex":0.000096960386,"about_ca_system_score_gemma":0.00059781404,"threshold_uncertainty_score":0.50241363},"labels":[],"label_agreement":null},{"id":"W2802874188","doi":"10.1016/j.clbc.2018.04.013","title":"Impact of Detection Method and Age on Survival Outcomes in Triple-Negative Breast Cancer: A Population-Based Cohort Analysis","year":2018,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saint John Regional Hospital; Dalhousie University; Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Medicine; Triple-negative breast cancer; Breast cancer; Oncology; Cohort; Population; Internal medicine; Survival analysis; Triple negative; Cancer; Gynecology; Environmental health","score_opus":0.025369665966971794,"score_gpt":0.4156564737991756,"score_spread":0.3902868078322038,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2802874188","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99689376,0.000086629574,0.00064779073,0.0003801078,0.00026836572,0.0002824499,0.0013755717,0.000012375965,0.000052934374],"genre_scores_gemma":[0.99891764,0.00014474662,0.00018776182,0.00015971778,0.00033427673,0.00013204174,0.00006369104,0.000022633245,0.000037476086],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99805045,0.0003030461,0.0005570521,0.0006328944,0.00019355916,0.00026300884],"domain_scores_gemma":[0.99876505,0.00025525512,0.0002953258,0.0003451034,0.00022123313,0.000118012955],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042412934,0.00026937798,0.00080324995,0.00015441954,0.000074836906,0.000013026604,0.000111379675,0.00019457226,0.00011736593],"category_scores_gemma":[0.00013691904,0.00020811586,0.00043102496,0.0004969964,0.0002381635,0.000007629887,0.00005843092,0.00013443164,0.000001417467],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018430928,0.00025506027,0.9654023,0.000008361567,0.0023460235,0.0000015887955,0.000025415804,0.00043081777,0.00039076508,0.0000021337485,0.000021604794,0.029272806],"study_design_scores_gemma":[0.002427264,0.0002958106,0.9954197,0.000030583164,0.0006338119,0.0000027425153,0.000014064694,0.00038576132,0.00054797414,0.00002949153,0.000006854448,0.00020595628],"about_ca_topic_score_codex":0.031046597,"about_ca_topic_score_gemma":0.027985621,"teacher_disagreement_score":0.030017355,"about_ca_system_score_codex":0.00019759266,"about_ca_system_score_gemma":0.00015988688,"threshold_uncertainty_score":0.9897511},"labels":[],"label_agreement":null},{"id":"W2807780575","doi":"10.1016/j.clbc.2018.05.010","title":"A Systematic Review of Heart Dose in Breast Radiotherapy","year":2018,"lang":"en","type":"review","venue":"Clinical Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":120,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Breast cancer; Radiation therapy; Dosimetry; Heart disease; Heart rate; Breathing; Nuclear medicine; Cardiology; Internal medicine; Cancer; Blood pressure; Anesthesia","score_opus":0.04167221562212159,"score_gpt":0.4238226244999446,"score_spread":0.38215040887782303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2807780575","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000010381767,0.99607396,0.0000037576094,0.00052966806,0.0005133122,0.0017795286,0.0010098262,0.000013734843,0.000065805805],"genre_scores_gemma":[0.00001599291,0.99590343,0.00010135349,0.0012989236,0.0011857013,0.0011043755,0.00015888806,0.00009730572,0.00013405508],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99511915,0.0007944673,0.0024656013,0.0009410274,0.00026883173,0.0004109094],"domain_scores_gemma":[0.99708813,0.00020647176,0.0011074996,0.0011987367,0.00024399224,0.00015516765],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010479371,0.0006411571,0.0049159485,0.00008958228,0.000035469566,0.000011708018,0.0005421902,0.00054104,0.00017725414],"category_scores_gemma":[0.00018014632,0.00045688474,0.0015466985,0.0003786959,0.00040605164,0.000004636067,0.00019784538,0.00030168678,0.000042001564],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008439578,0.0003172814,0.00045289722,0.9303244,0.0015547512,0.000005219939,0.000006372598,6.4528436e-8,8.1685505e-7,0.000003048205,0.010433918,0.056816835],"study_design_scores_gemma":[0.00067047874,0.000084611944,0.000752903,0.747692,0.0018555842,0.0004174921,0.000003359089,3.0028662e-7,4.7697137e-7,0.0000021536794,0.2481151,0.00040552413],"about_ca_topic_score_codex":0.00010397122,"about_ca_topic_score_gemma":0.000045489352,"teacher_disagreement_score":0.23768118,"about_ca_system_score_codex":0.00017160075,"about_ca_system_score_gemma":0.0007840575,"threshold_uncertainty_score":0.9997883},"labels":[],"label_agreement":null},{"id":"W2809807627","doi":"10.1016/j.clbc.2018.06.015","title":"Radiation-induced Skin Toxicity in Breast Cancer Patients: A Systematic Review of Randomized Trials","year":2018,"lang":"en","type":"review","venue":"Clinical Breast Cancer","topic":"Effects of Radiation Exposure","field":"Medicine","cited_by":123,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Radiation therapy; Breast cancer; Randomized controlled trial; Incidence (geometry); Dermatology; Cancer; Systematic review; Internal medicine; MEDLINE; Oncology","score_opus":0.07297618904876768,"score_gpt":0.4552145097670153,"score_spread":0.3822383207182476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809807627","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000121052064,0.97597593,0.0000042448305,0.0012302168,0.0017597675,0.01897174,0.0018070451,0.000050311086,0.00007967028],"genre_scores_gemma":[0.00025970032,0.98937637,0.000030811345,0.0021544723,0.0020353612,0.005649878,0.00026097186,0.00012311085,0.00010933908],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9748039,0.011110603,0.01155198,0.0010032452,0.0010410253,0.0004891937],"domain_scores_gemma":[0.97398996,0.014031364,0.008989535,0.0012283066,0.001318928,0.00044191032],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.021608612,0.0008618243,0.028818296,0.0004191738,0.00004148752,0.000024843323,0.00051483046,0.0010185462,0.0015382277],"category_scores_gemma":[0.03214947,0.0005457249,0.0052494095,0.0010830634,0.00030221872,0.00015057786,0.00009547076,0.0010013914,0.00011445996],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030319297,0.0005870179,0.00040390567,0.8224526,0.002212387,0.000004435833,0.000017850678,1.0267289e-7,7.253757e-8,0.000008925473,0.0044829664,0.16679783],"study_design_scores_gemma":[0.058249593,0.00012772524,0.0011232477,0.9093118,0.023136321,0.00004651454,0.0000021068927,0.000011506719,4.6523758e-7,0.000005862869,0.0075181522,0.0004667206],"about_ca_topic_score_codex":0.00034703594,"about_ca_topic_score_gemma":0.000037358237,"teacher_disagreement_score":0.16633111,"about_ca_system_score_codex":0.00091494445,"about_ca_system_score_gemma":0.0026203184,"threshold_uncertainty_score":0.9996994},"labels":[],"label_agreement":null},{"id":"W2884297513","doi":"10.1016/j.clbc.2018.07.016","title":"Impact of Regional Nodal Irradiation on the Outcomes of N1 Breast Cancer Patients Referred for Adjuvant Treatment: A Patient-Level Pooled Analysis of 2 Clinical Trials","year":2018,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Radiation therapy; Breast cancer; Proportional hazards model; Univariate analysis; Supraclavicular lymph nodes; Internal medicine; Oncology; Stage (stratigraphy); Axilla; Multivariate analysis; Survival analysis; Randomized controlled trial; Cancer; Surgery","score_opus":0.18284313137461775,"score_gpt":0.48569050990991464,"score_spread":0.30284737853529686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2884297513","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9758611,0.00028667424,0.000028649307,0.0011346859,0.00056304794,0.00072195166,0.02136446,0.000006452246,0.000033010005],"genre_scores_gemma":[0.99755496,0.0006597403,0.000068838905,0.00029056068,0.0006161747,0.00027955187,0.00045730473,0.00003183029,0.000041056184],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9955659,0.0006559497,0.002448777,0.0006591875,0.00035374914,0.00031644286],"domain_scores_gemma":[0.9941175,0.0016389791,0.0022734874,0.000671658,0.0011505667,0.0001478094],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010641173,0.00036634182,0.0019868396,0.00012319599,0.00008452311,0.0000070226074,0.00026616544,0.00029706373,0.0002066812],"category_scores_gemma":[0.0011343542,0.00020746293,0.0024438624,0.00036434302,0.0006362608,0.0000101997275,0.000084073814,0.000098272154,0.0000017055495],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009861134,0.002219899,0.87025243,0.000011874347,0.02068253,1.5263029e-7,0.00010320612,0.00006711721,0.00032888955,0.000020388155,0.0016175401,0.09483482],"study_design_scores_gemma":[0.0061717983,0.002463816,0.9854756,0.00005816071,0.0047772303,7.731904e-7,0.000037705584,0.00013624431,0.0004683296,0.000019702082,0.0002010736,0.00018956498],"about_ca_topic_score_codex":0.0020136763,"about_ca_topic_score_gemma":0.00089752045,"teacher_disagreement_score":0.11522315,"about_ca_system_score_codex":0.00013511935,"about_ca_system_score_gemma":0.0005377449,"threshold_uncertainty_score":0.84600925},"labels":[],"label_agreement":null},{"id":"W2884344149","doi":"10.1016/j.clbc.2018.07.019","title":"Clinical Outcomes of Single Versus Double Hormone Receptor–Positive Breast Cancer Patients Treated With Neoadjuvant Chemotherapy","year":2018,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Health Sciences Centre; Sunnybrook Health Science Centre; Western University","funders":"","keywords":"Medicine; Internal medicine; Breast cancer; Confidence interval; Odds ratio; Univariate analysis; Oncology; Chemotherapy; Logistic regression; Cancer; Gastroenterology; Multivariate analysis","score_opus":0.028335911381362194,"score_gpt":0.347683456628805,"score_spread":0.3193475452474428,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2884344149","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99367326,0.0005400697,0.00001920571,0.0016808382,0.0010837647,0.00046925555,0.001941397,0.000040684194,0.0005515006],"genre_scores_gemma":[0.99498993,0.0016307622,0.00021551941,0.0008460857,0.0016071262,0.00013987986,0.00019690911,0.000085315325,0.00028848252],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969742,0.00014527378,0.0009691105,0.0010310176,0.00034340943,0.00053704105],"domain_scores_gemma":[0.9973809,0.00014715036,0.0005680535,0.0006372673,0.0009916407,0.00027498967],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00024251867,0.00048575515,0.0009286332,0.000043844804,0.0001397486,0.00002159726,0.00033036448,0.00037568226,0.0002984089],"category_scores_gemma":[0.00003847847,0.00035254474,0.00040100506,0.00024468135,0.001310452,0.00001925601,0.0001736643,0.00021305369,0.000029963054],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030340103,0.0019540195,0.90322953,0.0000087487915,0.0021973406,0.0000017264882,0.000052649477,0.000002005023,0.0011019908,0.0000049103237,0.004725711,0.056381233],"study_design_scores_gemma":[0.021926876,0.0026141182,0.9680369,0.00009680643,0.00032725252,0.0000059737154,0.000038869013,0.0000024285496,0.0037360517,0.0000025062434,0.0027790358,0.00043321654],"about_ca_topic_score_codex":0.0014025756,"about_ca_topic_score_gemma":0.00078994187,"teacher_disagreement_score":0.0648073,"about_ca_system_score_codex":0.00014336775,"about_ca_system_score_gemma":0.00026490982,"threshold_uncertainty_score":0.99989265},"labels":[],"label_agreement":null},{"id":"W2884986199","doi":"10.1016/j.clbc.2018.07.018","title":"Including the Ductal Carcinoma-In-Situ (DCIS) Score in the Development of a Multivariable Prediction Model for Recurrence After Excision of DCIS","year":2018,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre","funders":"Canadian Cancer Society Research Institute; Canadian Cancer Society; Cancer Care Ontario","keywords":"Medicine; Ductal carcinoma; In situ; Breast cancer; Oncology; Carcinoma in situ; Internal medicine; Mastectomy; Radiology; Cancer","score_opus":0.07834848226788581,"score_gpt":0.3749532434243623,"score_spread":0.2966047611564765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2884986199","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964676,0.0005255398,0.001801195,0.000352282,0.00022539303,0.0004033588,0.00014288603,0.0000024700373,0.000079312864],"genre_scores_gemma":[0.9975004,0.00009625082,0.0015736439,0.00011206233,0.0002925562,0.00038429972,0.000017520053,0.000010840291,0.000012420006],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986468,0.000074339936,0.0005914012,0.00034106392,0.00014799686,0.00019837845],"domain_scores_gemma":[0.9992005,0.00012400359,0.00017746688,0.0002947325,0.00017729751,0.000025951382],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006988905,0.00013306069,0.00022711731,0.000030569387,0.00006977386,0.0000048939623,0.00023232673,0.00011242486,0.0000064334654],"category_scores_gemma":[0.00011265985,0.00008061137,0.00009119653,0.00013714467,0.0002771022,0.00000774481,0.00017299657,0.00009848074,6.059125e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022786912,0.00037493653,0.95065975,0.000059837526,0.00008443864,7.184511e-7,0.0026875117,0.00017720407,0.0048727086,0.00002069927,0.00028816806,0.038495336],"study_design_scores_gemma":[0.0015799215,0.000121312456,0.98926926,0.00019864373,0.000037075955,0.000004505025,0.0002710866,0.0029838688,0.0050568325,0.000121699246,0.00025023823,0.0001055864],"about_ca_topic_score_codex":0.00009247368,"about_ca_topic_score_gemma":0.0014604058,"teacher_disagreement_score":0.038609482,"about_ca_system_score_codex":0.00004539347,"about_ca_system_score_gemma":0.00024992568,"threshold_uncertainty_score":0.3287236},"labels":[],"label_agreement":null},{"id":"W2887856562","doi":"10.1016/j.clbc.2018.07.007","title":"Expanded-Access Study of Palbociclib in Combination With Letrozole for Treatment of Postmenopausal Women With Hormone Receptor–Positive, HER2-Negative Advanced Breast Cancer","year":2018,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Pfizer (Canada); Ottawa Hospital","funders":"MedImmune; AbbVie; Puma Biotechnology; Novartis; Pfizer; Eli Lilly and Company","keywords":"Palbociclib; Medicine; Letrozole; Neutropenia; Metastatic breast cancer; Breast cancer; Adverse effect; Internal medicine; Oncology; Febrile neutropenia; Expanded access; Fulvestrant; Cancer; Estrogen receptor; Chemotherapy; Tamoxifen","score_opus":0.03019194093956165,"score_gpt":0.38807140220821973,"score_spread":0.3578794612686581,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887856562","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938944,0.00035210088,0.00020489129,0.0011472872,0.00018440829,0.0031305873,0.0009715686,0.00004640237,0.000068374844],"genre_scores_gemma":[0.9955575,0.0003736052,0.00082996377,0.00021876779,0.00035619855,0.0023960508,0.000029282559,0.00009543888,0.00014323337],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99700683,0.00015471825,0.0009878307,0.0007904835,0.0004946551,0.00056546007],"domain_scores_gemma":[0.9967917,0.00038068616,0.00079759565,0.0004958756,0.001278122,0.0002560248],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00024795404,0.00045352383,0.0014414935,0.00017349474,0.000084954154,0.000014922662,0.00021468675,0.00013927299,0.00025343226],"category_scores_gemma":[0.000026473377,0.00031613203,0.00008384534,0.00070497365,0.00083682063,0.00038581045,0.000053101572,0.00016289247,0.0000017948705],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.17755687,0.011916586,0.51450604,0.00013697309,0.0015193967,0.000013588206,0.0051750406,0.00014982629,0.0049090395,0.000024052642,0.000028014267,0.28406456],"study_design_scores_gemma":[0.05312357,0.04021123,0.8981829,0.0006791081,0.00026672386,0.000039177903,0.003507238,0.00003558154,0.003402768,0.00007271128,0.0001304994,0.00034844826],"about_ca_topic_score_codex":0.0019433198,"about_ca_topic_score_gemma":0.002440752,"teacher_disagreement_score":0.38367692,"about_ca_system_score_codex":0.0010164502,"about_ca_system_score_gemma":0.0005904843,"threshold_uncertainty_score":0.9999291},"labels":[],"label_agreement":null},{"id":"W2888237016","doi":"10.1016/j.clbc.2018.08.002","title":"Axillary Management in Breast Cancer Patients: A Comprehensive Review of the Key Trials","year":2018,"lang":"en","type":"review","venue":"Clinical Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":40,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston Health Sciences Centre; Cancer Care South East","funders":"","keywords":"Medicine; Breast cancer; Axilla; Axillary Lymph Node Dissection; Sentinel node; Sentinel lymph node; Radiation therapy; Clinical trial; Randomized controlled trial; Oncology; Biopsy; Surgery; General surgery; Cancer; Internal medicine","score_opus":0.09273697392234953,"score_gpt":0.4358140334634458,"score_spread":0.3430770595410963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2888237016","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000096353324,0.98908657,8.0490616e-7,0.0010357312,0.0018796436,0.0024086665,0.0052350336,0.000010587512,0.0002465865],"genre_scores_gemma":[0.00005599439,0.9941532,0.000031203672,0.002425363,0.0013747565,0.0014544363,0.00027702464,0.00008858055,0.00013945397],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9937208,0.0014204615,0.0028163579,0.0011325846,0.00042869672,0.00048106897],"domain_scores_gemma":[0.9958256,0.00025232456,0.0020120658,0.001209554,0.0005659193,0.0001345285],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009312441,0.0007548007,0.0038540694,0.000075470416,0.00008095404,0.000014210478,0.00087731105,0.00049831736,0.0003107331],"category_scores_gemma":[0.00016718479,0.0004550113,0.0020145443,0.0005106165,0.0005821221,0.000006564538,0.0009770144,0.0003831432,0.000025328138],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019766953,0.0004999494,0.004834039,0.048077174,0.0028127937,0.0000037292978,0.000008737885,3.3840277e-7,2.1373673e-7,0.000006549376,0.038319755,0.90523905],"study_design_scores_gemma":[0.0013709501,0.00004858138,0.034211148,0.11149609,0.00280517,0.000023588007,0.000006512669,1.0460611e-7,8.6200436e-7,0.0000062142017,0.8496143,0.00041648737],"about_ca_topic_score_codex":0.00022424305,"about_ca_topic_score_gemma":0.00008699742,"teacher_disagreement_score":0.9048226,"about_ca_system_score_codex":0.00025571446,"about_ca_system_score_gemma":0.00060671434,"threshold_uncertainty_score":0.9997902},"labels":[],"label_agreement":null},{"id":"W2889734568","doi":"10.1016/j.clbc.2018.08.012","title":"Physician Survey of Timing of Adjuvant Endocrine Therapy Relative to Radiotherapy in Early Stage Breast Cancer Patients","year":2018,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"Ottawa Hospital","keywords":"Medicine; Breast cancer; Oncology; Stage (stratigraphy); Radiation therapy; Internal medicine; Adjuvant; Endocrine system; Adjuvant therapy; Adjuvant radiotherapy; Cancer; Gynecology; Hormone","score_opus":0.04168327726248598,"score_gpt":0.3778543600038195,"score_spread":0.3361710827413335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2889734568","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945723,0.0009796708,0.00004897517,0.00044341615,0.0003858387,0.00037946133,0.003074399,0.000007430012,0.000108507316],"genre_scores_gemma":[0.9966991,0.0017474772,0.00012725763,0.00067500176,0.0004634752,0.000094745905,0.00005087213,0.000044265034,0.00009778064],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99793255,0.00023405325,0.0006944871,0.00056503987,0.0002213546,0.00035250554],"domain_scores_gemma":[0.998362,0.000104105406,0.00036334232,0.0003988835,0.0006545231,0.00011713065],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023630742,0.00026865283,0.00062862434,0.00006560166,0.000043364395,0.0000059543163,0.00025318895,0.00011985696,0.00013406416],"category_scores_gemma":[0.000051117495,0.00022578736,0.00015508673,0.0003301454,0.0004052602,0.000014142618,0.00011594567,0.0001293222,0.000003945734],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031992304,0.0006365571,0.9204805,0.000013281761,0.00040007755,7.8331766e-7,0.00025660373,0.000017448909,0.003960896,0.000004981762,0.00035912954,0.070670545],"study_design_scores_gemma":[0.0035093583,0.0006255037,0.9884929,0.00013594884,0.000021982078,8.9542357e-7,0.00002004313,0.000010341078,0.006293637,0.00000615291,0.0006627151,0.00022052933],"about_ca_topic_score_codex":0.0138827935,"about_ca_topic_score_gemma":0.004390237,"teacher_disagreement_score":0.070450015,"about_ca_system_score_codex":0.0000925665,"about_ca_system_score_gemma":0.00020190056,"threshold_uncertainty_score":0.9926838},"labels":[],"label_agreement":null},{"id":"W2904914229","doi":"10.1016/j.clbc.2018.12.005","title":"Impact of Baseline Cardiovascular Comorbidity on Outcomes in Women With Breast Cancer: A Real-world, Population-based Study","year":2018,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Chemotherapy-induced cardiotoxicity and mitigation","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services; University of Calgary","funders":"","keywords":"Medicine; Breast cancer; Hazard ratio; Internal medicine; Cancer registry; Proportional hazards model; Cancer; Odds ratio; Confidence interval; Population; Comorbidity; Mastectomy; Oncology","score_opus":0.03877624950441126,"score_gpt":0.3948362463287303,"score_spread":0.35605999682431905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2904914229","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99715996,0.000031840635,0.000026447504,0.0009843139,0.0001985881,0.00097250513,0.00045556814,0.000051180035,0.00011960459],"genre_scores_gemma":[0.9980189,0.00007463348,0.000036674348,0.0007432838,0.0008177377,0.0001787687,0.000026845284,0.000044970926,0.000058178786],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99740803,0.0003236792,0.0007519195,0.00055077573,0.0006031291,0.00036244153],"domain_scores_gemma":[0.99805874,0.0002823997,0.00023693968,0.00075653096,0.00039161425,0.0002737926],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012618157,0.00028427865,0.0012904651,0.0001910999,0.00005736135,0.00001195204,0.00012242966,0.00013821076,0.0005924684],"category_scores_gemma":[0.00007796474,0.00019933471,0.0005089249,0.00061516714,0.00016310374,0.00007665509,0.000021157932,0.00037801152,0.0000065934573],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0060672355,0.0016524157,0.9403872,0.000039379367,0.0013309661,0.000016873417,0.00013497628,0.00066770933,0.00014571668,0.0000016309876,0.000078335244,0.049477596],"study_design_scores_gemma":[0.009804773,0.001336745,0.98746437,0.00036124355,0.00027179084,0.000010195205,0.00007029161,0.00024888213,0.00016799786,0.000007931037,0.000042703927,0.00021308307],"about_ca_topic_score_codex":0.03131754,"about_ca_topic_score_gemma":0.006397436,"teacher_disagreement_score":0.049264513,"about_ca_system_score_codex":0.0010494834,"about_ca_system_score_gemma":0.00071385206,"threshold_uncertainty_score":0.975133},"labels":[],"label_agreement":null},{"id":"W2907792903","doi":"10.1016/j.clbc.2019.01.001","title":"Comparison of Radioactive Seed Localized Excision and Wire Localized Excision of Breast Lesions: A Community Hospital’s Experience","year":2019,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; North York General Hospital; University of Toronto","funders":"","keywords":"Medicine; Surgical excision; Breast cancer; Surgery; Radiology; Cancer; Internal medicine","score_opus":0.03508224849894968,"score_gpt":0.39261687460153416,"score_spread":0.35753462610258446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2907792903","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99532175,0.0025444701,0.00045039732,0.0003764613,0.00036339648,0.00047420218,0.00033061067,0.00001660779,0.00012210729],"genre_scores_gemma":[0.99790204,0.0012423111,0.00039913054,0.00013098202,0.00011916505,0.00006464975,0.000056506644,0.000032128188,0.000053101907],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974905,0.00044821014,0.00091836293,0.0005497074,0.00030528966,0.0002878831],"domain_scores_gemma":[0.99775666,0.00033839478,0.0005637794,0.0007999542,0.00037151566,0.00016969473],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00040522104,0.00031692913,0.0009904108,0.000050930274,0.00013039827,0.000011396106,0.00034743102,0.00029962705,0.00009944538],"category_scores_gemma":[0.00013909476,0.00026127102,0.0002528028,0.00019147318,0.00093435094,0.000019036464,0.0004866916,0.00030797246,0.000005871963],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044316673,0.0015111739,0.92652106,0.00011657949,0.00034729546,0.0000013164199,0.001123376,0.000042729753,0.015585045,0.000023859151,0.00039996594,0.049895927],"study_design_scores_gemma":[0.0057038907,0.00082352984,0.97949326,0.00046738243,0.00012406615,0.000029928495,0.0031297815,0.00023455596,0.008703335,0.000067003995,0.00087720196,0.00034606268],"about_ca_topic_score_codex":0.001144236,"about_ca_topic_score_gemma":0.00009465372,"teacher_disagreement_score":0.052972198,"about_ca_system_score_codex":0.000056114477,"about_ca_system_score_gemma":0.00014767368,"threshold_uncertainty_score":0.99998397},"labels":[],"label_agreement":null},{"id":"W2914403239","doi":"10.1016/j.clbc.2019.01.003","title":"Intensive Imaging Surveillance of Survivors of Breast Cancer May Increase Risk of Radiation-induced Malignancy","year":2019,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Radiation Dose and Imaging","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"European Society for Medical Oncology","keywords":"Medicine; Mammography; Breast cancer; Radiology; Asymptomatic; Cancer; Malignancy; Nuclear medicine; Medical physics; Internal medicine","score_opus":0.01734164103829911,"score_gpt":0.3408402520503995,"score_spread":0.32349861101210037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2914403239","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99325526,0.001274928,0.00003734226,0.0023895153,0.00088656205,0.00042773702,0.0012535253,0.000024400166,0.00045071894],"genre_scores_gemma":[0.9966956,0.0019021891,0.00004617385,0.00071073585,0.00036997825,0.000020620686,0.00002897584,0.000040327785,0.00018539584],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99721605,0.00026368946,0.0013723235,0.00044405652,0.00040833646,0.00029556648],"domain_scores_gemma":[0.9960161,0.0006551854,0.0012842285,0.00058950024,0.0012388375,0.00021614287],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00089262734,0.00022434954,0.0010778431,0.00016721088,0.000026581263,0.0000066021494,0.00019392617,0.00011695982,0.001380395],"category_scores_gemma":[0.00056450086,0.00019375877,0.00035758963,0.00047177236,0.00023243263,0.00018502641,0.000067535446,0.00033325964,0.000020570153],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00067107833,0.00015017184,0.85865337,0.00019972664,0.0002641743,0.0000034306554,0.00011887058,0.000056226785,0.0037634755,0.0000204167,0.00051843876,0.13558061],"study_design_scores_gemma":[0.0030798893,0.00006836554,0.9897922,0.0006737294,0.00019239068,0.000036732064,0.00019957268,0.001204574,0.004404782,0.00001789436,0.00014809023,0.00018177443],"about_ca_topic_score_codex":0.014873662,"about_ca_topic_score_gemma":0.00018841762,"teacher_disagreement_score":0.13539885,"about_ca_system_score_codex":0.000095493284,"about_ca_system_score_gemma":0.0006672751,"threshold_uncertainty_score":0.99953246},"labels":[],"label_agreement":null},{"id":"W2921234713","doi":"10.1016/j.clbc.2019.03.002","title":"Isolated Tumor Cells in Sentinel Lymph Nodes of Primary Invasive Breast Carcinoma: A Cohort Analysis","year":2019,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Medicine; Immunohistochemistry; Breast cancer; Sentinel node; Sentinel lymph node; Cohort; Pathology; Oncology; Lymph node; Internal medicine; Cancer","score_opus":0.010948372823360811,"score_gpt":0.27797298712294627,"score_spread":0.26702461429958546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2921234713","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969243,0.00072394655,0.000021309676,0.00031113884,0.0002563441,0.00027382132,0.0009179746,0.000013359514,0.0005578156],"genre_scores_gemma":[0.9980929,0.00039684967,0.00006189808,0.0006596965,0.00022420111,0.00007528716,0.00023212319,0.000033849134,0.00022322661],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976337,0.00014901893,0.0007972408,0.0008127423,0.00021833912,0.0003889466],"domain_scores_gemma":[0.99852055,0.00011664011,0.00035314113,0.0006239736,0.00025666258,0.000129028],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002859022,0.0003040269,0.0009169683,0.00013049986,0.000033011867,0.000012150047,0.000274757,0.00019546834,0.0002238666],"category_scores_gemma":[0.00002721722,0.000271486,0.0004873248,0.000583101,0.00023925354,0.000009416835,0.0002711359,0.00014578851,0.000033514385],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008822024,0.0004194017,0.9797121,0.00007361841,0.0016079432,0.000012936815,0.00002452662,0.00013463531,0.015613463,0.000002677116,0.00020014499,0.0013163488],"study_design_scores_gemma":[0.0026474327,0.000031722226,0.9942154,0.00006036628,0.0007065879,0.000035842637,0.000052423784,0.00011935489,0.0017888662,0.0000056543804,0.00005764087,0.00027867325],"about_ca_topic_score_codex":0.0015712829,"about_ca_topic_score_gemma":0.00022448461,"teacher_disagreement_score":0.014503334,"about_ca_system_score_codex":0.00012261198,"about_ca_system_score_gemma":0.00042266544,"threshold_uncertainty_score":0.9999737},"labels":[],"label_agreement":null},{"id":"W2945204224","doi":"10.1016/j.clbc.2019.05.007","title":"Symptoms Predictive of Overall Quality of Life Using the Edmonton Symptom Assessment Scale in Breast Cancer Patients Receiving Radiotherapy","year":2019,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Cancer survivorship and care","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"London Health Sciences Centre; Health Sciences Centre; Western University; Sunnybrook Health Science Centre","funders":"Ofelia Cancer Research Fund; Joey and Mary Furfari Cancer Research Fund; Michael and Karyn Goldstein Cancer Research Fund; Joseph and Silvana Melara Cancer Research Fund","keywords":"Medicine; Anxiety; Breast cancer; Quality of life (healthcare); Depression (economics); Physical therapy; Hospital Anxiety and Depression Scale; Cancer; Stepwise regression; Internal medicine; Psychiatry","score_opus":0.029791024623103138,"score_gpt":0.39234177196101305,"score_spread":0.36255074733790993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2945204224","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941592,0.0008851633,0.000078799036,0.0013969811,0.0015233383,0.0008074897,0.00071221037,0.000021110314,0.00041567665],"genre_scores_gemma":[0.9971023,0.00094459957,0.00004880286,0.001168898,0.0005242754,0.00006435321,0.000015066454,0.000041876,0.000089826826],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965893,0.00043979997,0.0013724216,0.00052089547,0.0007206755,0.00035692536],"domain_scores_gemma":[0.9974633,0.0004725529,0.0007312253,0.0005958104,0.00052747317,0.0002096494],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010766108,0.0002523937,0.0010970813,0.000081061095,0.00003620422,0.000012512034,0.00024812287,0.0002326545,0.0008514798],"category_scores_gemma":[0.00004740911,0.00018106091,0.00036799858,0.00034793135,0.00027870134,0.00014579244,0.00008956729,0.0005120552,0.0000011878348],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002384007,0.00064371765,0.9769743,0.00026090944,0.00029462742,3.2704773e-7,0.0006313848,0.00037273535,0.0008349531,0.000017844584,0.00011062498,0.017474582],"study_design_scores_gemma":[0.005013851,0.00022659208,0.99082446,0.0012532162,0.00011366496,0.0000031246745,0.00024403833,0.0019602624,0.00003278981,0.000015306161,0.00012875018,0.00018394277],"about_ca_topic_score_codex":0.02008643,"about_ca_topic_score_gemma":0.003083353,"teacher_disagreement_score":0.017290639,"about_ca_system_score_codex":0.0006859646,"about_ca_system_score_gemma":0.0010320238,"threshold_uncertainty_score":0.9864389},"labels":[],"label_agreement":null},{"id":"W2947085112","doi":"10.1016/j.clbc.2019.05.002","title":"Frequency of Immune Cell Subtypes in Peripheral Blood Correlates With Outcome for Patients With Metastatic Breast Cancer Treated With High-Dose Chemotherapy","year":2019,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences North; NOSM University; Laurentian University","funders":"","keywords":"Medicine; Breast cancer; Chemotherapy; Immune system; Oncology; Metastatic breast cancer; Internal medicine; Peripheral; Peripheral blood; Cancer; Immunology","score_opus":0.010271630282281561,"score_gpt":0.2735510560594746,"score_spread":0.26327942577719304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2947085112","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939603,0.002297779,0.000015066069,0.00033629907,0.0006768844,0.0014894718,0.0010930137,0.000047529524,0.00008361581],"genre_scores_gemma":[0.9965155,0.00028811218,0.0003988481,0.00029337607,0.000042008636,0.00037173808,0.00017560569,0.00011603871,0.0017987458],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971513,0.00018928196,0.0011124018,0.00075201574,0.00012346791,0.0006714889],"domain_scores_gemma":[0.99768627,0.00039315017,0.0007594576,0.0006300482,0.0004762631,0.000054784505],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00028470182,0.0005091453,0.001308026,0.000108021624,0.000072395305,0.000015547595,0.0004038095,0.0003068983,0.0027910783],"category_scores_gemma":[0.000011127109,0.0003222503,0.0001786302,0.00036612974,0.00067513343,0.00018817688,0.000044596913,0.0005928953,0.00003472573],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011410499,0.0017433128,0.9777688,0.00019250037,0.0011648638,0.000004698309,0.00015405024,0.00017199016,0.0042307996,0.000026878417,0.000060331815,0.0030713093],"study_design_scores_gemma":[0.037238073,0.0016746579,0.955429,0.00047102108,0.0005478438,0.000034556513,0.00008507237,0.00000781845,0.0038365084,0.000016696167,0.00012350778,0.0005352322],"about_ca_topic_score_codex":0.0044824397,"about_ca_topic_score_gemma":0.000864047,"teacher_disagreement_score":0.025827572,"about_ca_system_score_codex":0.00017484972,"about_ca_system_score_gemma":0.0004377939,"threshold_uncertainty_score":0.99992293},"labels":[],"label_agreement":null},{"id":"W2950065662","doi":"10.1016/j.clbc.2019.05.020","title":"Efficacy of Neoadjuvant Endocrine Therapy Versus Neoadjuvant Chemotherapy in ER-positive Breast Cancer: Results From a Prospective Institutional Database","year":2019,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Waterloo; BC Cancer Agency","funders":"AbbVie","keywords":"Medicine; Breast cancer; Oncology; Neoadjuvant therapy; Chemotherapy; Endocrine system; Internal medicine; Prospective cohort study; Cancer; Hormone","score_opus":0.023558056259878144,"score_gpt":0.34408901428048977,"score_spread":0.3205309580206116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2950065662","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9744583,0.003096897,0.00002004663,0.003285452,0.0012492081,0.00088599423,0.016549215,0.000025080992,0.00042984096],"genre_scores_gemma":[0.9887321,0.008110774,0.0001780568,0.0006065779,0.0011701686,0.00020326674,0.00086454855,0.000048139253,0.0000863609],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969378,0.00014575153,0.00088897586,0.0012036699,0.0003403071,0.00048348436],"domain_scores_gemma":[0.998095,0.0002982298,0.00039766135,0.0007372392,0.00030605268,0.00016584092],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00022751937,0.0004408738,0.00074833294,0.00006806952,0.00007521135,0.000017299368,0.00036687448,0.00020208457,0.00031090423],"category_scores_gemma":[0.000078505225,0.00037099473,0.00029138246,0.0002673978,0.000479195,0.000026775742,0.0002184306,0.00032913376,0.000026187912],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1553131,0.0029458273,0.5998162,0.0000270742,0.0021915254,0.000044066783,0.00039786714,0.00051628414,0.020418763,0.00014966933,0.0011371194,0.2170425],"study_design_scores_gemma":[0.049114782,0.00039351755,0.93924093,0.00031536797,0.00006726314,0.000022889666,0.000074547155,0.000045841152,0.008347556,0.000028785498,0.0019456634,0.00040282865],"about_ca_topic_score_codex":0.007506226,"about_ca_topic_score_gemma":0.0013675907,"teacher_disagreement_score":0.33942476,"about_ca_system_score_codex":0.00025461437,"about_ca_system_score_gemma":0.00068665337,"threshold_uncertainty_score":0.9998742},"labels":[],"label_agreement":null},{"id":"W2956139542","doi":"10.1016/j.clbc.2019.05.013","title":"Effect of Exercise on Taxane Chemotherapy–Induced Peripheral Neuropathy in Women With Breast Cancer: A Randomized Controlled Trial","year":2019,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of Alberta; University of British Columbia","funders":"University of British Columbia","keywords":"Medicine; Chemotherapy-induced peripheral neuropathy; Taxane; Breast cancer; Randomized controlled trial; Oncology; Peripheral neuropathy; Internal medicine; Chemotherapy; Cancer; Physical therapy; Endocrinology; Diabetes mellitus","score_opus":0.011403874610716057,"score_gpt":0.355187699852125,"score_spread":0.34378382524140894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2956139542","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9853583,0.00042227528,4.0353083e-7,0.0029644147,0.0015483437,0.009130233,0.00007936462,0.000042794723,0.00045387042],"genre_scores_gemma":[0.99061793,0.0014779753,0.0000041971653,0.0014789494,0.0008236921,0.0044092587,0.000006089173,0.00006213372,0.0011197471],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9965267,0.0009012414,0.0010959734,0.0006130971,0.00037047674,0.00049251755],"domain_scores_gemma":[0.9970821,0.0015966927,0.0005374424,0.00037440512,0.0001292999,0.00028005036],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016228234,0.00041985986,0.0042774333,0.00012974486,0.00002526914,0.000012151717,0.00014482775,0.00021665945,0.0051667956],"category_scores_gemma":[0.00006452448,0.00024331376,0.0005759055,0.0002862853,0.00023245944,0.00006133028,0.000025024163,0.0005190363,0.000021708807],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.89131695,0.0014311065,0.03126635,0.000153782,0.00077346596,0.00004224388,0.00017023846,0.000028893926,0.00097491534,0.0000021542467,0.00016527316,0.07367466],"study_design_scores_gemma":[0.95181763,0.008795212,0.03702569,0.0007071345,0.0008136399,0.0000332986,0.000015550248,0.00022305224,0.00024604428,0.0000028931129,0.000098699915,0.00022117032],"about_ca_topic_score_codex":0.00066992117,"about_ca_topic_score_gemma":0.000037238726,"teacher_disagreement_score":0.073453486,"about_ca_system_score_codex":0.00037783643,"about_ca_system_score_gemma":0.00056278886,"threshold_uncertainty_score":0.9957426},"labels":[],"label_agreement":null},{"id":"W2962460569","doi":"10.1016/j.clbc.2019.06.007","title":"Incidence of Brain Metastases in Nonmetastatic and Metastatic Breast Cancer: Is There a Role for Screening?","year":2019,"lang":"en","type":"review","venue":"Clinical Breast Cancer","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto; McMaster University Medical Centre","funders":"Pfizer Canada; Roche; Novartis; AstraZeneca","keywords":"Medicine; Breast cancer; Incidence (geometry); Oncology; Internal medicine; Metastatic breast cancer; Cancer","score_opus":0.1126630097334715,"score_gpt":0.4602386974483536,"score_spread":0.3475756877148821,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2962460569","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00048489662,0.96855676,0.00018016006,0.0024589573,0.0002544718,0.003930856,0.024079278,0.000026294461,0.000028347638],"genre_scores_gemma":[0.0009868758,0.9910176,0.003918143,0.0014430464,0.00028116815,0.0014815814,0.0002894098,0.0001668854,0.00041530735],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9941607,0.00070246425,0.0025228036,0.0013243037,0.0005862907,0.0007034358],"domain_scores_gemma":[0.9931155,0.003805371,0.0014274506,0.0009274523,0.0002734722,0.00045075774],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0020817171,0.0009058715,0.006185796,0.00033673877,0.000060243485,0.000044083477,0.00037078655,0.0003169296,0.0011388282],"category_scores_gemma":[0.00030916312,0.00063078105,0.0016048696,0.0006454356,0.0004298686,0.00015081499,0.00028935727,0.0007231569,0.000022735027],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050287985,0.0006704381,0.0049176672,0.026507713,0.0030185424,0.000060352195,0.000047461133,0.000004371794,3.9206378e-7,0.000062744584,0.0016127843,0.9625946],"study_design_scores_gemma":[0.013152499,0.0013560264,0.022391755,0.0889893,0.037063368,0.001703773,0.0002600368,0.00046258955,0.0000031871025,0.0003673491,0.83277816,0.0014719324],"about_ca_topic_score_codex":0.0018966408,"about_ca_topic_score_gemma":0.00036595573,"teacher_disagreement_score":0.9611227,"about_ca_system_score_codex":0.0002163749,"about_ca_system_score_gemma":0.0015926867,"threshold_uncertainty_score":0.9997743},"labels":[],"label_agreement":null},{"id":"W2969651887","doi":"10.1016/j.clbc.2019.06.013","title":"Impact of NCI Socioeconomic Index on the Outcomes of Nonmetastatic Breast Cancer Patients: Analysis of SEER Census Tract–Level Socioeconomic Database","year":2019,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Socioeconomic status; Breast cancer; Hazard ratio; Proportional hazards model; Demography; Epidemiology; Confidence interval; Cancer registry; Cohort; Cancer; Multivariate analysis; Oncology; Gynecology; Gerontology; Internal medicine; Population; Environmental health","score_opus":0.09886965925997132,"score_gpt":0.4275932679825297,"score_spread":0.3287236087225584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2969651887","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98168784,0.00013068078,0.000011494009,0.001816535,0.000296377,0.00048199095,0.015411248,0.00000987987,0.00015393566],"genre_scores_gemma":[0.997971,0.00020592759,0.00003808832,0.0013405102,0.00012241653,0.0000324978,0.00014221453,0.000031352683,0.000115968964],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99688065,0.00014590136,0.0016296374,0.0005226756,0.00041502586,0.00040610277],"domain_scores_gemma":[0.9962077,0.000990042,0.0013104827,0.0008239147,0.00045221517,0.00021560257],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00087779487,0.00031897676,0.0018013571,0.00020300908,0.000038443904,0.000009404419,0.0003667652,0.00017489945,0.006543949],"category_scores_gemma":[0.00010067722,0.00020535698,0.0014119662,0.00028591685,0.00041478005,0.00017749083,0.000100478304,0.00044644793,0.000045907578],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013106372,0.00055536965,0.9796333,0.000074004274,0.0054376777,0.0000012437608,0.0001151084,0.001411552,0.00008062776,0.00003843684,0.0010359776,0.010306089],"study_design_scores_gemma":[0.0027400535,0.00032461484,0.99231493,0.00017347145,0.002489276,0.000003331364,0.00021462012,0.0014667474,0.000027322661,0.000016907192,0.00003748105,0.00019122279],"about_ca_topic_score_codex":0.0077926097,"about_ca_topic_score_gemma":0.00041730446,"teacher_disagreement_score":0.016283166,"about_ca_system_score_codex":0.0005188053,"about_ca_system_score_gemma":0.0007455189,"threshold_uncertainty_score":0.9988146},"labels":[],"label_agreement":null},{"id":"W2969655256","doi":"10.1016/j.clbc.2019.07.006","title":"Selecting Patients for Oncotype DX Testing Using Standard Clinicopathologic Information","year":2019,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Ottawa Hospital; University of Ottawa","funders":"Ottawa Hospital Research Institute","keywords":"Medicine; Breast cancer; Oncology; Gynecology; Internal medicine; Cancer; Medical physics","score_opus":0.04354266090632091,"score_gpt":0.3739665315014595,"score_spread":0.33042387059513856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2969655256","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99660623,0.00013492868,0.00059871655,0.0001295795,0.001099969,0.0005102912,0.00043253324,0.000030958396,0.00045681192],"genre_scores_gemma":[0.9942945,0.00005052693,0.0038347326,0.0009252344,0.00064610306,0.00006383392,0.00012750359,0.000023881326,0.00003365308],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985469,0.00006167135,0.00057252834,0.00036357078,0.00013982384,0.00031551713],"domain_scores_gemma":[0.99855185,0.0001753558,0.00034491083,0.0002462786,0.00060381735,0.000077782264],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004049855,0.00018685327,0.00030981074,0.000028399036,0.00012892528,0.000029529527,0.00013254855,0.0001905315,0.000025782918],"category_scores_gemma":[0.0005896078,0.00016288919,0.00015133948,0.00012783988,0.00007110356,0.000022626675,0.00012721943,0.00012812697,0.000023982586],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00073008286,0.000066213026,0.90491927,0.000029612153,0.00007021355,1.2385124e-7,0.000020056164,0.00016051135,0.0004242049,0.000004849665,0.0006270546,0.09294783],"study_design_scores_gemma":[0.0050026933,0.0009021423,0.9796781,0.00012408757,0.000121874255,0.000011931903,0.00007933543,0.0004261922,0.0006574842,0.000061349725,0.012544488,0.0003903329],"about_ca_topic_score_codex":0.000048292288,"about_ca_topic_score_gemma":0.000017865184,"teacher_disagreement_score":0.092557505,"about_ca_system_score_codex":0.000096780896,"about_ca_system_score_gemma":0.00024660493,"threshold_uncertainty_score":0.6642428},"labels":[],"label_agreement":null},{"id":"W2972053075","doi":"10.1016/j.clbc.2019.08.008","title":"The Role of CXCL13 and CXCL9 in Early Breast Cancer","year":2019,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Chemokine receptors and signaling","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Division of Materials Research; Bristol-Myers Squibb Canada; Ipsen Biopharmaceuticals; British Microcirculation Society; Amgen; Boehringer Ingelheim; Roche; European Organisation for Research and Treatment of Cancer; Novartis; Meso Scale Diagnostics; Sanofi; Merck; Pfizer; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; CXCL13; Breast cancer; Internal medicine; Chemokine; Hazard ratio; Oncology; Cancer; Immunology; Inflammation; Chemokine receptor","score_opus":0.013339141883159402,"score_gpt":0.33139878025470615,"score_spread":0.31805963837154677,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2972053075","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99139863,0.0032460638,7.895323e-7,0.0037623816,0.00033791727,0.00024050304,0.00006668262,0.000012524349,0.0009345116],"genre_scores_gemma":[0.99661005,0.001821224,0.000016303517,0.0003355985,0.00055103295,0.000024748919,0.0000018770513,0.000020450709,0.00061869825],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987105,0.00004598219,0.0005138132,0.00027939482,0.00020308979,0.0002472156],"domain_scores_gemma":[0.99904066,0.00030668167,0.0001356003,0.00024924145,0.00012182573,0.0001459834],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041752527,0.00012457585,0.00043415953,0.00003144158,0.000031024087,0.000014349429,0.00009937245,0.00012965935,0.00075120403],"category_scores_gemma":[0.000033678247,0.00007884396,0.000125764,0.00016078891,0.00017336874,0.000050573326,0.00006545537,0.0003453814,0.00001781746],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000475106,0.00007101707,0.8324881,0.000032314394,0.000048243495,0.0000013555963,0.000069409565,0.000003368784,0.0014520923,0.00007066993,0.00017991678,0.16510838],"study_design_scores_gemma":[0.0018366947,0.00006626064,0.988837,0.00038261304,0.00005062884,0.000035208468,0.000117612006,0.00033838,0.0004507987,0.00013583919,0.007645934,0.0001030391],"about_ca_topic_score_codex":0.0019642005,"about_ca_topic_score_gemma":0.00023256459,"teacher_disagreement_score":0.16500536,"about_ca_system_score_codex":0.00005745084,"about_ca_system_score_gemma":0.00019627658,"threshold_uncertainty_score":0.8225157},"labels":[],"label_agreement":null},{"id":"W2972122997","doi":"10.1016/j.clbc.2019.08.009","title":"Progression-free Survival Outcome Is Independent of Objective Response in Patients With Estrogen Receptor-positive, Human Epidermal Growth Factor Receptor 2-negative Advanced Breast Cancer Treated With Palbociclib Plus Letrozole Compared With Letrozole: Analysis From PALOMA-2","year":2019,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Daiichi Sankyo Europe; Genentech; Daiichi Sankyo Company; Plexxikon; PharmaMar; Eisai; MacroGenics; Amgen; Nippon Kayaku; Astellas Pharma; Mylan; Genomic Health; Novartis Pharma; Novartis; Pfizer; Ontario Brain Institute; Merck; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Palbociclib; Letrozole; Medicine; Breast cancer; Internal medicine; Oncology; Placebo; Metastatic breast cancer; Estrogen receptor; Progression-free survival; Odds ratio; Population; Adverse effect; Cancer; Gynecology; Tamoxifen; Chemotherapy; Pathology","score_opus":0.02003432836318951,"score_gpt":0.3391463333567022,"score_spread":0.31911200499351267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2972122997","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98208696,0.00020604377,0.00013568284,0.0012625989,0.00020136085,0.0026311653,0.013285343,0.00013441623,0.00005642586],"genre_scores_gemma":[0.9958948,0.000036649362,0.001937019,0.00048127695,0.00021078794,0.0005236281,0.0005466028,0.00020481762,0.00016440073],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99217623,0.0009619843,0.0018659782,0.0019607928,0.0019445313,0.0010904855],"domain_scores_gemma":[0.99297684,0.0011866149,0.0017847229,0.0014170452,0.0019513624,0.00068341783],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000504741,0.0011030898,0.003372206,0.0005526862,0.00017064974,0.00004705692,0.0006458896,0.00041202188,0.002819317],"category_scores_gemma":[0.00012356679,0.0007506729,0.00047503668,0.0023286396,0.0010659083,0.00064227224,0.00023071963,0.0012600519,0.000021943513],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19629699,0.0011872198,0.79006785,0.000076032884,0.004936942,0.000027711616,0.00073603133,0.0004532479,0.0008324634,0.0000052235328,0.000017284721,0.0053630173],"study_design_scores_gemma":[0.048805326,0.002743051,0.94168526,0.0014625533,0.0013195368,0.00000936448,0.00082971615,0.00006774623,0.0021196774,0.000010259782,0.000022560345,0.0009249426],"about_ca_topic_score_codex":0.0055562025,"about_ca_topic_score_gemma":0.001906997,"teacher_disagreement_score":0.15161744,"about_ca_system_score_codex":0.0018422935,"about_ca_system_score_gemma":0.0010485562,"threshold_uncertainty_score":0.99949443},"labels":[],"label_agreement":null},{"id":"W3005471759","doi":"10.1016/j.clbc.2020.01.013","title":"Population-based Study of Prosigna-PAM50 and Outcome Among Postmenopausal Women With Estrogen Receptor-positive and HER2-negative Operable Invasive Lobular or Ductal Breast Cancer","year":2020,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Celgene; Roche; Novartis; AstraZeneca","keywords":"Medicine; Oncology; Breast cancer; Internal medicine; Estrogen receptor; Postmenopausal women; Population; Cancer","score_opus":0.022222844624507913,"score_gpt":0.3124580324885053,"score_spread":0.2902351878639974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3005471759","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995267,0.00036095883,0.000008053534,0.0017422026,0.00008042859,0.0010081314,0.0015021785,0.000019534475,0.000011533851],"genre_scores_gemma":[0.9978058,0.00017334212,0.00016917558,0.00086020865,0.00031849113,0.0005302427,0.000056390298,0.00005316168,0.000033204517],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977409,0.00020598403,0.00056130375,0.00088746514,0.0002409836,0.0003633448],"domain_scores_gemma":[0.9986566,0.00014456837,0.00031667989,0.00023912235,0.00031490915,0.00032814874],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00014329192,0.00038627008,0.0006943004,0.000029704786,0.0001526752,0.000034238772,0.00014788393,0.00015318966,0.00013754446],"category_scores_gemma":[0.00008402026,0.00027889427,0.000049406004,0.00018926598,0.0003782832,0.000026090225,0.00018867994,0.00019056234,0.0000013351872],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007756781,0.00052489334,0.9858259,0.00007164521,0.0010260234,0.000018200792,0.0008892011,0.0001400291,0.0014353449,0.000002183237,0.00005336333,0.0022564495],"study_design_scores_gemma":[0.0053689918,0.0027511208,0.98798114,0.00011416561,0.00024957757,0.000023338576,0.0017971589,0.000019888676,0.0013247353,0.0000035149137,0.000013931869,0.00035245132],"about_ca_topic_score_codex":0.0043193093,"about_ca_topic_score_gemma":0.0019336978,"teacher_disagreement_score":0.0025388051,"about_ca_system_score_codex":0.000111917514,"about_ca_system_score_gemma":0.0003418178,"threshold_uncertainty_score":0.9999663},"labels":[],"label_agreement":null},{"id":"W3010178347","doi":"10.1016/j.clbc.2020.03.001","title":"Surgical and Oncologic Outcomes of Nipple-Sparing Mastectomy for a Cohort of Breast Cancer Patients, Including Cases with High-Risk Features","year":2020,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Breast Implant and Reconstruction","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; Montreal General Hospital; Cegep de Saint Jerome; McGill University; McGill University Health Centre","funders":"","keywords":"Medicine; Mastectomy; Breast cancer; Cohort; General surgery; Cancer; Surgery; Oncology; Internal medicine","score_opus":0.04764079366895344,"score_gpt":0.351772085054998,"score_spread":0.30413129138604456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3010178347","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99467593,0.00034313553,0.000019088233,0.0018944185,0.00032017558,0.00067446596,0.0020093513,0.000035111225,0.000028296961],"genre_scores_gemma":[0.99845475,0.00034908138,0.00037433745,0.00013308659,0.0005102312,0.00007647042,0.00003888704,0.000025420668,0.00003774421],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99832875,0.000068570276,0.0006907651,0.00041553716,0.00024448778,0.00025191967],"domain_scores_gemma":[0.9980916,0.0006855001,0.0005102278,0.0001338616,0.00031366482,0.00026516904],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022018248,0.0002194488,0.0010644688,0.000055614568,0.00007263303,0.000008604349,0.00008044498,0.00020795512,0.0001305581],"category_scores_gemma":[0.00007558506,0.00013755735,0.0001777866,0.00017605559,0.00038217648,0.00007926143,0.00008370928,0.00032364082,5.323081e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0051987926,0.00018558375,0.87437135,0.00023874678,0.0004874953,0.000014735349,0.000041635933,0.000012990981,0.00001720643,0.000031018077,0.00024054457,0.11915991],"study_design_scores_gemma":[0.0075502526,0.00064629974,0.9870594,0.00034116767,0.000818441,0.0030771308,0.0000706074,0.00005776422,0.000097059834,0.000011533776,0.00010471695,0.0001656004],"about_ca_topic_score_codex":0.0018454755,"about_ca_topic_score_gemma":0.00037814418,"teacher_disagreement_score":0.11899431,"about_ca_system_score_codex":0.000058297952,"about_ca_system_score_gemma":0.00020619425,"threshold_uncertainty_score":0.56094253},"labels":[],"label_agreement":null},{"id":"W3011736972","doi":"10.1016/j.clbc.2020.03.005","title":"Evaluating Family History Links between Breast Cancer and Prostate Cancer Among PLCO Trial Participants","year":2020,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Cancer Institute","keywords":"Medicine; Breast cancer; Prostate cancer; Oncology; Family history; Internal medicine; Hazard ratio; Proportional hazards model; Cancer; Gynecology; Prostate; Incidence (geometry); Confidence interval","score_opus":0.25127705688116014,"score_gpt":0.45284809938464776,"score_spread":0.20157104250348762,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3011736972","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9523986,0.013230368,0.000002765822,0.028686322,0.001503456,0.0020238976,0.0017980469,0.00014472076,0.00021184102],"genre_scores_gemma":[0.9723909,0.01077751,0.000072704315,0.008379482,0.0053693377,0.002295759,0.00005258295,0.00010613466,0.0005555773],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99567014,0.0001780371,0.0013648274,0.0012480314,0.00065519137,0.00088378787],"domain_scores_gemma":[0.9968362,0.0003957525,0.00054305285,0.00041164152,0.00038004847,0.0014332985],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006873557,0.000503204,0.0013791206,0.000058114885,0.00013989356,0.00004647759,0.00017936275,0.0004266948,0.0011752808],"category_scores_gemma":[0.00015873453,0.0004057248,0.00033600378,0.00024606858,0.00057402975,0.00022585869,0.00017736878,0.0010699502,0.000033500673],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013429361,0.00027803384,0.7537901,0.00018772557,0.00069502206,0.000043418582,0.0006050059,0.0000381543,0.00009796633,0.0000052716177,0.004996,0.22583395],"study_design_scores_gemma":[0.047108933,0.0011159276,0.9384351,0.0009628638,0.0017787615,0.0000067326605,0.00008562357,0.00079199544,0.00005635396,0.00001933794,0.009191648,0.0004467506],"about_ca_topic_score_codex":0.0037094662,"about_ca_topic_score_gemma":0.0002579942,"teacher_disagreement_score":0.2253872,"about_ca_system_score_codex":0.0011426866,"about_ca_system_score_gemma":0.0017580073,"threshold_uncertainty_score":0.9998395},"labels":[],"label_agreement":null},{"id":"W3013629755","doi":"10.1016/j.clbc.2020.03.006","title":"Use of Adjuvant Breast Hypofractionation Radiation Treatment at a Cancer Center in Ontario From 2011 to 2018","year":2020,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hamilton Health Sciences; Health Sciences Centre; University of Toronto; Juravinski Cancer Centre; Sunnybrook Health Science Centre","funders":"Michael and Karyn Goldstein Cancer Research Fund; Joseph and Silvana Melara Cancer Research Fund","keywords":"Medicine; Breast cancer; Adjuvant; Center (category theory); Adjuvant radiotherapy; Radiation therapy; Cancer; Oncology; Medical physics; Internal medicine","score_opus":0.07963249277138526,"score_gpt":0.3361842361129861,"score_spread":0.2565517433416008,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3013629755","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9867104,0.00060659857,0.000045003737,0.008630582,0.00056811445,0.0003692301,0.0030112255,0.000012734782,0.00004607991],"genre_scores_gemma":[0.9944639,0.0013532127,0.00017863323,0.0021448992,0.00074558874,0.0002484132,0.00047736894,0.000029658066,0.00035829315],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99831295,0.0000836399,0.0005405008,0.0006477701,0.00017265911,0.00024246995],"domain_scores_gemma":[0.999114,0.00006609779,0.00021738953,0.00026645718,0.00012498525,0.00021108089],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000053407297,0.00024317227,0.00040932407,0.00003613096,0.000045881483,0.000012106211,0.000108687884,0.00016255368,0.00095248624],"category_scores_gemma":[0.000028527973,0.00021321414,0.00017953843,0.000088197165,0.00007534689,0.000019285033,0.00012703345,0.00010153449,0.000059879534],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024317526,0.00038736226,0.90843713,0.000004898367,0.00031844058,0.0000029656012,0.00026038734,0.00029764755,0.0034823478,0.0000012656621,0.0067215287,0.077654265],"study_design_scores_gemma":[0.002420221,0.00018182101,0.9445812,0.00004201146,0.00009086667,0.000005641106,0.000018603,0.000033818782,0.0023578797,0.000003881227,0.050070483,0.0001935608],"about_ca_topic_score_codex":0.17899252,"about_ca_topic_score_gemma":0.3225581,"teacher_disagreement_score":0.14356558,"about_ca_system_score_codex":0.00080848683,"about_ca_system_score_gemma":0.00033174857,"threshold_uncertainty_score":0.9999608},"labels":[],"label_agreement":null},{"id":"W3033263543","doi":"10.1016/j.clbc.2020.05.016","title":"Oncoplastic Repair in Breast Conservation: Comprehensive Evaluation of Techniques and Oncologic Outcomes of 937 Patients","year":2020,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Breast Implant and Reconstruction","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Seroma; Breast cancer; Surgery; Breast-conserving surgery; Ductal carcinoma; Breast surgery; Mastectomy; Oncoplastic Surgery; General surgery; Mammaplasty; Complication; Cancer; Internal medicine","score_opus":0.10171453167683273,"score_gpt":0.40269072572653775,"score_spread":0.300976194049705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3033263543","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99474776,0.00011767158,0.0000057507073,0.0039544757,0.00023066471,0.0005230229,0.00023112158,0.000040324354,0.00014919751],"genre_scores_gemma":[0.99867827,0.00007791142,0.00048339972,0.0005494993,0.00014270279,0.000026629337,0.000026795367,0.000008403744,0.000006397899],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983956,0.00016580132,0.0007908128,0.00024098692,0.00030140442,0.00010536769],"domain_scores_gemma":[0.9983998,0.00033878838,0.00034584137,0.00011019692,0.000696471,0.00010889695],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000332133,0.00011516268,0.00059749343,0.000062210616,0.000015627107,0.0000017731765,0.00004088771,0.00016321207,0.00013281316],"category_scores_gemma":[0.000110111505,0.00008811882,0.00011165255,0.00019014638,0.00028533654,0.000066953915,0.0000392028,0.000188163,0.0000019612983],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007725926,0.00018515743,0.78191125,0.00011792544,0.00006784001,0.0000022646534,0.00004053094,0.0000021454764,0.00003738893,0.000015998126,0.00031552458,0.21653135],"study_design_scores_gemma":[0.0041534323,0.00033178448,0.9932081,0.00027621092,0.00025691456,0.0005847368,0.000076440585,0.00080464553,0.000058378664,0.000056419573,0.00011318854,0.00007974624],"about_ca_topic_score_codex":0.0001499592,"about_ca_topic_score_gemma":0.000031830376,"teacher_disagreement_score":0.21645162,"about_ca_system_score_codex":0.0000647815,"about_ca_system_score_gemma":0.00029000815,"threshold_uncertainty_score":0.3593381},"labels":[],"label_agreement":null},{"id":"W3040901621","doi":"10.1016/j.clbc.2020.07.004","title":"Looking for Metastasis in Early Breast Cancer: Does Bone Scan Help? A Retrospective Review","year":2020,"lang":"en","type":"review","venue":"Clinical Breast Cancer","topic":"Medical Imaging Techniques and Applications","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Eastern Health","keywords":"Medicine; Breast cancer; Radiology; Pelvis; Metastasis; Bone scintigraphy; Retrospective cohort study; Abdomen; Cancer; Nuclear medicine; Surgery; Internal medicine","score_opus":0.08204565611476444,"score_gpt":0.4735750478685154,"score_spread":0.39152939175375095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3040901621","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000056138692,0.9451093,0.00019535725,0.04361261,0.0003568038,0.004713302,0.005689913,0.00020611689,0.00011095708],"genre_scores_gemma":[0.000059728554,0.9825587,0.0019305906,0.00509438,0.0024657897,0.0072313203,0.00019876599,0.00015748608,0.00030322967],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9947171,0.0002411569,0.0024592492,0.0014283326,0.00052043353,0.0006336957],"domain_scores_gemma":[0.9964151,0.00051856105,0.0010312297,0.00090040755,0.00038861888,0.0007460936],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013320369,0.00067930896,0.005600608,0.00014897274,0.00008704132,0.000040758525,0.00048087322,0.00048157314,0.0009590353],"category_scores_gemma":[0.0005479706,0.00044355818,0.0017554718,0.0010803303,0.00037169133,0.00008285008,0.00021749469,0.0017957445,0.00003763922],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005955602,0.00020472013,0.0013850752,0.03433899,0.00037243028,0.000035828023,0.000007057347,8.66702e-9,3.4199013e-7,0.00012603163,0.0316025,0.9318675],"study_design_scores_gemma":[0.00068876956,0.00007595704,0.0017939575,0.16407077,0.004504972,0.00021842778,0.0000030065644,0.000012911587,3.763652e-7,0.0001118082,0.82810116,0.00041790647],"about_ca_topic_score_codex":0.0010023633,"about_ca_topic_score_gemma":0.00013010061,"teacher_disagreement_score":0.93144953,"about_ca_system_score_codex":0.00085742713,"about_ca_system_score_gemma":0.0017078947,"threshold_uncertainty_score":0.9999542},"labels":[],"label_agreement":null},{"id":"W3092280067","doi":"10.1016/j.clbc.2020.09.014","title":"Final Efficacy Results of Neratinib in HER2-positive Hormone Receptor-positive Early-stage Breast Cancer From the Phase III ExteNET Trial","year":2020,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":215,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Eli Lilly Japan; Chugai Pharmaceutical; PharmaMar; AstraZeneca Australia; Kyowa Hakko Kirin; Astellas Pharma; Eisai; GlaxoSmithKline Australia; Puma Biotechnology; Genentech; Seattle Genetics; Genomic Health; AbbVie; Mount Sylvia Diatomite; Roche; Daiichi-Sankyo; Teva Pharmaceutical Industries; Pfizer Australia; Celgene; Novartis; Merck; GlaxoSmithKline; British Microcirculation Society; Amgen; Ontario Brain Institute; Pfizer; Bayer; AstraZeneca; Eli Lilly and Company","keywords":"Neratinib; Medicine; Breast cancer; Oncology; Hormone receptor; Internal medicine; Stage (stratigraphy); Gynecology; Cancer; Trastuzumab","score_opus":0.12503202366143637,"score_gpt":0.45440523439789093,"score_spread":0.32937321073645454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3092280067","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.916825,0.0013044694,0.00003795495,0.058240756,0.0007568712,0.0025520248,0.019610548,0.00006016671,0.0006122183],"genre_scores_gemma":[0.98585486,0.0020119296,0.00013726758,0.0043495484,0.006368305,0.00036891742,0.0003214319,0.00008919363,0.00049857085],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9937054,0.0010193479,0.0020843078,0.0012683882,0.0011353178,0.00078725786],"domain_scores_gemma":[0.9949683,0.002265969,0.00058263086,0.0007755082,0.0006133549,0.000794233],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014480464,0.0004668491,0.0014375176,0.00007315601,0.00013069333,0.00006431602,0.0006124309,0.00042115286,0.002405925],"category_scores_gemma":[0.0009995273,0.0003411882,0.00046702442,0.0008961946,0.0009459919,0.00016079837,0.00028486756,0.0020136205,0.00008677054],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.72036326,0.0029770923,0.018561654,0.000054152068,0.0007022086,0.00023382706,0.0030395149,0.0000964979,0.004264358,0.000030045916,0.04858436,0.201093],"study_design_scores_gemma":[0.27892834,0.004133756,0.7041625,0.0012595265,0.00030692475,0.000016398395,0.00036027396,0.0007885921,0.0011932096,0.000011556472,0.008337277,0.0005016863],"about_ca_topic_score_codex":0.025830435,"about_ca_topic_score_gemma":0.00096486934,"teacher_disagreement_score":0.6856008,"about_ca_system_score_codex":0.00042842492,"about_ca_system_score_gemma":0.002001949,"threshold_uncertainty_score":0.99990404},"labels":[],"label_agreement":null},{"id":"W3111478139","doi":"10.1016/j.clbc.2020.11.018","title":"A Survey of Breast Pathologists’ Practice in Staging Multiple Foci of Invasive Carcinoma","year":2020,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Medicine; Breast cancer; Cancer staging; Invasive lobular carcinoma; Stage (stratigraphy); Breast carcinoma; Carcinoma; Lymph node; Cancer; Oncology; Radiology; Pathology; Internal medicine; Invasive ductal carcinoma","score_opus":0.06303935938080452,"score_gpt":0.36418010919487426,"score_spread":0.30114074981406974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111478139","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99285746,0.0018744484,0.0000651415,0.002786936,0.00015003051,0.00023181936,0.0018642034,0.0000086768605,0.00016126012],"genre_scores_gemma":[0.99766916,0.0007791945,0.00025436052,0.0009361847,0.00019202613,0.000042893615,0.00009386069,0.000025207934,0.0000071291543],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978772,0.00042029738,0.0007300334,0.00054165756,0.00017377464,0.0002570587],"domain_scores_gemma":[0.99793535,0.0006898287,0.00045354382,0.00032403276,0.00047095687,0.00012625451],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051292713,0.00020233598,0.000541299,0.000028324932,0.00002543855,0.0000052477385,0.00023999684,0.00016735005,0.000032031894],"category_scores_gemma":[0.002383573,0.00018482927,0.00015091608,0.00025512028,0.00036384127,0.00001075431,0.00027917992,0.00018060186,0.0000034071588],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019105437,0.00032701698,0.98076534,0.0000673197,0.00016190826,0.000016472122,0.0002500079,0.000049586964,0.004348444,0.0000031915747,0.0004256293,0.011674529],"study_design_scores_gemma":[0.0023559455,0.00019336255,0.99394923,0.000057390742,0.000058917794,0.000022332482,0.00032320322,0.000030891686,0.0026610421,0.0000036887993,0.00017568105,0.00016833097],"about_ca_topic_score_codex":0.0050501637,"about_ca_topic_score_gemma":0.0020813637,"teacher_disagreement_score":0.013183862,"about_ca_system_score_codex":0.000032912652,"about_ca_system_score_gemma":0.0003987436,"threshold_uncertainty_score":0.7634371},"labels":[],"label_agreement":null},{"id":"W3118554446","doi":"10.1016/j.clbc.2021.01.007","title":"Five-Year Adjuvant Endocrine Therapy Adherence Trajectories Among Women With Breast Cancer: A Nationwide French Study Using Administrative Data","year":2021,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Michel-Sarrazin","funders":"Institut National Du Cancer; Ligue Contre le Cancer","keywords":"Medicine; Breast cancer; Adjuvant; Oncology; Endocrine system; Gynecology; Adjuvant therapy; Family medicine; Obstetrics; Internal medicine; Cancer; Hormone","score_opus":0.17569329027489405,"score_gpt":0.45231029446857246,"score_spread":0.2766170041936784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3118554446","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99398774,0.00078885,0.00008884335,0.0023389377,0.00047736662,0.00082811987,0.0010140109,0.00007792913,0.00039822573],"genre_scores_gemma":[0.99324375,0.0011537448,0.00041418683,0.0010733327,0.00095043756,0.00045564922,0.000088745044,0.00003762301,0.0025824993],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99664944,0.00024602495,0.00081422145,0.0010816774,0.0007226718,0.00048593245],"domain_scores_gemma":[0.9966778,0.00026700494,0.00039260194,0.001234586,0.00093016657,0.0004978413],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00042921587,0.0003257809,0.00080389756,0.000049940223,0.00016126048,0.00006625997,0.0004883903,0.000100230456,0.009205811],"category_scores_gemma":[0.00016887476,0.00024404709,0.00007066997,0.0006785475,0.0004600144,0.00035020374,0.0001588104,0.0005837147,0.000052304236],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011389793,0.0013548778,0.9538132,0.00004501962,0.0005155636,0.00018719207,0.00066376117,0.0000060985644,0.00013431908,0.000011348141,0.0016919813,0.04043766],"study_design_scores_gemma":[0.0054922192,0.0006957093,0.98676944,0.0005604764,0.00015465611,0.00024652854,0.004256255,0.00029899128,0.000057327165,0.000026287167,0.001142501,0.0002996201],"about_ca_topic_score_codex":0.0023604122,"about_ca_topic_score_gemma":0.0014168181,"teacher_disagreement_score":0.04013804,"about_ca_system_score_codex":0.00018901099,"about_ca_system_score_gemma":0.003367797,"threshold_uncertainty_score":0.99519515},"labels":[],"label_agreement":null},{"id":"W3135671961","doi":"10.1016/j.clbc.2021.03.001","title":"Uridine Glucuronosyltransferase 2B7 Polymorphism-Based Pharmacogenetic Dosing of Epirubicin in FEC Chemotherapy for Early-Stage Breast Cancer","year":2021,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Alberta Innovates - Health Solutions; Alberta Cancer Foundation","keywords":"Medicine; Epirubicin; Breast cancer; Pharmacogenetics; Oncology; Chemotherapy; Internal medicine; Dosing; Stage (stratigraphy); Glucuronosyltransferase; Cancer; Genotype; Genetics; Gene; Biology","score_opus":0.05108618909565029,"score_gpt":0.42020743389212056,"score_spread":0.3691212447964703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135671961","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96530044,0.004542267,0.00014352548,0.025684554,0.001011298,0.0009386387,0.002240664,0.00004516014,0.00009344265],"genre_scores_gemma":[0.9862619,0.0026658196,0.00021870063,0.0083178785,0.0012479475,0.0003905133,0.00008900387,0.00008486329,0.00072339585],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99730843,0.00015907922,0.0009922667,0.00071902655,0.0002501718,0.00057103334],"domain_scores_gemma":[0.99832326,0.0004537095,0.00021199715,0.00034751877,0.00030182203,0.00036170313],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00033432705,0.0003578858,0.0010396095,0.0001330974,0.00005855179,0.000012908056,0.00014537369,0.00021928393,0.0070527997],"category_scores_gemma":[0.000021523367,0.0003310429,0.00051600975,0.00048860314,0.00026633448,0.00006985613,0.000024932791,0.00036779098,0.0000075114826],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014738006,0.002825568,0.7558588,0.00047845356,0.0006392466,0.00015870064,0.00012538764,0.0002576739,0.11657046,0.000012661622,0.001534997,0.10680005],"study_design_scores_gemma":[0.04019524,0.0004932411,0.7999945,0.000628887,0.0009205047,0.000072177565,0.000021660193,0.0010889268,0.1482495,0.000017442115,0.007903239,0.00041464999],"about_ca_topic_score_codex":0.0018383026,"about_ca_topic_score_gemma":0.00072036026,"teacher_disagreement_score":0.1063854,"about_ca_system_score_codex":0.00031828953,"about_ca_system_score_gemma":0.0016218645,"threshold_uncertainty_score":0.99991417},"labels":[],"label_agreement":null},{"id":"W3156978057","doi":"10.1016/j.clbc.2021.04.005","title":"Improving Collection of Real-World Data: The Experience of the Joven & Fuerte Prospective Cohort for Mexican Young Women With Breast Cancer","year":2021,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Instituto Nacional de Cancerología; Roche; Novartis; Pfizer; Myriad Genetics; AstraZeneca; Eli Lilly and Company","keywords":"Data collection; Medicine; Data quality; Breast cancer; Missing data; Psychosocial; Prospective cohort study; Medical physics; Consistency (knowledge bases); Cohort; Data science; Gynecology; Cancer; Computer science; Internal medicine; Artificial intelligence; Statistics; Psychiatry","score_opus":0.08796769502643914,"score_gpt":0.41264270116469515,"score_spread":0.324675006138256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3156978057","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918174,0.00029619137,0.00027292705,0.0040182266,0.0006042349,0.0011450106,0.0010833531,0.000024333753,0.0007383367],"genre_scores_gemma":[0.99583846,0.00036455708,0.00029711347,0.000686896,0.00058055704,0.00061475637,0.000015722395,0.000026790123,0.0015751445],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976653,0.00011015491,0.0006854864,0.00062030973,0.0005447348,0.00037400317],"domain_scores_gemma":[0.99695927,0.00026274266,0.000586989,0.0010589139,0.0009861543,0.0001459051],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007978499,0.0001890224,0.0006426439,0.000030336883,0.00019254313,0.000022895318,0.0004373305,0.00007361507,0.00020504517],"category_scores_gemma":[0.00024881813,0.00010500339,0.00013877542,0.000918617,0.0007463354,0.00018518537,0.0002446307,0.00033569863,6.282543e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032702456,0.00011123488,0.98149645,0.00008701686,0.00032154028,0.0000026575165,0.00080186815,0.000025307314,0.0008348136,0.00006240522,0.0014211009,0.011565353],"study_design_scores_gemma":[0.0013745533,0.00014330356,0.99401265,0.0004969252,0.0003308789,0.00011130427,0.0016440279,0.00027717554,0.00066018885,0.00003975711,0.00077364553,0.00013558262],"about_ca_topic_score_codex":0.025084406,"about_ca_topic_score_gemma":0.046050217,"teacher_disagreement_score":0.020965813,"about_ca_system_score_codex":0.0004746455,"about_ca_system_score_gemma":0.0017409467,"threshold_uncertainty_score":0.98140764},"labels":[],"label_agreement":null},{"id":"W3201363474","doi":"10.1016/j.clbc.2021.09.004","title":"Impact of the 21-Gene Recurrence Score Assay on the Treatment of Estrogen Receptor-Positive, HER2-Negative, Breast Cancer Patients With 1-3 Positive Nodes: A Prospective Clinical Utility Study","year":2021,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Positive Living North; Interior Health; BC Cancer Agency","funders":"Merck Sharp and Dohme; Bristol-Myers Squibb Canada; Genomic Health; Roche; Novartis; Amgen; Pfizer; Genentech; Celgene; AstraZeneca; Eli Lilly and Company; Sanofi; Merck","keywords":"Medicine; Breast cancer; Internal medicine; Estrogen receptor; Prospective cohort study; Estrogen; Oncology; Adjuvant; Chemotherapy; Cancer; Adjuvant therapy; Gynecology","score_opus":0.027367305196067584,"score_gpt":0.3569691101792106,"score_spread":0.32960180498314307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3201363474","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9863912,0.000409307,0.000009336047,0.00070234545,0.00047896232,0.0016081592,0.010259727,0.000009860781,0.00013113709],"genre_scores_gemma":[0.99789745,0.0008094595,0.00006453922,0.0001821125,0.0004103956,0.00046599892,0.0000773045,0.00004407677,0.000048694674],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9957534,0.0012349216,0.0009377913,0.001152541,0.0005005826,0.00042074366],"domain_scores_gemma":[0.99581736,0.0006395719,0.0007474342,0.001018792,0.0016061008,0.0001707451],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00041488785,0.0005285757,0.0009151516,0.000022573273,0.0002130152,0.00002032518,0.0003881835,0.00021348118,0.00017329506],"category_scores_gemma":[0.0002407898,0.00026931634,0.0007800241,0.00043177922,0.0012333828,0.00001383095,0.00022421936,0.00030978752,0.0000034841646],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0068982895,0.011329161,0.9579489,0.000009763486,0.003961045,0.0000029891398,0.00033327832,0.000021001539,0.0001470621,0.000008000884,0.00022620056,0.01911428],"study_design_scores_gemma":[0.005162188,0.0034663584,0.98405445,0.0002753056,0.00052741106,0.000008097898,0.00021618042,0.0000043364776,0.005972863,0.000016940598,0.000023837143,0.00027205842],"about_ca_topic_score_codex":0.002322272,"about_ca_topic_score_gemma":0.0009348519,"teacher_disagreement_score":0.026105495,"about_ca_system_score_codex":0.00036789573,"about_ca_system_score_gemma":0.0011876654,"threshold_uncertainty_score":0.9999759},"labels":[],"label_agreement":null},{"id":"W3207420121","doi":"10.1016/j.clbc.2021.10.005","title":"Symptom Burden Associated With Radiation Dermatitis in Breast Cancer Patients Undergoing Radiotherapy","year":2021,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Effects of Radiation Exposure","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Anxiety; Breast cancer; Nausea; Physical therapy; Cancer; Radiation therapy; Prospective cohort study; Quality of life (healthcare); Internal medicine; Psychiatry","score_opus":0.010879890797165635,"score_gpt":0.31952372586439803,"score_spread":0.3086438350672324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3207420121","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97151244,0.0012705934,0.00004127136,0.025486901,0.0006153532,0.00045294434,0.00031248172,0.00009133555,0.00021670018],"genre_scores_gemma":[0.9897305,0.0026416334,0.00010893058,0.005937654,0.00088533835,0.000108326574,0.0001898705,0.000064901156,0.00033289162],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976191,0.00031961733,0.00068537286,0.0005068713,0.0004804825,0.0003885467],"domain_scores_gemma":[0.99785954,0.00076494884,0.00032874447,0.00030344352,0.00047410405,0.00026923956],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00027619247,0.00023974437,0.00061919977,0.00010282479,0.000069307105,0.000043618034,0.000103138496,0.00027565207,0.0011213401],"category_scores_gemma":[0.00032677318,0.0002107187,0.0001444166,0.00058814615,0.0001025486,0.00023989932,0.00002521714,0.00045668322,0.000016798118],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020955325,0.0004127643,0.92874485,0.00006339324,0.00034508857,0.00004335048,0.00015613089,0.00053920934,0.000057437413,0.0000107444,0.0036764506,0.06574104],"study_design_scores_gemma":[0.011084212,0.00015603886,0.9847597,0.0010724944,0.00013776885,0.000048508227,0.000032767864,0.0013965983,0.000037326114,0.000012138584,0.0010148027,0.0002476837],"about_ca_topic_score_codex":0.00044562807,"about_ca_topic_score_gemma":0.0011909485,"teacher_disagreement_score":0.06549335,"about_ca_system_score_codex":0.00094494416,"about_ca_system_score_gemma":0.0011846804,"threshold_uncertainty_score":0.99979174},"labels":[],"label_agreement":null},{"id":"W3211195093","doi":"10.1016/j.clbc.2021.10.006","title":"Current Status and Problems of Breast Cancer Treatment with Schizophrenia","year":2021,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St Mary's Hospital Centre","funders":"","keywords":"Medicine; Breast cancer; Schizophrenia (object-oriented programming); Cancer; Internal medicine; Disease; Oncology; Population; Retrospective cohort study; Guideline; Psychiatry; Pathology","score_opus":0.047065268609711955,"score_gpt":0.3835169114648212,"score_spread":0.33645164285510926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211195093","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9653565,0.026309555,0.000007906375,0.006207169,0.00024106927,0.00056682806,0.0011749787,0.00004013475,0.000095852105],"genre_scores_gemma":[0.95418346,0.044005815,0.0005434897,0.00011202282,0.0005063554,0.00031628768,0.000059353242,0.000038461192,0.00023478371],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977788,0.00010513965,0.00052805187,0.00063835346,0.00043386742,0.0005157983],"domain_scores_gemma":[0.9979785,0.00016032779,0.00015566402,0.0004459605,0.0004733,0.0007862271],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00012616163,0.00028390807,0.00074483076,0.000067930254,0.000067652334,0.00002646488,0.000060703667,0.000098101424,0.0010620963],"category_scores_gemma":[0.000023884277,0.00017659899,0.00018371997,0.00032168973,0.00036632613,0.000075060416,0.00007394788,0.00029420288,0.000014876598],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0105985785,0.0012380047,0.5220416,0.00015105162,0.0005909911,0.00007290824,0.00003353072,0.0000040062364,0.000089505724,0.00009096872,0.0001309076,0.4649579],"study_design_scores_gemma":[0.017799148,0.00093602156,0.9757022,0.0010196344,0.0005313497,0.0003743953,0.00003700128,0.00006550185,0.00028564982,0.00010326043,0.002961775,0.0001840623],"about_ca_topic_score_codex":0.0011771318,"about_ca_topic_score_gemma":0.002475765,"teacher_disagreement_score":0.46477383,"about_ca_system_score_codex":0.00028583326,"about_ca_system_score_gemma":0.0027332571,"threshold_uncertainty_score":0.99985105},"labels":[],"label_agreement":null},{"id":"W3216488953","doi":"10.1016/j.clbc.2021.11.011","title":"Primary Care Physicians’ Perspectives in Leading Breast Cancer Follow-Up Care","year":2021,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"North York General Hospital; University of Toronto; University of British Columbia","funders":"","keywords":"Medicine; Family medicine; Capitation; Remuneration; Breast cancer; Primary care; Receipt; Salary; Nursing; Cancer; Health care; Internal medicine","score_opus":0.08810438922747067,"score_gpt":0.4159483378810889,"score_spread":0.32784394865361827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3216488953","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92825425,0.04975204,0.000024913628,0.00825094,0.0019915556,0.00043465017,0.000844827,0.00012342255,0.010323384],"genre_scores_gemma":[0.9883198,0.0028005869,0.0001547158,0.004968187,0.002459339,0.00012293157,0.00008766116,0.000057109126,0.0010296294],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969364,0.00014077399,0.0006907412,0.0010001592,0.0005743205,0.0006576087],"domain_scores_gemma":[0.99777716,0.00013236965,0.00017671056,0.000529896,0.0010865186,0.00029735465],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018516537,0.00033622913,0.0009774314,0.000084587686,0.00012804399,0.00005093053,0.00022059718,0.00027069644,0.00089215784],"category_scores_gemma":[0.00008522044,0.00032089543,0.00050979614,0.0006898576,0.0002544986,0.00026235613,0.00015515681,0.00085377897,0.000049969934],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00097598165,0.00012028084,0.70892423,0.00035195504,0.00015005548,0.00033358828,0.0043477817,0.000057965346,0.00043948623,0.00006338214,0.0022216218,0.28201365],"study_design_scores_gemma":[0.0039536357,0.000085464075,0.95112187,0.0032086826,0.0002673567,0.00018486305,0.03694132,0.000028407901,0.00014091715,0.00002139828,0.0036503063,0.0003957743],"about_ca_topic_score_codex":0.002381791,"about_ca_topic_score_gemma":0.004879765,"teacher_disagreement_score":0.28161788,"about_ca_system_score_codex":0.0017871287,"about_ca_system_score_gemma":0.0018768022,"threshold_uncertainty_score":0.9999243},"labels":[],"label_agreement":null},{"id":"W4214522566","doi":"10.1016/j.clbc.2022.02.008","title":"Characteristics, Clinical Differences and Outcomes of Breast Cancer Patients with Negative or Low HER2 Expression","year":2022,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NOSM University; Essar Steel Algoma (Canada); Sault Area Hospital; Algoma University","funders":"","keywords":"Medicine; Breast cancer; Immunohistochemistry; Internal medicine; Oncology; Trastuzumab; Cancer; Stage (stratigraphy)","score_opus":0.067916034245382,"score_gpt":0.43671123553147156,"score_spread":0.36879520128608956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4214522566","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99010044,0.00012636022,0.000006644483,0.0043324884,0.0009796119,0.00082802534,0.0035129515,0.00004088652,0.00007259187],"genre_scores_gemma":[0.9954163,0.0010403153,0.000121058794,0.0014823835,0.00058416574,0.0003919634,0.000031220512,0.000059397247,0.00087322615],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9956937,0.0005404863,0.0013396771,0.00081796205,0.0011139018,0.00049429707],"domain_scores_gemma":[0.9964122,0.0013562033,0.00058011303,0.00051731674,0.0005693865,0.0005647757],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00084313157,0.00031630864,0.0013664418,0.00009116416,0.00018741011,0.00002598974,0.0003247537,0.00017092978,0.006882189],"category_scores_gemma":[0.00046017053,0.00019363673,0.00020140018,0.00031808237,0.0010101051,0.00010670445,0.00048687655,0.0011750044,0.000007665744],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007994101,0.0014983943,0.9024532,0.00018609944,0.0002494389,0.000025384104,0.0001316875,8.611502e-7,0.000012841643,0.000003925002,0.0017924419,0.08565163],"study_design_scores_gemma":[0.005797598,0.0012849445,0.99073786,0.0006422433,0.0001650385,0.000020809583,0.00014378747,0.00006740467,0.000016354978,0.000014942089,0.0008584802,0.0002505465],"about_ca_topic_score_codex":0.0008820645,"about_ca_topic_score_gemma":0.00016041222,"teacher_disagreement_score":0.08828465,"about_ca_system_score_codex":0.00022008542,"about_ca_system_score_gemma":0.0011743604,"threshold_uncertainty_score":0.99402565},"labels":[],"label_agreement":null},{"id":"W4229014874","doi":"10.1016/j.clbc.2021.10.003","title":"Time to Update Evidence-Based Guideline Recommendations About Concurrent Tamoxifen and Antidepressant Use? A Systematic Review","year":2021,"lang":"en","type":"review","venue":"Clinical Breast Cancer","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Thunder Bay Regional Health Sciences Centre; University of Ottawa; Ottawa Hospital","funders":"","keywords":"Medicine; Tamoxifen; Breast cancer; Randomized controlled trial; Oncology; Cochrane Library; MEDLINE; Internal medicine; Intensive care medicine; Psychiatry; Cancer","score_opus":0.07293141517454359,"score_gpt":0.43453364012296586,"score_spread":0.36160222494842226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4229014874","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00000802217,0.9945166,0.00011561438,0.0018375394,0.00042481688,0.0023625442,0.0006991106,0.00002227763,0.000013487401],"genre_scores_gemma":[0.0000057210714,0.9930039,0.00020880385,0.0038259458,0.00043117368,0.0006722174,0.00132816,0.00007157864,0.0004524907],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99487513,0.0013737631,0.002201783,0.0009959553,0.000209301,0.00034406065],"domain_scores_gemma":[0.99704117,0.00049082824,0.0007997504,0.0009125909,0.00034043126,0.00041521082],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014264298,0.0005307728,0.0029212649,0.00005634181,0.000088106695,0.000084312625,0.00037879712,0.0005640383,0.00037823655],"category_scores_gemma":[0.0016978676,0.00038098765,0.00090766704,0.00026911317,0.00013406105,0.000010835229,0.00033284858,0.00048332868,0.000244888],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001841982,0.00013640022,0.000015014072,0.35795453,0.0010929857,0.000021157613,0.0000012049079,0.0000029855767,0.000012249898,0.000005144947,0.137328,0.5034119],"study_design_scores_gemma":[0.0001519022,0.00005864176,0.0000030342735,0.47876906,0.0028715807,0.0000919817,2.912288e-7,0.000016374055,0.0000039800248,2.0415767e-7,0.51772064,0.00031231754],"about_ca_topic_score_codex":0.0000111161,"about_ca_topic_score_gemma":0.0000016535862,"teacher_disagreement_score":0.5030996,"about_ca_system_score_codex":0.000050763443,"about_ca_system_score_gemma":0.00082383724,"threshold_uncertainty_score":0.9998642},"labels":[],"label_agreement":null},{"id":"W4285011880","doi":"10.1016/j.clbc.2022.07.004","title":"Exclusion of Patients With Brain Metastases in Published Phase III Clinical Trials for Advanced Breast Cancer","year":2022,"lang":"en","type":"editorial","venue":"Clinical Breast Cancer","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; McMaster University; Juravinski Hospital; Western University; Hamilton Health Sciences; University of Toronto","funders":"","keywords":"Medicine; Clinical trial; Oncology; Breast cancer; Internal medicine; Generalizability theory; Clinical endpoint; Confidence interval; Cancer; Metastatic breast cancer; Brain metastasis; Metastasis","score_opus":0.07960240926807692,"score_gpt":0.4800662895248192,"score_spread":0.4004638802567423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285011880","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06330859,0.0035141075,0.0001658617,0.0108817695,0.6963021,0.010956091,0.21468344,0.00012801027,0.000060004113],"genre_scores_gemma":[0.048230603,0.0071915598,0.0023955086,0.0035757837,0.884554,0.010336169,0.040972482,0.0007523676,0.0019914939],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98580825,0.002812724,0.006317762,0.002160659,0.0019938885,0.0009066872],"domain_scores_gemma":[0.972071,0.020018812,0.003978977,0.0013754576,0.0017496507,0.0008061179],"candidate_categories":["metaresearch","metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.01405207,0.0009777723,0.006714033,0.00038590917,0.00016317425,0.000059280726,0.0005725545,0.0011257438,0.007684516],"category_scores_gemma":[0.011603588,0.00067432737,0.0020675221,0.00074814877,0.00054004113,0.00029909183,0.00040856324,0.0022897522,0.0000034837428],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08248189,0.009088228,0.01959862,0.00046506454,0.002066499,0.000048248174,0.000022384644,0.000025082483,0.00000190867,0.000008468003,0.6333751,0.2528185],"study_design_scores_gemma":[0.18732606,0.005389274,0.043693088,0.0016772231,0.004957881,0.000008068641,0.000073026305,0.00004448737,0.0000046976484,0.000050019145,0.7559915,0.00078465266],"about_ca_topic_score_codex":0.0012330916,"about_ca_topic_score_gemma":0.00069792254,"teacher_disagreement_score":0.25203386,"about_ca_system_score_codex":0.00076175027,"about_ca_system_score_gemma":0.0046400977,"threshold_uncertainty_score":0.9995708},"labels":[],"label_agreement":null},{"id":"W4285046055","doi":"10.1016/j.clbc.2022.07.003","title":"Locoregional Recurrence and Survival Outcomes in Breast Cancer Treated With Modern Neoadjuvant Chemotherapy: A Contemporary Population-based Analysis","year":2022,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency; University of Victoria","funders":"","keywords":"Medicine; Breast cancer; Oncology; Internal medicine; Taxane; Anthracycline; Mastectomy; Radiation therapy; Chemotherapy; Breast-conserving surgery; Triple-negative breast cancer; Neoadjuvant therapy; Population; Cancer","score_opus":0.028358492020909336,"score_gpt":0.3302457103527544,"score_spread":0.30188721833184506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285046055","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9879455,0.0014379894,0.00010506913,0.007434646,0.00014190085,0.00032131487,0.0025483773,0.000025697569,0.00003948141],"genre_scores_gemma":[0.99682486,0.0002889031,0.000056212666,0.0015152976,0.00014964104,0.0005929371,0.00044485985,0.000037835976,0.00008946165],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977839,0.0002300112,0.000501975,0.0008498753,0.00031835097,0.0003158991],"domain_scores_gemma":[0.99900407,0.00010577488,0.00025612584,0.0003701978,0.00012104263,0.0001428224],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00024725898,0.00032983258,0.00071936566,0.00012176455,0.00017024379,0.000020960357,0.0001937918,0.00010403779,0.0002064837],"category_scores_gemma":[0.000010837023,0.00026501727,0.0002230686,0.000509142,0.00021019675,0.000010766841,0.000128027,0.00022955221,5.8476763e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002626186,0.00043482962,0.9787117,0.000011169173,0.0012101023,0.000012255891,0.0000343511,0.0024424288,0.000037067544,0.000005252496,0.0002066031,0.014268038],"study_design_scores_gemma":[0.0043280777,0.00011253175,0.99322814,0.000031276508,0.00025476192,0.000014998151,0.00006128846,0.0013358132,0.000012565355,0.000018436693,0.00026802538,0.00033411535],"about_ca_topic_score_codex":0.008517342,"about_ca_topic_score_gemma":0.0036367727,"teacher_disagreement_score":0.014516393,"about_ca_system_score_codex":0.00016432613,"about_ca_system_score_gemma":0.00039725186,"threshold_uncertainty_score":0.9999802},"labels":[],"label_agreement":null},{"id":"W4287511610","doi":"10.1016/j.clbc.2022.07.010","title":"Clinical Breast Examination is Important in Surveillance After Mastectomy","year":2022,"lang":"en","type":"letter","venue":"Clinical Breast Cancer","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Mastectomy; Breast cancer; Breast examination; General surgery; Mammography; Internal medicine; Cancer","score_opus":0.08916666850516008,"score_gpt":0.41121106323506224,"score_spread":0.32204439472990215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4287511610","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.15558165,0.0047701155,0.000021169886,0.825078,0.006046246,0.0017013325,0.0042754887,0.00021428913,0.002311715],"genre_scores_gemma":[0.2335685,0.0025538104,0.00013603515,0.7431424,0.015661804,0.00064804294,0.00057307293,0.00016823981,0.003548049],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9909815,0.0010189131,0.0034707333,0.0019150125,0.0015467743,0.0010670201],"domain_scores_gemma":[0.99595106,0.0009072927,0.0010341626,0.0012804231,0.00043835974,0.0003887008],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0040424936,0.00071246526,0.0021995383,0.00027196459,0.000091409536,0.0000660207,0.00058341527,0.0017344282,0.020194013],"category_scores_gemma":[0.0003260699,0.00064397044,0.0010839343,0.0007628071,0.00046437327,0.00019425659,0.00039200872,0.007127937,0.00015379419],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011232825,0.00012579146,0.5703266,0.00014496059,0.00013635994,0.0024557358,0.00002410206,8.3750007e-7,4.0946813e-7,9.3744643e-7,0.37835288,0.047308084],"study_design_scores_gemma":[0.0019888862,0.00025456143,0.613221,0.0005633453,0.00013966035,0.0007445743,0.000027492115,0.000063593325,2.4975344e-7,0.000024636985,0.38253152,0.00044049314],"about_ca_topic_score_codex":0.0012461685,"about_ca_topic_score_gemma":0.0005116962,"teacher_disagreement_score":0.08193555,"about_ca_system_score_codex":0.00084085413,"about_ca_system_score_gemma":0.001315825,"threshold_uncertainty_score":0.9996012},"labels":[],"label_agreement":null},{"id":"W4293927079","doi":"10.1016/j.clbc.2022.08.004","title":"High Risk Breast Cancer Screening is a Double Edged Sword: A Qualitative Study of Patient Perspectives on the Ontario High Risk Breast Cancer Screening Program","year":2022,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Public Health Ontario; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Psychosocial; Breast cancer; Mammography; Distress; Breast cancer screening; Qualitative research; Family medicine; Breast MRI; Cancer; Clinical psychology; Psychiatry; Internal medicine","score_opus":0.1006526776267866,"score_gpt":0.4288519155018461,"score_spread":0.3281992378750595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293927079","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97801524,0.0011469082,0.00006348777,0.0096481,0.001030283,0.0036191032,0.0061140982,0.00019375053,0.00016902838],"genre_scores_gemma":[0.99061304,0.0005925579,0.00064108847,0.00205955,0.0013096399,0.004173951,0.00004188842,0.00013483061,0.00043345807],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9903924,0.0017939392,0.0020773204,0.0019720392,0.0025198834,0.0012444314],"domain_scores_gemma":[0.99353856,0.001013898,0.0020872522,0.0013331391,0.0013803807,0.0006467828],"candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0027747282,0.0008885187,0.0018559237,0.00025585166,0.0014402164,0.000120593,0.00086361053,0.00025525904,0.009455483],"category_scores_gemma":[0.00014119982,0.00065983075,0.0008391469,0.0015286659,0.0007281831,0.00033048753,0.0007464316,0.0036219163,0.00001512959],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02769741,0.004030043,0.64797276,0.000046453122,0.0032036107,0.000068692105,0.09149728,0.003842522,0.000006581424,0.0001350131,0.004945188,0.21655443],"study_design_scores_gemma":[0.011063469,0.0036787202,0.7852213,0.00091375055,0.0017786412,0.00011488917,0.19447283,0.00035128332,0.000021536305,0.000086649765,0.0015550825,0.0007418925],"about_ca_topic_score_codex":0.75752884,"about_ca_topic_score_gemma":0.12930974,"teacher_disagreement_score":0.6282191,"about_ca_system_score_codex":0.0020684127,"about_ca_system_score_gemma":0.0015576984,"threshold_uncertainty_score":0.99985975},"labels":[],"label_agreement":null},{"id":"W4309269762","doi":"10.1016/j.clbc.2022.11.003","title":"The Role of Imaging in the Diagnosis of Primary and Secondary Breast Angiosarcoma: Twenty-Five-Year Experience of a Provincial Cancer Institution","year":2022,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Vascular Tumors and Angiosarcomas","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency; Providence Health Care","funders":"","keywords":"Medicine; Interquartile range; Angiosarcoma; Context (archaeology); Mammography; Breast cancer; Radiology; Magnetic resonance imaging; Retrospective cohort study; Breast imaging; Cancer; Internal medicine","score_opus":0.013635804386185373,"score_gpt":0.3014781439902644,"score_spread":0.287842339604079,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309269762","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98780686,0.008578957,0.0000018916019,0.0022600023,0.00015977745,0.00038837618,0.00043161918,0.000006107225,0.000366398],"genre_scores_gemma":[0.9984009,0.000749161,0.000019035417,0.00037309754,0.00016183125,0.0002567689,0.000009946794,0.000010627217,0.000018586585],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984163,0.00019891966,0.00058936555,0.00023512918,0.0003746279,0.00018568258],"domain_scores_gemma":[0.99906874,0.00022103412,0.0002670616,0.00028353158,0.00010283829,0.00005680955],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007271099,0.00010862057,0.00038257,0.00005196762,0.00012202413,0.000006389997,0.00022091014,0.000032379856,0.00013753535],"category_scores_gemma":[0.000059433925,0.0000684029,0.00019349827,0.0002842911,0.0006274059,0.00007669278,0.00021250227,0.0003098421,2.120453e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004972598,0.00041577808,0.8724547,0.00007500262,0.000040312087,0.000011332755,0.0011774341,0.000008231799,0.000529331,0.00031295774,0.00023910956,0.12423852],"study_design_scores_gemma":[0.0016729659,0.0000980223,0.9900896,0.00018097211,0.00008762142,0.00012850626,0.0028585072,0.000117951124,0.00019645238,0.000085321866,0.0044062543,0.000077857],"about_ca_topic_score_codex":0.0028034695,"about_ca_topic_score_gemma":0.00028101282,"teacher_disagreement_score":0.12416066,"about_ca_system_score_codex":0.000074515425,"about_ca_system_score_gemma":0.0005621133,"threshold_uncertainty_score":0.4238026},"labels":[],"label_agreement":null},{"id":"W4321793442","doi":"10.1016/j.clbc.2023.02.011","title":"Characteristics Assessment of Online YouTube Videos on Radiotherapy for Breast Cancer","year":2023,"lang":"en","type":"review","venue":"Clinical Breast Cancer","topic":"Health Literacy and Information Accessibility","field":"Health Professions","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"Canadian Association of Radiation Oncology","keywords":"Medicine; Breast cancer; Radiation therapy; Cancer; Medical physics; Oncology; Internal medicine","score_opus":0.30104063096543826,"score_gpt":0.6468970359415411,"score_spread":0.34585640497610287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4321793442","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004203982,0.68211454,0.0010272894,0.0059207077,0.01838816,0.013001102,0.27835837,0.00041168762,0.00035771856],"genre_scores_gemma":[0.000022185723,0.97907424,0.0006926703,0.0072982935,0.0064746193,0.0034903102,0.0014717327,0.0001529688,0.0013229967],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9877371,0.0014908373,0.008543791,0.0008189611,0.0005149044,0.00089436636],"domain_scores_gemma":[0.98636186,0.0056327935,0.0052754665,0.0010641331,0.0011394834,0.0005262617],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.004457858,0.000639172,0.004155026,0.00023488484,0.0004260516,0.000024683468,0.00072747906,0.0012960313,0.0038914692],"category_scores_gemma":[0.00053771154,0.00044708367,0.0010995001,0.00057833607,0.00019147398,0.00029824564,0.00015525855,0.0025522262,0.00010906423],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021493692,0.00034757634,0.010384743,0.06322924,0.00029591558,6.3505263e-7,0.000081636346,0.0000012204495,2.2082999e-8,0.00012759837,0.00906914,0.9162473],"study_design_scores_gemma":[0.001137892,0.000096627045,0.13537942,0.042579956,0.00036199603,0.0000024063977,0.000030529423,0.00057915214,5.4900573e-9,0.000017062468,0.8194525,0.0003624362],"about_ca_topic_score_codex":0.00036612374,"about_ca_topic_score_gemma":0.00011038148,"teacher_disagreement_score":0.9158849,"about_ca_system_score_codex":0.0012942235,"about_ca_system_score_gemma":0.00851545,"threshold_uncertainty_score":0.9997981},"labels":[],"label_agreement":null},{"id":"W4380743011","doi":"10.1016/j.clbc.2023.06.003","title":"Low Serum Vitamin D Associated With Increased Tumor Size and Higher Grade in Premenopausal Canadian Women With Breast Cancer","year":2023,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Vitamin D Research Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Health Services; University of Calgary; University of Manitoba","funders":"Alberta Cancer Foundation; Alberta Health Services","keywords":"Medicine; Breast cancer; Vitamin D and neurology; Prospective cohort study; Internal medicine; Cancer; Risk factor; Vitamin; Cohort; Population; vitamin D deficiency; Gynecology; Physiology; Gastroenterology; Oncology","score_opus":0.025822437989258526,"score_gpt":0.33577728468462187,"score_spread":0.30995484669536333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380743011","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98242563,0.00011595269,1.3602683e-7,0.014511113,0.00016562204,0.0007939149,0.0015509083,0.0001316782,0.00030503178],"genre_scores_gemma":[0.99383765,0.00023548666,0.000015408787,0.0026967537,0.00041877397,0.0007816502,0.000023296718,0.00009224876,0.0018987325],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963241,0.00024281266,0.00054554915,0.00079978956,0.0006899398,0.0013977841],"domain_scores_gemma":[0.9970234,0.00078579684,0.00015543809,0.0003794261,0.00034710107,0.0013088613],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010044882,0.0003886514,0.0009364812,0.00023591483,0.0001657547,0.000047957477,0.00018983107,0.00018258687,0.001044566],"category_scores_gemma":[0.00039263075,0.00026622764,0.000045411987,0.0013687143,0.0007272795,0.00014651053,0.00013031145,0.0008174822,0.00002821961],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012639028,0.0003103801,0.9882444,0.00016520072,0.0006394659,0.00107495,0.00022041073,0.000010055514,0.00019069499,0.0000038930125,0.0033811391,0.004495469],"study_design_scores_gemma":[0.00822091,0.0006381452,0.98823434,0.0014239337,0.0001251934,0.00008998986,0.0003518117,0.0000674127,0.000016379403,0.000014912775,0.00045622454,0.0003607632],"about_ca_topic_score_codex":0.076426074,"about_ca_topic_score_gemma":0.3286544,"teacher_disagreement_score":0.25222835,"about_ca_system_score_codex":0.0014518598,"about_ca_system_score_gemma":0.00224568,"threshold_uncertainty_score":0.999979},"labels":[],"label_agreement":null},{"id":"W4385252052","doi":"10.1016/j.clbc.2023.07.005","title":"Evaluation of Association Between Menstrual Cycle Timing and Quantitative Background Parenchymal Enhancement on Breast MRI in Premenopausal Women","year":2023,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"MRI in cancer diagnosis","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Aging","keywords":"Menstrual cycle; Medicine; Follicular phase; Luteal phase; Parenchyma; Body mass index; Breast cancer; Menstruation; Gynecology; Physiology; Internal medicine; Pathology; Hormone; Cancer","score_opus":0.1740580846854266,"score_gpt":0.4689678883820856,"score_spread":0.294909803696659,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385252052","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929111,0.000070194284,0.000013976971,0.0051341765,0.0003590684,0.0006258819,0.000289282,0.000032155407,0.0005641758],"genre_scores_gemma":[0.9980009,0.0007160661,0.00014365,0.0001917855,0.00040145495,0.00038049847,0.000050941937,0.000023795928,0.000090907044],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966243,0.00041721304,0.00084258564,0.0004958933,0.0012219569,0.00039808202],"domain_scores_gemma":[0.9974958,0.0012147191,0.00040111318,0.00022342286,0.0004929362,0.00017203121],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0055921194,0.00017348309,0.0005744477,0.00015403975,0.000043897606,0.000016374934,0.0000812379,0.00017545602,0.0007626603],"category_scores_gemma":[0.0002804184,0.00016569953,0.000058188885,0.00046880444,0.000104668965,0.000121191704,0.00007162725,0.0003020803,0.000051811938],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040907186,0.0002758915,0.8932924,0.0000922587,0.00039979143,0.0000018386095,0.0006830137,0.00022350413,0.0001857099,0.000040934323,0.0018820006,0.10251356],"study_design_scores_gemma":[0.0039835,0.00067278213,0.99019885,0.00058879267,0.00036981129,0.0000019962133,0.0005596179,0.002822552,0.00019438124,0.00030505494,0.00015176141,0.00015091438],"about_ca_topic_score_codex":0.00036105255,"about_ca_topic_score_gemma":0.00017001672,"teacher_disagreement_score":0.10236265,"about_ca_system_score_codex":0.0017730686,"about_ca_system_score_gemma":0.00047523546,"threshold_uncertainty_score":0.8350596},"labels":[],"label_agreement":null},{"id":"W4386200239","doi":"10.1016/j.clbc.2023.08.005","title":"Real-World Evidence on the Use of Endocrine Therapy for Ductal Carcinoma In Situ in Patients Treated With Breast-Conserving Surgery Followed by Postoperative Radiation Therapy: A Brazilian Retrospective Cohort Study","year":2023,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Ductal carcinoma; Breast-conserving surgery; Breast cancer; Retrospective cohort study; Cohort; Adjuvant; Adjuvant therapy; Radiation therapy; Internal medicine; Oncology; Cohort study; Randomized controlled trial; Mastectomy; Cancer; Surgery","score_opus":0.05005409503406344,"score_gpt":0.34008860490730886,"score_spread":0.2900345098732454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386200239","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951437,0.00017327198,6.4251964e-7,0.0018245874,0.00011751999,0.0021891254,0.00052234734,0.00001759805,0.000011194757],"genre_scores_gemma":[0.99663454,0.001474296,0.000005267248,0.00037099808,0.000090733694,0.0011241292,0.00018938945,0.000042342956,0.00006832161],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997676,0.00042242988,0.00058171124,0.0007254032,0.00025206507,0.00034234868],"domain_scores_gemma":[0.99807817,0.0008612599,0.00026084785,0.0004383845,0.0003015249,0.000059831204],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004896284,0.0002973551,0.0005940477,0.000119964025,0.00008838313,0.000023306799,0.00016170842,0.00007817803,0.000015517933],"category_scores_gemma":[0.00021224207,0.00019548683,0.00015623683,0.0006443335,0.00016942645,0.00002789587,0.000060126087,0.0001525098,0.0000012045939],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009893329,0.0009975609,0.98069024,0.000004925324,0.00037527207,0.0000075128205,0.00018065823,0.000019035491,0.0010039166,0.0000019899467,0.0020286664,0.0047968957],"study_design_scores_gemma":[0.004678764,0.0010150357,0.99211395,0.0001083959,0.00003350712,0.0000020341954,0.00008572761,0.000016155638,0.0016953571,0.0000026965636,0.00004301429,0.000205345],"about_ca_topic_score_codex":0.006960475,"about_ca_topic_score_gemma":0.008783641,"teacher_disagreement_score":0.011423729,"about_ca_system_score_codex":0.00021611532,"about_ca_system_score_gemma":0.00020666128,"threshold_uncertainty_score":0.99965227},"labels":[],"label_agreement":null},{"id":"W4386645518","doi":"10.1016/j.clbc.2023.09.006","title":"Factors Influencing Recurrence in Medial Breast Cancer Tumors After Skin Sparing Mastectomy and Immediate Breast Reconstruction","year":2023,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Breast Implant and Reconstruction","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of the Fraser Valley; University of British Columbia; University of Calgary","funders":"University of British Columbia","keywords":"Medicine; Breast cancer; Mastectomy; Breast reconstruction; Radiation therapy; Surgery; Stage (stratigraphy); Rectus abdominis muscle; Retrospective cohort study; Cancer; Internal medicine","score_opus":0.037666733097456655,"score_gpt":0.32966291518386787,"score_spread":0.2919961820864112,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386645518","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99259514,0.00025458317,0.0000037866766,0.001955931,0.0037122725,0.00044300602,0.0007648468,0.00018198718,0.00008846467],"genre_scores_gemma":[0.99664325,0.0007700346,0.000040943512,0.0001496289,0.0020561018,0.00016257008,0.000042526517,0.000057391648,0.00007755273],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966296,0.00014983407,0.0011631802,0.0008866442,0.00039973174,0.000771008],"domain_scores_gemma":[0.9983505,0.00027076338,0.0003372547,0.00029943525,0.00018929526,0.00055274885],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00063255243,0.00043867322,0.00088454876,0.00046774794,0.00011502227,0.000056914512,0.00013864829,0.00041962115,0.00063580123],"category_scores_gemma":[0.00004790847,0.0003528622,0.00021924124,0.00091782666,0.0005493658,0.0004476134,0.00014822074,0.0010245855,0.000051546158],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00066441856,0.000033428623,0.5920856,0.00009232599,0.00005121376,0.00003858092,0.0001691582,0.0000071706636,0.000075354925,0.0000024883825,0.00004697788,0.4067333],"study_design_scores_gemma":[0.0027012425,0.00003693689,0.97621816,0.0019488307,0.00012179942,0.01753876,0.0004945579,0.0003852334,0.00005471902,0.0000614485,0.000043280656,0.00039503837],"about_ca_topic_score_codex":0.001779541,"about_ca_topic_score_gemma":0.0014803042,"teacher_disagreement_score":0.40633824,"about_ca_system_score_codex":0.0002994226,"about_ca_system_score_gemma":0.0004922946,"threshold_uncertainty_score":0.99989235},"labels":[],"label_agreement":null},{"id":"W4388996953","doi":"10.1016/j.clbc.2023.11.008","title":"Brain Metastases in the Setting of Stable Versus Progressing Extracranial Disease Among Patients With Metastatic Breast Cancer","year":2023,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Health Sciences Centre; Sunnybrook Health Science Centre; Statistics Canada; University of Toronto","funders":"","keywords":"Medicine; Breast cancer; Disease; Oncology; Internal medicine; Clinical trial; Cohort; Metastatic breast cancer; Cancer; Retrospective cohort study; Brain metastasis; Metastasis","score_opus":0.04573150718103655,"score_gpt":0.38631829801391615,"score_spread":0.34058679083287957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388996953","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9852503,0.00049257337,0.000018441599,0.009522676,0.00033719948,0.0012039394,0.0030810456,0.000058041383,0.000035763023],"genre_scores_gemma":[0.99794024,0.00009571558,0.00034976166,0.00059843995,0.0002480607,0.00042030448,0.00023506235,0.00005156951,0.000060831513],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968655,0.0004881399,0.00079735287,0.00054714706,0.0007391398,0.00056270073],"domain_scores_gemma":[0.99733305,0.0012797394,0.00036803485,0.00048358718,0.00022112289,0.00031444192],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012876758,0.00030495893,0.0007169055,0.00012642411,0.000121540834,0.00004494217,0.00018725905,0.000054769986,0.00043839516],"category_scores_gemma":[0.00024005635,0.00017563722,0.00025149746,0.00096216064,0.0003711549,0.00019794452,0.0000748523,0.0003526316,0.000010592177],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0055956217,0.0013233506,0.8925533,0.00022290432,0.00055400905,0.00020969205,0.00015724279,0.00021610575,0.0000026055143,0.000029413382,0.0012900148,0.09784571],"study_design_scores_gemma":[0.011814197,0.0002886596,0.98450184,0.0007783816,0.001211692,0.000011039474,0.0003174161,0.00054260506,0.0000035424607,0.000027878521,0.0003133199,0.00018943881],"about_ca_topic_score_codex":0.0011235221,"about_ca_topic_score_gemma":0.0007116572,"teacher_disagreement_score":0.09765627,"about_ca_system_score_codex":0.00012016835,"about_ca_system_score_gemma":0.0004974868,"threshold_uncertainty_score":0.7162278},"labels":[],"label_agreement":null},{"id":"W4389822986","doi":"10.1016/j.clbc.2023.12.001","title":"Concurrent Use of Statins in Patients Undergoing Curative Intent Treatment for Triple Negative Breast Cancer: A Systematic Review and Meta-Analysis","year":2023,"lang":"en","type":"review","venue":"Clinical Breast Cancer","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Hamilton Health Sciences Foundation","keywords":"Medicine; Breast cancer; Meta-analysis; Oncology; Triple-negative breast cancer; Internal medicine; Cancer; Triple negative","score_opus":0.20917259294176682,"score_gpt":0.45381579388930104,"score_spread":0.24464320094753422,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389822986","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000025812853,0.9671661,0.00006087077,0.00016237615,0.0012841284,0.0054785055,0.025811626,0.00000886013,0.0000017101387],"genre_scores_gemma":[0.00006074909,0.9916509,0.000035669756,0.00027107185,0.00063588703,0.0059887213,0.00071249163,0.00006657448,0.00057795126],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9950337,0.00080878934,0.0025624179,0.0010006459,0.00022787285,0.0003665914],"domain_scores_gemma":[0.99593836,0.0007898177,0.0019556424,0.00057881436,0.00053458917,0.00020279722],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00056060404,0.00065325276,0.008403088,0.0001682183,0.000048493777,0.00003201319,0.0002303937,0.0002955429,0.000059478978],"category_scores_gemma":[0.00055589504,0.00042542562,0.0033564698,0.0005801088,0.0001887094,0.0000141447645,0.0001467163,0.00019783268,0.000002043587],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018926023,0.0007858111,0.00043446274,0.59771526,0.27702954,3.0433227e-7,0.00010722543,0.00001914165,2.8393546e-7,0.00003156792,0.0054459856,0.11824112],"study_design_scores_gemma":[0.0024573852,0.00043778372,0.0005906164,0.041850112,0.83832806,0.000004722008,0.000049109203,0.000015650854,7.7899745e-7,0.0000056920544,0.11554616,0.0007139048],"about_ca_topic_score_codex":0.0009501414,"about_ca_topic_score_gemma":0.0043588155,"teacher_disagreement_score":0.56129855,"about_ca_system_score_codex":0.00024451708,"about_ca_system_score_gemma":0.00096318556,"threshold_uncertainty_score":0.99981976},"labels":[],"label_agreement":null},{"id":"W4395469260","doi":"10.1016/j.clbc.2024.04.011","title":"The Impact of COVID-19 on Breast Cancer Care: A Qualitative Analysis of Surgeons’ Perspectives","year":2024,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"","keywords":"Medicine; Pandemic; Breast cancer; Coronavirus disease 2019 (COVID-19); Health care; 2019-20 coronavirus outbreak; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Family medicine; Qualitative research; Cancer; Disease; Pathology; Internal medicine; Infectious disease (medical specialty)","score_opus":0.1288651069566403,"score_gpt":0.5887012954384878,"score_spread":0.4598361884818475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4395469260","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89146477,0.016969211,0.00005942893,0.081961915,0.0005386046,0.00062043255,0.007969557,0.00008825879,0.0003278134],"genre_scores_gemma":[0.9931078,0.004987711,0.0000063165703,0.0011633586,0.00039156826,0.000062582905,0.000025725032,0.000031294698,0.00022366738],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969014,0.0005551744,0.001002386,0.0005750027,0.0005400152,0.00042601544],"domain_scores_gemma":[0.991285,0.0062778746,0.00031731912,0.0005888279,0.0008000116,0.000730934],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015762588,0.0002637016,0.0011564288,0.00038113826,0.00011947286,0.00002682765,0.00018067041,0.00019297091,0.0014561516],"category_scores_gemma":[0.001537586,0.00015199355,0.0014792784,0.0019124325,0.00073830795,0.0000667529,0.000052834625,0.00055923895,0.000008830069],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013219224,0.00095072715,0.7040329,0.0018716413,0.020467587,0.00008249714,0.10021228,0.0012491223,0.0001380805,0.0024325799,0.01912109,0.13622224],"study_design_scores_gemma":[0.0010315707,0.0005421869,0.97461915,0.0005327842,0.002203534,0.000018104594,0.018546851,0.00055409747,0.0000082223605,0.0001294676,0.0016426253,0.00017138277],"about_ca_topic_score_codex":0.07734803,"about_ca_topic_score_gemma":0.0067132427,"teacher_disagreement_score":0.27058625,"about_ca_system_score_codex":0.001705668,"about_ca_system_score_gemma":0.008479003,"threshold_uncertainty_score":0.99945664},"labels":[],"label_agreement":null},{"id":"W4401832653","doi":"10.1016/j.clbc.2024.08.010","title":"Analysis of Factors Associated With Pathological Complete Response in Patients With HER2-Positive Breast Cancer Receiving Neoadjuvant Chemotherapy","year":2024,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Breast cancer; Oncology; Chemotherapy; Neoadjuvant therapy; Pathological; Internal medicine; Complete response; Cancer","score_opus":0.02265700414410472,"score_gpt":0.3211083829367441,"score_spread":0.2984513787926394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401832653","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925034,0.00052884466,0.000057343663,0.0012534617,0.00013844305,0.00027651928,0.0051887026,0.00003063027,0.00002262509],"genre_scores_gemma":[0.9986979,0.00026897647,0.00002970022,0.00036431776,0.00009289614,0.00008904575,0.00036838936,0.000047793532,0.000040977633],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997531,0.00036906643,0.0005491663,0.0008424645,0.00030984526,0.00039847224],"domain_scores_gemma":[0.99864805,0.00034131165,0.00023576552,0.00033460732,0.00031458214,0.00012567286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038421698,0.00036325544,0.000812209,0.00014764295,0.00006423903,0.000027639406,0.00018762464,0.00023500796,0.00016979265],"category_scores_gemma":[0.00006430013,0.0002361066,0.00026832474,0.00093492755,0.00044118313,0.000013393813,0.00008765732,0.0002568675,0.0000011880034],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010424954,0.00059333415,0.97530097,0.000012202888,0.004363058,0.000014686939,0.0001953185,0.00029569163,0.00026284446,0.0000020170141,0.00008449571,0.008450446],"study_design_scores_gemma":[0.0025960687,0.0005769961,0.99485886,0.0004186004,0.0008954678,0.0000026751943,0.00007127036,0.00007977717,0.00010611183,0.000002663035,0.00007312942,0.0003183908],"about_ca_topic_score_codex":0.000550671,"about_ca_topic_score_gemma":0.0014512433,"teacher_disagreement_score":0.019557897,"about_ca_system_score_codex":0.00022754235,"about_ca_system_score_gemma":0.00025141783,"threshold_uncertainty_score":0.96281475},"labels":[],"label_agreement":null},{"id":"W4403541257","doi":"10.1016/j.clbc.2024.10.008","title":"Real World Evidence Study to Assess Incidence, Treatment Patterns, Clinical Outcomes, and Health Care Resource Utilization in Early-Stage, High-Risk HER2-Negative Breast Cancer in Alberta, Canada","year":2024,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Health Services; AstraZeneca (Canada); University of Calgary","funders":"AstraZeneca","keywords":"Medicine; Breast cancer; Incidence (geometry); Stage (stratigraphy); Oncology; Health care; Family medicine; Cancer; Internal medicine; Environmental health; Gynecology; Economic growth","score_opus":0.07110996056037043,"score_gpt":0.4306683173923992,"score_spread":0.35955835683202875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403541257","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9871408,0.001764414,0.000009872787,0.006707945,0.00079606747,0.0013211307,0.002204872,0.000024790097,0.00003011142],"genre_scores_gemma":[0.98784447,0.009030582,0.000048612685,0.0011824736,0.000554766,0.0006764533,0.00006345996,0.00006692394,0.00053223764],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9950276,0.0009027062,0.0013873228,0.0016383794,0.00040345307,0.00064053683],"domain_scores_gemma":[0.99778837,0.00073519914,0.0002864564,0.0006048994,0.0001650146,0.0004200526],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008005796,0.0005345426,0.001004904,0.00015269041,0.0001312868,0.00007953965,0.0002891376,0.00016698241,0.00006058227],"category_scores_gemma":[0.00015180782,0.00044139827,0.00015801225,0.00059116335,0.00015444623,0.000031885404,0.00033572916,0.00044286528,0.0000039399692],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007421763,0.0004616303,0.9309981,0.00006869615,0.00036993445,0.00006413752,0.00089146575,0.00019589649,4.0877214e-7,0.0000075305325,0.0007571049,0.06544296],"study_design_scores_gemma":[0.0022238218,0.0005824535,0.993258,0.0008367178,0.00012441933,0.0000059214926,0.0012586308,0.0000330597,0.000010411137,0.000003417616,0.0012540985,0.0004090446],"about_ca_topic_score_codex":0.9866797,"about_ca_topic_score_gemma":0.99874544,"teacher_disagreement_score":0.06503391,"about_ca_system_score_codex":0.0017697384,"about_ca_system_score_gemma":0.0028374018,"threshold_uncertainty_score":0.9998038},"labels":[],"label_agreement":null},{"id":"W4403909260","doi":"10.1016/j.clbc.2024.10.017","title":"Another Biosignature for Ductal Carcinoma In Situ—Have We Moved the Needle?","year":2024,"lang":"en","type":"letter","venue":"Clinical Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; In situ; Ductal carcinoma; Breast cancer; Carcinoma in situ; Surgery; Pathology; Carcinoma; Cancer; Internal medicine","score_opus":0.031110235486006967,"score_gpt":0.3331387168952305,"score_spread":0.30202848140922356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403909260","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009565003,0.02589742,0.000018681336,0.9562356,0.0032686237,0.0010518098,0.003255519,0.00003588729,0.0006714872],"genre_scores_gemma":[0.27586594,0.0027945815,0.00008190739,0.67754936,0.033753294,0.0016283242,0.0009507486,0.0002960467,0.0070798066],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971486,0.00014935165,0.0006398284,0.0011987987,0.0002294879,0.00063396984],"domain_scores_gemma":[0.9985952,0.00022827278,0.0002097274,0.0007631751,0.00014466503,0.000058971465],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00024005322,0.0006014456,0.00067575206,0.00007023334,0.00008948494,0.000059829592,0.0005382864,0.0015754562,0.000088057175],"category_scores_gemma":[0.000058347086,0.00039878246,0.00070426794,0.00014416815,0.0004263633,0.0000043062996,0.00029456773,0.0014544128,0.00003084917],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039423592,0.00007319112,0.008964578,0.00016788766,0.00065958255,0.00008168751,0.00008017643,0.0000037093293,0.00048007787,0.0000053420295,0.9840398,0.005049746],"study_design_scores_gemma":[0.0016560995,0.000116202355,0.03390279,0.00025849044,0.00039082606,0.00008170102,0.00007561324,0.00001211412,0.0005115791,0.00021875418,0.96219885,0.0005769506],"about_ca_topic_score_codex":0.00023193056,"about_ca_topic_score_gemma":0.00067468727,"teacher_disagreement_score":0.27868623,"about_ca_system_score_codex":0.00013319709,"about_ca_system_score_gemma":0.00036600232,"threshold_uncertainty_score":0.9998464},"labels":[],"label_agreement":null},{"id":"W4404600357","doi":"10.1016/j.clbc.2024.11.010","title":"Climate Therapy: Sustainability Solutions for Breast Cancer Care in the Anthropocene Era","year":2024,"lang":"en","type":"review","venue":"Clinical Breast Cancer","topic":"Advances in Oncology and Radiotherapy","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Health Research Board","keywords":"Breast cancer; Medicine; Health care; Anthropocene; Poverty; Climate change; Sustainability; Cancer; Economic growth; Environmental ethics; Ecology; Internal medicine","score_opus":0.08803724021212457,"score_gpt":0.5510367534266708,"score_spread":0.46299951321454624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404600357","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000023260454,0.971817,0.000043448737,0.01439921,0.0038085822,0.004030884,0.005609015,0.00009099639,0.0001775791],"genre_scores_gemma":[0.0003742216,0.9865665,0.00010084521,0.0025167444,0.00611865,0.0038918725,0.00014228161,0.00012843272,0.00016048964],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9955303,0.00058489793,0.0014976858,0.0011024952,0.00027229608,0.0010123258],"domain_scores_gemma":[0.9964947,0.0015341176,0.00039295637,0.00091826887,0.000475758,0.00018417714],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015648123,0.00064736244,0.0027503031,0.00014053931,0.0003415033,0.000036515914,0.0005181112,0.0010079445,0.0006818362],"category_scores_gemma":[0.00013187126,0.0003474887,0.0015920469,0.00067220017,0.001318027,0.000086997585,0.00011235915,0.0021111192,0.000020183274],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006970902,0.000443196,0.0019557865,0.015477261,0.00046626045,0.00005387595,0.0001457204,0.0000035781782,1.0702503e-8,0.00030031678,0.00528077,0.97517616],"study_design_scores_gemma":[0.0018414475,0.0003156698,0.006685459,0.010047743,0.002084094,0.0005007095,0.00028863864,0.000015657675,1.9925881e-8,0.000373857,0.97744083,0.00040589814],"about_ca_topic_score_codex":0.000119382086,"about_ca_topic_score_gemma":0.0002606224,"teacher_disagreement_score":0.97477025,"about_ca_system_score_codex":0.001896836,"about_ca_system_score_gemma":0.004657157,"threshold_uncertainty_score":0.9998977},"labels":[],"label_agreement":null},{"id":"W4404958104","doi":"10.1016/j.clbc.2024.11.020","title":"Breast Cancers With Intermediate Estrogen Receptor Expression: Characteristics, Prognosis and Treatment","year":2024,"lang":"en","type":"review","venue":"Clinical Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sault Area Hospital","funders":"","keywords":"Medicine; Breast cancer; Estrogen receptor; Oncology; Estrogen; Internal medicine; Expression (computer science); Cancer research; Gynecology; Cancer","score_opus":0.04153391169801477,"score_gpt":0.37359940888585663,"score_spread":0.33206549718784184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404958104","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014078527,0.9877291,0.0000027947879,0.00034373678,0.0012058463,0.00095358136,0.008247377,0.00006302618,0.000046712885],"genre_scores_gemma":[0.0011412735,0.9908123,0.00011129698,0.00011661386,0.003783597,0.0023679626,0.0010024472,0.00018842766,0.00047607356],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965118,0.0001875731,0.0009369157,0.0015967306,0.00021530928,0.0005516627],"domain_scores_gemma":[0.99826556,0.00007986793,0.0004977682,0.0006227817,0.00014087376,0.00039311458],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00013890823,0.00101823,0.0020784508,0.00007800133,0.00011871655,0.000093914576,0.00029358765,0.000567088,0.00011923769],"category_scores_gemma":[0.000017178667,0.00061871024,0.0006485899,0.0001736049,0.0006060329,0.000008844518,0.00035940585,0.00036968285,0.000072196686],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003890895,0.0001756334,0.0048160306,0.0019715847,0.0027235458,0.000031857435,0.000028487952,8.423627e-8,0.0000029851174,0.0000026371708,0.004966939,0.9848911],"study_design_scores_gemma":[0.001018808,0.00048046786,0.0028143153,0.01390004,0.0046110554,0.0006389501,0.000029376919,6.9789684e-7,0.000012089978,0.0000014066168,0.97566617,0.0008266442],"about_ca_topic_score_codex":0.00016786822,"about_ca_topic_score_gemma":0.000118762124,"teacher_disagreement_score":0.98406446,"about_ca_system_score_codex":0.00045969646,"about_ca_system_score_gemma":0.0012652718,"threshold_uncertainty_score":0.9996264},"labels":[],"label_agreement":null},{"id":"W4405663958","doi":"10.1016/j.clbc.2024.12.012","title":"Evaluation of the Impact of Breast Radiation Therapy on Quality of Life Requires Appropriate Instruments at Relevant Timepoints","year":2024,"lang":"en","type":"letter","venue":"Clinical Breast Cancer","topic":"Cancer survivorship and care","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre","funders":"","keywords":"Medicine; Breast cancer; Medical physics; Quality of life (healthcare); Radiation therapy; Quality (philosophy); Intensive care medicine; Cancer; Internal medicine; Nursing","score_opus":0.12088703593966212,"score_gpt":0.44470427840901094,"score_spread":0.32381724246934884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405663958","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9033755,0.001811455,8.5754004e-7,0.0875129,0.0024864608,0.0011667133,0.0030276105,0.000022222013,0.00059627404],"genre_scores_gemma":[0.97241753,0.001077224,0.0000023993086,0.02297338,0.0027239413,0.00008736197,0.00022754,0.00007181127,0.00041882787],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99360484,0.0013447772,0.0019348495,0.0005973877,0.002247958,0.00027020532],"domain_scores_gemma":[0.9954889,0.00042523592,0.0017538652,0.0010888245,0.0011253888,0.000117809606],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0034708858,0.00036527237,0.0013214118,0.00012689042,0.00003232793,0.000009586436,0.00029808117,0.00079518906,0.0013252095],"category_scores_gemma":[0.0005229149,0.00021585979,0.0013626603,0.000366279,0.0003890962,0.000053444182,0.000116260526,0.0011754287,0.000019294108],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008036188,0.00065677846,0.22524622,0.0017156381,0.004097503,0.0000033860076,0.00065744057,0.000083247716,0.0007382761,0.000010185455,0.23002279,0.52873236],"study_design_scores_gemma":[0.00407237,0.0005123862,0.9873512,0.0022041628,0.0009958139,0.00001665712,0.000017099068,0.0003152476,0.00025581685,0.00038816468,0.0036246036,0.00024649905],"about_ca_topic_score_codex":0.007042511,"about_ca_topic_score_gemma":0.00025023776,"teacher_disagreement_score":0.7621049,"about_ca_system_score_codex":0.00093013956,"about_ca_system_score_gemma":0.0025195626,"threshold_uncertainty_score":0.9995877},"labels":[],"label_agreement":null},{"id":"W4408165416","doi":"10.1016/j.clbc.2025.03.002","title":"Development of Machine Learning Models for Predicting Radiation Dermatitis in Breast Cancer Patients Using Clinical Risk Factors, Patient-Reported Outcomes, and Serum Cytokine Biomarkers","year":2025,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Effects of Radiation Exposure","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Ontario Institute for Cancer Research; University of Toronto","funders":"Temerty Faculty of Medicine, University of Toronto; Institute of Biomedical Science; Princess Margaret Cancer Foundation; University of Toronto; AstraZeneca","keywords":"Medicine; Breast cancer; Oncology; Internal medicine; Cancer","score_opus":0.03289625724407347,"score_gpt":0.35754594014717733,"score_spread":0.32464968290310386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408165416","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99484235,0.00037624285,0.0009692022,0.0008323869,0.0007757112,0.0011580945,0.00097613566,0.00005462097,0.000015261536],"genre_scores_gemma":[0.9961182,0.00048155308,0.002577874,0.00041669075,0.00009274118,0.00008522921,0.00017244746,0.000038666683,0.000016635027],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960799,0.000293553,0.0023694509,0.0005667598,0.00034205528,0.00034825742],"domain_scores_gemma":[0.996829,0.0011086063,0.001208817,0.00022796319,0.00040051842,0.00022513048],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009978847,0.00028575084,0.000935197,0.0002463019,0.00014913501,0.000018473767,0.00009003697,0.000316837,0.000034604935],"category_scores_gemma":[0.0010982486,0.00024687365,0.00021402641,0.00035717545,0.00012582724,0.00023178269,0.00009486823,0.00051582896,2.895794e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046069964,0.0003717106,0.81677186,0.00019385571,0.0006053632,0.0000016166707,0.00019829672,0.0012796674,0.000025656851,0.0000023041757,0.00008040628,0.18000856],"study_design_scores_gemma":[0.007470501,0.000106459294,0.89346325,0.0006179103,0.00035749548,0.0000044789604,0.0000615046,0.097434685,0.00005229003,0.000016105034,0.00023241146,0.00018292597],"about_ca_topic_score_codex":0.0012417809,"about_ca_topic_score_gemma":0.00032753314,"teacher_disagreement_score":0.17982563,"about_ca_system_score_codex":0.00035790165,"about_ca_system_score_gemma":0.0007146265,"threshold_uncertainty_score":0.99999833},"labels":[],"label_agreement":null},{"id":"W4409254738","doi":"10.1016/j.clbc.2025.04.007","title":"Expert Perspectives on Controversies and Critical Knowledge Gaps in Breast Cancer Management: Proceedings of the First Bridging the Gaps in Breast Cancer Symposium","year":2025,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Relay Therapeutics; National Cancer Institute; Gilead Sciences","keywords":"Medicine; Breast cancer; Bridging (networking); Cancer; Internal medicine","score_opus":0.009842488139956453,"score_gpt":0.32730691804731155,"score_spread":0.3174644299073551,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409254738","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.77482116,0.025150452,0.000003314821,0.19298302,0.0011682143,0.0009650121,0.0011092637,0.000028979604,0.0037705703],"genre_scores_gemma":[0.9753144,0.020214625,0.0000083016275,0.002827744,0.000648818,0.00065478386,0.0000028427062,0.000033136257,0.00029537137],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976693,0.000081257145,0.0005884584,0.00091143325,0.0002176015,0.00053197355],"domain_scores_gemma":[0.99884695,0.0002608246,0.00015978722,0.00034501046,0.00030082167,0.00008658329],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00032089755,0.00039361417,0.0005496136,0.00010423344,0.00023058472,0.000053270833,0.0004548403,0.00020548637,0.000056930432],"category_scores_gemma":[0.000065505956,0.00026377145,0.00021932114,0.0004587865,0.0011443559,0.000025867095,0.0005479122,0.0003672927,0.0000015010322],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024203386,0.0008910086,0.9627522,0.0003501956,0.0006486532,0.0000048488473,0.0014317301,0.000042548796,0.0008636841,0.002079328,0.016054634,0.012460783],"study_design_scores_gemma":[0.0031236089,0.00003685905,0.98612255,0.0016964553,0.00016735136,0.000029212688,0.003028019,0.000060021328,0.00046487877,0.00006683892,0.004906414,0.0002978218],"about_ca_topic_score_codex":0.002113458,"about_ca_topic_score_gemma":0.0023956043,"teacher_disagreement_score":0.2004932,"about_ca_system_score_codex":0.00035547474,"about_ca_system_score_gemma":0.0002095023,"threshold_uncertainty_score":0.99998146},"labels":[],"label_agreement":null},{"id":"W4409257721","doi":"10.1016/j.clbc.2025.04.001","title":"High Ki-67 expression is associated with increased risk of distant recurrence in Oncotype Dx low risk breast cancer","year":2025,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Medicine; Breast cancer; Oncology; Internal medicine; Gynecology; Cancer","score_opus":0.009806990534439437,"score_gpt":0.31580114123425934,"score_spread":0.3059941506998199,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409257721","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98810375,0.0023033693,0.00008846281,0.0009559242,0.0005871765,0.00035544264,0.0074342513,0.000025630052,0.00014602451],"genre_scores_gemma":[0.99146193,0.0071621975,0.00011238206,0.00046272125,0.0002618367,0.0002419218,0.00013666917,0.000036341233,0.00012398255],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970511,0.0004299944,0.00081275316,0.0009483205,0.00029233284,0.0004654737],"domain_scores_gemma":[0.99780536,0.0002666031,0.00069729454,0.0006556258,0.00041637744,0.00015871515],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00048198525,0.00040376792,0.00076060253,0.00007784085,0.00013202918,0.000018261711,0.00034754194,0.00036509542,0.00019637123],"category_scores_gemma":[0.00030007807,0.00030871847,0.00022322952,0.00049013854,0.0004806223,0.000014106512,0.00024891828,0.00044877693,0.000004287797],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036192464,0.0008020894,0.96481484,0.000049852308,0.00072558474,0.0000073328406,0.000059874317,0.00010554311,0.0012899024,0.000010066847,0.0031748328,0.025340829],"study_design_scores_gemma":[0.004686114,0.00014458869,0.9868219,0.0014309698,0.00037327115,0.000004297217,0.00006254026,0.000052592335,0.0054715932,0.00011389723,0.000494271,0.00034397433],"about_ca_topic_score_codex":0.011829374,"about_ca_topic_score_gemma":0.006843521,"teacher_disagreement_score":0.024996854,"about_ca_system_score_codex":0.00024082477,"about_ca_system_score_gemma":0.00071010436,"threshold_uncertainty_score":0.9999365},"labels":[],"label_agreement":null},{"id":"W4409316409","doi":"10.1016/j.clbc.2025.04.006","title":"Patient Reported Outcomes in Breast Cancer: A Plea for the Silent and Forgotten","year":2025,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Breast Implant and Reconstruction","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; University of British Columbia, Okanagan Campus; Kelowna General Hospital","funders":"","keywords":"Medicine; Plea; Breast cancer; Cancer; Family medicine; Oncology; Gynecology; Internal medicine; Law","score_opus":0.03351985211653033,"score_gpt":0.3741289316235006,"score_spread":0.3406090795069703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409316409","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9381369,0.00083439675,0.00005435541,0.05736426,0.0020702642,0.0009877917,0.00037606346,0.000040947038,0.00013503159],"genre_scores_gemma":[0.9956342,0.000675655,0.00007078468,0.0021391613,0.00037142404,0.00041434844,0.00001166658,0.000015701651,0.00066708087],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99843645,0.00004082939,0.0007508395,0.00036709572,0.00013428365,0.00027047354],"domain_scores_gemma":[0.99877656,0.0005133285,0.00018981948,0.000261267,0.00014207361,0.00011696495],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003191638,0.00016422964,0.00050622126,0.00007764856,0.00009311113,0.000018510262,0.00006649633,0.0001662563,0.00010006125],"category_scores_gemma":[0.00005101977,0.00009569072,0.00018659516,0.00018204241,0.00020743578,0.00005051435,0.000057756937,0.00029596547,0.0000014879223],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00076199,0.00009047663,0.5425069,0.000045950488,0.0001813932,0.0000047032026,0.000025983909,0.0000024893423,0.000008288858,0.000045381912,0.0016607068,0.45466575],"study_design_scores_gemma":[0.003471851,0.00004831862,0.98931706,0.0003895427,0.00032895058,0.0025076254,0.00017338306,0.0004904559,0.000011482861,0.00015507937,0.0029945327,0.00011173783],"about_ca_topic_score_codex":0.0012644967,"about_ca_topic_score_gemma":0.0005481724,"teacher_disagreement_score":0.45455402,"about_ca_system_score_codex":0.00011537878,"about_ca_system_score_gemma":0.00035131795,"threshold_uncertainty_score":0.39021543},"labels":[],"label_agreement":null},{"id":"W4409879700","doi":"10.1016/j.clbc.2025.04.017","title":"Safety and Effectiveness of Adriamycin and Cyclophosphamide Followed by Dose Dense (Every 2 Weeks) Paclitaxel Given With Trastuzumab as Neoadjuvant Treatment in HER2-Positive Early-Stage Breast Cancer","year":2025,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St Mary's Hospital Centre; McGill University; Princess Margaret Cancer Centre","funders":"University Health Network","keywords":"Medicine; Trastuzumab; Breast cancer; Regimen; Oncology; Anthracycline; Internal medicine; Discontinuation; Neoadjuvant therapy; Cancer","score_opus":0.005940179759944021,"score_gpt":0.2996759952733951,"score_spread":0.29373581551345107,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409879700","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9857512,0.0085263755,0.000050604576,0.0011975324,0.00019738798,0.00083569693,0.0032621883,0.000015469022,0.00016355718],"genre_scores_gemma":[0.98837245,0.010348605,0.000045092114,0.00023450225,0.000091223825,0.0003921404,0.00008260789,0.00004050305,0.00039288684],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99744093,0.0003801517,0.00058857625,0.0009889881,0.00016884512,0.0004325284],"domain_scores_gemma":[0.9987388,0.00033208926,0.00021908093,0.00036292564,0.0001619598,0.00018510305],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00031340602,0.00047927108,0.00091874093,0.000063884196,0.00011151286,0.00002379097,0.00012844198,0.00026871994,0.000027915296],"category_scores_gemma":[0.00003533532,0.00037247667,0.0001566022,0.00022553428,0.000594051,0.00001945343,0.00016854712,0.00017905806,0.000001192756],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02514126,0.00081709516,0.9335729,0.00013760773,0.0014398189,0.000045398916,0.00017357539,0.000047839883,0.003663541,0.000031589858,0.00016344698,0.034765963],"study_design_scores_gemma":[0.011666878,0.00085670024,0.9810554,0.00080210064,0.00033684893,0.000043814518,0.00017999005,0.0000074227323,0.0038943016,0.0000279326,0.00076998316,0.00035867436],"about_ca_topic_score_codex":0.013785185,"about_ca_topic_score_gemma":0.0032756075,"teacher_disagreement_score":0.04748249,"about_ca_system_score_codex":0.00031907228,"about_ca_system_score_gemma":0.00047019828,"threshold_uncertainty_score":0.99987274},"labels":[],"label_agreement":null},{"id":"W4409973230","doi":"10.1016/j.clbc.2025.04.019","title":"Navigating Endocrine Sensitivity Assessment in Nonmetastatic Breast Cancer Through Early On-Treatment Ki67 Understanding","year":2025,"lang":"en","type":"review","venue":"Clinical Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"Ministério da Saúde; Fundação de Amparo à Pesquisa do Estado de Minas Gerais; Department of Science and Technology, Ministry of Science and Technology, India; Conselho Nacional de Desenvolvimento Científico e Tecnológico; Coordenação de Aperfeiçoamento de Pessoal de Nível Superior; Instituto Nacional de Ciência e Tecnologia em Teranóstica e Nanobiotecnologia; Ministry of Health","keywords":"Medicine; Breast cancer; Metastatic breast cancer; Oncology; Endocrine system; Internal medicine; Cancer; Gynecology; Hormone","score_opus":0.1112746711518572,"score_gpt":0.48301769329686145,"score_spread":0.37174302214500426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409973230","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013964236,0.9839333,0.0002795332,0.0020343724,0.0019206103,0.00195215,0.007821797,0.000063575986,0.0005982296],"genre_scores_gemma":[0.015847145,0.97980756,0.00026349805,0.00046686662,0.0013042134,0.0015024062,0.00045749597,0.00012609427,0.0002247103],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99436593,0.00088238175,0.0015463704,0.0018680765,0.00040227306,0.00093495956],"domain_scores_gemma":[0.9970376,0.00091208564,0.0007634604,0.000940921,0.00013302872,0.00021292386],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00045499968,0.0012463494,0.0030713803,0.00007522535,0.00022616306,0.00007745878,0.00030735115,0.0004988431,0.00010637572],"category_scores_gemma":[0.00006974425,0.00095765054,0.0012028276,0.0005060243,0.0003641272,0.00001810079,0.00041042562,0.00107679,0.000018366445],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023986878,0.0010385979,0.014277225,0.003192556,0.0029131696,0.000181073,0.00006478244,0.000083561456,0.0000030059875,0.00014375875,0.00040931095,0.9774531],"study_design_scores_gemma":[0.020404402,0.0020448733,0.12591335,0.23458849,0.016235482,0.0014430464,0.0008370961,0.00009362963,0.00004895976,0.0005316859,0.5900501,0.007808889],"about_ca_topic_score_codex":0.0043318123,"about_ca_topic_score_gemma":0.0024479062,"teacher_disagreement_score":0.9696442,"about_ca_system_score_codex":0.00298752,"about_ca_system_score_gemma":0.002028202,"threshold_uncertainty_score":0.9992874},"labels":[],"label_agreement":null},{"id":"W4412974461","doi":"10.1016/j.clbc.2025.07.013","title":"Appropriate Treatment for Stage 1 and 2 Her2-Positive and Triple-Negative Breast Cancer by Immigration Status in Ontario, Canada","year":2025,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre; Institute for Clinical Evaluative Sciences","funders":"Institute for Clinical Evaluative Sciences; Industrial Research and Consultancy Centre; Ontario Ministry of Health and Long-Term Care; Johns Hopkins University","keywords":"Medicine; Stage (stratigraphy); Breast cancer; Immigration; Triple negative; Oncology; Triple-negative breast cancer; Cancer; Internal medicine; Gynecology; Demography","score_opus":0.042806962429829294,"score_gpt":0.3755415888982367,"score_spread":0.3327346264684074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412974461","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98474514,0.0019643132,0.00009362246,0.0078866165,0.0003861282,0.0012278153,0.0033145505,0.000015222893,0.00036661013],"genre_scores_gemma":[0.9904972,0.001709264,0.00015067257,0.002647616,0.00012311984,0.00045110506,0.00008732754,0.000015323692,0.0043183938],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99827534,0.0000701705,0.00051906996,0.00055181235,0.00018658688,0.00039701298],"domain_scores_gemma":[0.9989519,0.0002947806,0.00014341033,0.00015096477,0.00019689047,0.0002620714],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020644447,0.00023439429,0.00058126735,0.0000486699,0.00009548677,0.00003119442,0.000047861216,0.00013430203,0.00018284953],"category_scores_gemma":[0.000048583424,0.00018926508,0.00007219376,0.00016586608,0.00014615018,0.00011612898,0.000034484234,0.0002490173,2.8424958e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004343912,0.000125386,0.8305256,0.00005361455,0.0002391083,0.000016122502,0.00033665317,0.000013968171,0.000061456136,0.000053374737,0.0048179664,0.15941288],"study_design_scores_gemma":[0.006960245,0.0003059713,0.9812822,0.00050107675,0.00020971602,0.000012776145,0.000706967,0.00041890185,0.00013247239,0.00006925502,0.009213595,0.00018682609],"about_ca_topic_score_codex":0.9935049,"about_ca_topic_score_gemma":0.9973337,"teacher_disagreement_score":0.15922605,"about_ca_system_score_codex":0.0022979095,"about_ca_system_score_gemma":0.003702269,"threshold_uncertainty_score":0.7718006},"labels":[],"label_agreement":null},{"id":"W620273790","doi":"10.1016/j.clbc.2015.06.003","title":"Timing of Postmastectomy Reconstruction Does Not Impair Breast Cancer-Specific Survival: A Population-Based Study","year":2015,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Breast Implant and Reconstruction","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University; Nova Scotia Health Authority; Izaak Walton Killam Health Centre","funders":"Canadian Cancer Society","keywords":"Breast reconstruction; Medicine; Mastectomy; Breast cancer; Hazard ratio; Proportional hazards model; Population; Survival analysis; Confidence interval; Oncology; Adjuvant therapy; Internal medicine; Cancer; Surgery","score_opus":0.08730859380808599,"score_gpt":0.3764642661218802,"score_spread":0.28915567231379424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W620273790","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904086,0.00011813446,0.00005534701,0.002189037,0.0054741274,0.0007582008,0.00069611776,0.00014611083,0.00015434258],"genre_scores_gemma":[0.99705434,0.00003588101,0.00029591436,0.00010553662,0.0021331813,0.0000719505,0.000045621407,0.0000498135,0.00020777006],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969082,0.00026404645,0.0012972493,0.00061545137,0.000544524,0.00037055492],"domain_scores_gemma":[0.9975271,0.00025470875,0.00057646533,0.00045565117,0.00071972987,0.00046629817],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009175993,0.00030798223,0.0009262643,0.00020743515,0.000095837306,0.000027667093,0.00014386684,0.00027409816,0.00082827936],"category_scores_gemma":[0.000041142346,0.00021804722,0.00029859933,0.00040686683,0.00020440054,0.00019534046,0.000045367065,0.00047717095,0.000019669293],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002157842,0.0003821866,0.6510296,0.000050492104,0.00013938994,0.000007639112,0.000050825307,0.000032326752,0.000098755074,0.000005288967,0.0001527032,0.34589297],"study_design_scores_gemma":[0.006642129,0.00024846251,0.987004,0.00043142407,0.0003043843,0.0033989178,0.0008322128,0.00061117526,0.00010830794,0.000025822112,0.00011234843,0.0002808204],"about_ca_topic_score_codex":0.0037401712,"about_ca_topic_score_gemma":0.0009944593,"teacher_disagreement_score":0.34561214,"about_ca_system_score_codex":0.0003379501,"about_ca_system_score_gemma":0.0007387917,"threshold_uncertainty_score":0.9069078},"labels":[],"label_agreement":null},{"id":"W7117512937","doi":"10.1016/j.clbc.2025.12.009","title":"Canadian Women’s Attitudes Toward Receiving Personalized Breast Cancer Risk Information: Insights From the PERSPECTIVE I&I Project","year":2025,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; Ministère de la Santé et des Services Sociaux (Québec); Université Laval; McMaster University; Cancer Care Ontario; Women's College Hospital; University Health Network; University of Toronto; Public Health Ontario","funders":"Cancer Research UK Cambridge Institute, University of Cambridge; Centre Hospitalier Universitaire de Québec; Génome Québec; Fondation du cancer du sein du Québec; Ontario Research Foundation; Fondation CHU de Québec; Cancer Research UK; Ministère de l'Économie, de la Science et de l'Innovation - Québec; Canadian Institutes of Health Research; Genome Canada; Université Laval","keywords":"Perspective (graphical); Breast cancer; Health care; Breast cancer screening; Adaptation (eye); Risk assessment; MEDLINE","score_opus":0.023976090620450412,"score_gpt":0.35556392115808116,"score_spread":0.33158783053763075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7117512937","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95017517,0.008563337,0.0004316252,0.027027115,0.0029124941,0.0009258852,0.0069086584,0.00005800398,0.0029976887],"genre_scores_gemma":[0.98400474,0.004271763,0.00022668068,0.0078923255,0.0015238159,0.0008842625,0.00014482178,0.000026389966,0.0010251788],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979417,0.000276891,0.00054301607,0.0005754573,0.00022287694,0.00044010626],"domain_scores_gemma":[0.99812967,0.00015830302,0.00023602328,0.000601332,0.0006740447,0.00020066032],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003474756,0.00027828867,0.0003167384,0.00008898198,0.00037989556,0.00013666606,0.0005420294,0.0003099557,0.00077555067],"category_scores_gemma":[0.00030402595,0.00021298065,0.0002111502,0.0004044418,0.000386665,0.000034864042,0.00016790046,0.00045795605,0.000039008457],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013636167,0.00016821196,0.7364117,0.000061447914,0.0026802453,0.000003034265,0.008093083,0.0004727862,0.00042891203,0.0007014364,0.16135225,0.088263266],"study_design_scores_gemma":[0.0012775597,0.000029286113,0.68227226,0.00013055211,0.00012630198,0.000009905208,0.0029302961,0.00004559788,0.00006426362,0.00042932195,0.31234023,0.00034441662],"about_ca_topic_score_codex":0.23635554,"about_ca_topic_score_gemma":0.29973295,"teacher_disagreement_score":0.150988,"about_ca_system_score_codex":0.0020035873,"about_ca_system_score_gemma":0.0060752337,"threshold_uncertainty_score":0.9995594},"labels":[],"label_agreement":null},{"id":"W955520680","doi":"10.1016/j.clbc.2015.06.010","title":"Invasive Pleomorphic Lobular Carcinoma of the Breast: Pathologic, Clinical, and Therapeutic Considerations","year":2015,"lang":"en","type":"review","venue":"Clinical Breast Cancer","topic":"Salivary Gland Tumors Diagnosis and Treatment","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Lobular carcinoma; Medicine; Invasive lobular carcinoma; Pathology; Breast cancer; Estrogen receptor; Carcinoma; Breast carcinoma; Oncology; Cancer; Disease; Internal medicine; Ductal carcinoma; Invasive ductal carcinoma","score_opus":0.22140273591805448,"score_gpt":0.4444355650434185,"score_spread":0.22303282912536404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W955520680","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012429527,0.9812834,5.2208605e-7,0.0021375865,0.00091719994,0.00164502,0.0013921022,0.000026911628,0.00016769454],"genre_scores_gemma":[0.11212857,0.8851093,0.000035973622,0.0014713476,0.0007807407,0.00026934134,0.00005948782,0.00005234927,0.00009290106],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99551296,0.0010306933,0.002017556,0.0007754444,0.00035712443,0.00030620483],"domain_scores_gemma":[0.99463373,0.0025615504,0.00097324257,0.0010068567,0.00042236742,0.00040222218],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011064329,0.00050602463,0.0034838163,0.000065476204,0.00011013537,0.00002759568,0.00019628688,0.0006121956,0.00046457598],"category_scores_gemma":[0.00045760666,0.00025906574,0.0012377598,0.00022736646,0.0012062388,0.000029633862,0.00021506257,0.0008740127,0.000039723847],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006457436,0.0009789673,0.6454238,0.0019472254,0.000994011,0.00029562836,0.000021687165,1.7747814e-7,2.1694435e-8,0.00027855622,0.003077886,0.34691742],"study_design_scores_gemma":[0.0040951697,0.0006766891,0.79354274,0.012434747,0.012469757,0.010456937,0.000028408169,0.0000033735093,4.3141245e-7,0.0009793139,0.16483766,0.00047479212],"about_ca_topic_score_codex":0.000121465826,"about_ca_topic_score_gemma":0.00005400789,"teacher_disagreement_score":0.34644264,"about_ca_system_score_codex":0.00008914421,"about_ca_system_score_gemma":0.0027430528,"threshold_uncertainty_score":0.9999862},"labels":[],"label_agreement":null}]}